ChemBuyersGuide.com

+1-212-348-5610

Chemical Search


























SynFine Research Inc.




Country: Canada

SynFine Research Inc.
120 Newkirk Road
Unit 19
Richmond Hill, Ontario
L4C 9S7
Canada


Phone: 905-737-2702
Phone 2: (866) SYNFINE
FAX: 905-737-6299
E-Mail:E-Mail this Supplier

Contact: Sandy Broome

https://www.synfine-standards.com/

SynFine Research, Inc. is an independent Contract Research and Development Organization serving 200+ customers in over 40 countries on all continents and spread throughout the chemical discipline (global pharmaceutical, biotechnology, specialty fine chemical industry, clinical and bio-analytical CROs, universities, hospitals and related research institutions) with a vast variety of custom synthesized compounds (e.g. stable labelled isotopes, metabolites, pharmaceutical related substances, and impurities in mg to g scale) and active pharmaceutical ingredients (APIs, at g scale) as Certified Reference Standards for research and analytical purposes.

SynFine’s core competency is organic synthesis process research and development complemented by integrated state-of-the-art analytical services (NMR, MS, HPLC-MS, GC-MSD), and is based on classical and modern chemical methodologies with a foundation that enables us to meet the challenges of the future in scientific evolution. We are dedicated to preserving a strong scientific base that would maintain our competitive edge and SynFine’s team of highly experienced scientists can effectively support your research endeavours.

Our commitment to excellence in science is complemented by uncompromised product quality, absolute confidentiality, dependable project management, timeliness of delivery, and responsiveness of customer service.

SynFine Research Inc. – services, which span the realm of medicinal chemistry
… from discovery to market …


Product List: 8,328

PON:Page:1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |


 


Product List

( R R 1S 2S)-1 2-DIHYDRO- 6-TRIHYDROXY-2-METHYL-1-NAPHTHALENEHEPTANOIC ACID SODIUM SALT(PRAVASTATIN IMPURITY)
CAS:720666-74-0
Formula: C18H23NaO5
SR-01146-012
MW: 342.36
R 195
( R S)-REL-BEDAQUILINE
CAS:654653-93-7
Formula: C32H31BrN2O2
SR-02408-003
MW: 555.5
(?R ?S)-rel-6-Bromo-?-[2-(dimethylamino)ethyl]-2-methoxy-?-1-naphthalenyl-?-phenyl-3-quinolineethanol
( R)- -METHYL-N-[[3-(TRIFLUOROMETHYL)PHENYL]METHYL]-1-NAPHTHALENEMETHANAMINE HYDROCHLORIDE
CAS:1229225-42-6
Formula: C20H19ClF3N
SR-01029-018
MW: 365.82
(R)-?-Methyl-N-[3-[3-(trifluoromethyl)phenyl]methyl]-1-naphthalenemethaneamine Hydrochloride;
( R)- -METHYL-N-[3-(3-METHYLPHENYL)PROPYL]-1-NAPHTHALENEMETHANAMINE HYDROCHLORIDE
Formula: C22H26ClN
SR-01029-015
MW: 339.9
( R)- -METHYL-N-[3-[3-(TRIFLUOROMETHYL)PHENYL]PROPYL]-2-NAPHTHALENEMETHANAMINE
Formula: C22H22F3N
SR-01029-011
MW: 357.41
( R)- -METHYL-N-[3-[4-(TRIFLUOROMETHYL)PHENYL]PROPYL]-1-NAPHTHALENEMETHANAMINE
CAS:1428185-71-0
Formula: C22H22F3N
SR-01029-013
MW: 357.41
( R)-(1S 2S 3R 5S)-PINANEDIOL-1-AMINO-3-METHYLBUTANE-1-BORONATE HYDROCHLORIDE
CAS:779357-85-6
Formula: C15H29BClNO2
SR-01529-012
MW: 301.66
"(?R 3aS 4S 6S 7aR)-Hexahydro-3a 5 5-trimethyl-?-(2-methylpropyl)-4 6-methano-1 3 2-benzodioxaborole-2-methanamine Hydrochloride; 3-Methyl-1-(2 9 9-trimethyl-3 5-dioxa-4-boratricyclo[6.1.1.02 6]dec-4-yl)butylamine Hydrochloride; "
( R)-(1S 2S 3R 5S)-PINANEDIOL-1-AMINO-3-METHYLBUTANE-1-BORONATE TRIFLUOROACETIC ACID SALT
CAS:179324-87-9
Formula: C17H29BF3NO4
SR-01529-015
MW: 379.22
(?R 3aS 4S 6S 7aR)-
( R)-5 6-DIHYDRO- -METHYL-N-[3-[3-(TRIFLUOROMETHYL)PHENYL]PROPYL]-1-NAPHTHALENEMETHANAMINE
CAS:802918-36-1
Formula: C22H24F3N
SR-01029-016
MW: 359.43
( R)-7 8-DIHYDRO- -METHYL-N-[3-[3-(TRIFLUOROMETHYL)PHENYL]PROPYL]-1-NAPHTHALENEMETHANAMINE
CAS:802918-35-0
Formula: C22H24F3N
SR-01029-017
MW: 359.43
( R)-N-[3-[3-(DIFLUOROMETHYL)PHENYL]PROPYL]- -METHYL-1-NAPHTHALENEMETHANAMINE
CAS:1025064-41-8
Formula: C22H23F2N
SR-01029-009
MW: 339.42
( R)-THREO-DIHYDRO BUPROPION MALEATE
Formula: C17H24ClNO5
SM-01018-004
MW: 357.83
(?R)-3-Chloro-?-[(1R)-1-[(1 1-dimethylethyl)amino]ethyl]-benzenemethanol Maleate
( S R)-BEDAQUILINE
CAS:843663-66-1
Formula: C32H31BrN2O2
SA-02408-002
MW: 555.5
(?S ?R)-6-Bromo-?-[2-(dimethylamino)ethyl]-2-methoxy-?-1-naphthalenyl-?-phenyl-3-Quinolineethanol
( S S)- -[(2-AMINOPHENYL)THIO]- -HYDROXY-4-METHOXYBENZENEPROPANOIC ACID
CAS:42399-48-4
Formula: C16H17NO4S
SR-01052-010
MW: 319.38
[S-(R* R*)]-?-[(2-Aminophenyl)thio]-?-hydroxy-4-methoxybenzenepropanoic Acid; d-threo-2-Hydroxy-3-(2-aminophenylthio)-3-(4-methoxyphenyl)propionic Acid
( S)- -[(1 1-TERT-BUTYLOXYCARBONYL)AMINO]-4-BENZYLOXY-BENZENEPROPIONIC ALDEHYDE
Formula: C21H25NO4
SR-02017-017
MW: 355.43
(?S)-?-[[(1 1-Dimethylethoxy)carbonyl]amino]-4-phenylmethoxy-benzenepropionic Aldehyde
( S)-3-[2-(2 6-DIMETHYLPHENOXY)ACETYL]-N-[(1S 3S 4S)-4-[[2-(2 6-DIMETHYLPHENOXY)ACETYL]AMINO]-3-HYDROXY-5-PHENYL-1-(PHENYLMETHYL
CAS:943250-66-6
Formula: C47H58N4O7
SR-02403-012
MW: 790.99
Lopinavir Impurity R
( S)-CYCLOHEXANEBUTANOIC ACID -[[(1S)-1-CARBOXYETHYL]AMINO]CYCLOHEXANEBUTANOIC ACID -ETHYL ESTER
CAS:460720-14-3
Formula: C15H27NO4
SR-01053-021
MW: 285.38
( S)-N-DEMETHYL DEPRENYL
CAS:56862-30-7
Formula: C12H15N
SM-01162-005
MW: 173.25
(?S)-?-Methyl-N-2-propynylbenzeneethanamine; (S)-?-Methyl-N-2-propynylbenzeneethanamine
( S)-THREO-DIHYDRO BUPROPION HYDROCHLORIDE
CAS:292055-71-1
Formula: C13H21Cl2NO
SR-01018-015 
MW: 278.22
(?S)-3-Chloro-?-[(1S)-1-[(1 1-dimethylethyl)amino]ethyl]benzenemethanol Hydrochloride
((4S)-4-CYCLOHEXYL-1-[(R)-[(S)-1-HYDROXY-2-METHYLPROPOXY](4-PHENYLBUTYL)PHOSPHINYL]ACETYL-D-PROLINE PROPIONATE (ESTER) HEMIBARIU
Formula: C30H46NO7P·0.5Ba·1.5H2O
SR-01074-009
MW: 658.34
USP Fosinopril Related Compound B; (D-Proline) Fosinopril Hemibarium Salt Sesquihydrate;
((E)-5-((M-[(2-CARBOXYETHYL)CARBAMOYL]PHENYL)AZO)-2-SALICYLIC ACID)
Formula: C17H15N3O6
SR-01011-018
MW: 357.32
USP Balsalazide Related Compound B;
(+)- -ACETYLMETHADOL HYDROCHLORIDE
CAS:53757-35-0
Formula: C23H32ClNO2
SR-01236-029
MW: 389.96
###############################################################################################################################################################################################################################################################
(+)- -METHADOL
CAS:17199-54-1
Formula: C21H29NO
SR-01236-009
MW: 311.46
(?R)-
(+)- -METHADOL-D3
Formula: C21H26D3NO
SI-01236-010
MW: 314.48
(?R)-
(+)- -NORACETYLMETHADOL HYDROCHLORIDE
Formula: C22H30ClNO2
SR-01236-030
MW: 375.93
"[R-(R* R*)]-?-ethyl-?-[2-(methylamino)propyl]-?-phenylbenzeneethanol Acetate (Ester) Hydrochloride; ?-d-Noracetylmethadol;"
(+)-(14 )-DIHYDROVINPOCETINE
CAS:57517-54-1
Formula: C22H28N2O2
SR-02231-009
MW: 352.47
###############################################################################################################################################################################################################################################################
(+)-(14 )-DIHYDROVINPOCETINE-D5
Formula: C22H23D5N2O2
SI-02231-010
MW: 357.5
###############################################################################################################################################################################################################################################################
(+)-11-NOR- 9-TETRAHYDRO CANNABINOL-9-CARBOXYLIC ACID
CAS:114028-39-6
Formula: C21H28O4
SM-01324-018
MW: 344.44
"(6aS 10aS)-6a 7 8 10a-Tetrahydro-1-hydroxy-6 6-dimethyl-3-pentyl-6H-dibenzo[b d]pyran-9-carboxylic Acid; (6aS-trans)-6a 7 8 10a-Tetrahydro-1-hydroxy-6 6-dimethyl-3-pentyl-6H-dibenzo[b d]pyran-9-carboxylic Acid; "
(+)-CIS-VINCAMINIC ACID ETHYL ESTER
CAS:40163-56-2
Formula: C22H28N2O3
SR-02231-007
MW: 368.47
###############################################################################################################################################################################################################################################################
(+)-CIS-VINCAMINIC ACID ETHYL-D5 ESTER
Formula: C22H23D5N2O3
SI-02231-013
MW: 373.5
###############################################################################################################################################################################################################################################################
(+)-DONEPEZIL HYDROCHLORIDE
CAS:142097-05-0
Formula: C24H30ClNO3
SA-01229-012
MW: 415.95
(R)-2 3-dihydro-5 6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-Inden-1-one Hydrochloride;
(+)-GALLOCATECHIN
CAS:970-73-0
Formula: C15H14O7
SR-02374-004
MW: 306.27
(2R 3S)-2-(3 4 5-Trihydroxyphenyl)chroman-3 5 7-triol; (2R-trans)-3 4-Dihydro-2-(3 4 5-trihydroxyphenyl)-2H-1-benzopyran-3 5 7-triol; Gallocatechol; d-Gallocatechol; (+)-Gallocatechol; (2R 3S)-(+)-Gallocatechin; Gallocatechin; NSC 674038; d-Gallocatechin
(+)-GALLOCATECHIN GALLATE-13C3
Formula: C1913C3H18O11
SI-02374-007
MW: 461.35
###############################################################################################################################################################################################################################################################
(+)-GALLOCATECHIN-13C3
Formula: C1213C3H14O7
SI-02374-005
MW: 309.25
###############################################################################################################################################################################################################################################################
(+)-N O-DIDESMETHYL TRAMADOL
CAS:144830-18-2
Formula: C14H21NO2
SR-01178-011
MW: 235.32
"3-[(1R 2R)-1-Hydroxy-2-[(methylamino)methyl]cyclohexyl]-phenol;(1R-cis)-3-[1-Hydroxy-2-[(methylamino)methyl]cyclohexyl]-phenol;"
(+)-NEBIVOLOL
CAS:118457-15-1
Formula: C22H25F2NO4
SR-01260-004
MW: 405.44
###############################################################################################################################################################################################################################################################
(+)-NEBIVOLOL O- -D-GLUCURONIDE(MIXTURE OF 2 DIASTEREOMERS)
Formula: C28H33F2NO10
SM-01260-017
MW: 581.56
(1R)-1-[(2R)-6-fluoro-3 4-dihydro-2H-1-benzopyran-2-yl]-2-[[(2R)-2-[(2S)-6-fluoro-3 4-dihydro-2H-1-benzopyran-2-yl]-2-hydroxyethyl]amino]ethyl
(+)-NEBIVOLOL-D4 HYDROCHLORIDE
Formula: C22H22D4ClF2NO4
SI-01260-005
MW: 445.92
###############################################################################################################################################################################################################################################################
(+)-O-DESMETHYL TRAMADOL HYDROCHLORIDE
CAS:148262-77-5
Formula: C15H24ClNO2
SM-01178-007
MW: 285.81
"3-[(1R 2R)-2-[(Dimethylamino)methyl]-1-hydroxycyclohexyl]phenol Hydrochloride;(1R-cis)-3-[2-[(Dimethylamino)methyl]-1-hydroxycyclohexyl]phenol Hydrochloride; EM 723;"
(+)-PSEUDOEPHEDRINE HYDROCHLORIDE
CAS:345-78-8
Formula: C10H16ClNO
SA-01468-000
MW: 201.69
(?S)-?-[(1S)-1-(Methylamino)ethyl]benzenemethanol Hydrochloride; (+)-Pseudoephedrine Hydrochloride;
(+)-TIANEPTINE MONOSODIUM SALT
CAS:169293-32-7
Formula: C21H24ClN2NaO4S
SM-01365-005
MW: 458.93
(+)-7-[(3-Chloro-6 11-dihydro-6-methyl-5 5-dioxidodibenzo[c f][1 2]thiazepin-11-yl)amino]heptanoic Acid Monosodium Salt
(+)-TRAMADOL HYDROCHLORIDE
CAS:148229-78-1
Formula: C16H26ClNO2
SA-01178-002
MW: 299.84
(1R 2R)-2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Hydrochloride; (1R-cis)-2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Hydrochloride; (+)-trans-Tramadol Hydrochloride; E 382;
(+/-)-11-HYDROXY- 9-TETRAHYDROCANNABINOL-D3
Formula: C21H27D3O3
SI-01324-003
MW: 333.48
(+/-)-11-Hydroxy-?9-Tetrahydrocannabinol-d3
(+/-)-4-CHLOROPHENYL-5-[(3 4-ISOPROPYLIDINE)-2-METHYLPYRIDINE]METHANOL
CAS:133545-64-9
Formula: C17H18ClNO3
SR-01492-004
MW: 319.78
(+/-)-?-(4-Chlorophenyl)-2 2 8-trimethyl-4H-1 3-dioxino[4 5-c]pyridine-5-methanol;
(+/-)-4-CHLOROPHENYL-5-[(3 4-ISOPROPYLIDINE)-2-METHYLPYRIDINE]METHANOL-D4
Formula: C17H14D4ClNO3
SI-01492-003
MW: 323.81
(+/-)-?-(4-Chlorophenyl)-2 2 8-trimethyl-4H-1 3-dioxino[4 5-c]pyridine-5-methanol-d4;
(+/-)-4-HYDROXY MEPHENYTOIN
CAS:61837-65-8
Formula: C12H14N2O3
SM-01099-003
MW: 234.25
5-Ethyl-5-(4-hydroxyphenyl)-3-methyl-
(+/-)-4-HYDROXY MEPHENYTOIN-D3
CAS:1173022-56-4
Formula: C12H11D3N2O3
SI-01099-001
MW: 237.27
5-Ethyl-5-(4-hydroxyphenyl)-3-methyl-
(+/-)-LISOFYLLINE
CAS:6493-06-7
Formula: C13H20N4O3
SM-01136-001
MW: 280.32
3 7-Dihydro-1-(5-hydroxyhexyl)-3 7-dimethyl-
(+/-)-ORTHO-COTININE
CAS:147732-31-8
Formula: C10H12N2O
SR-01435-006
MW: 176.22
1-Methyl-5-(2-pyridyl)-2-pyrrolidinone; (R S)-ortho-Cotinine
(+/-)-ORTHO-COTININE PERCHLORATE
CAS:147732-32-9
Formula: C10H13ClN2O5
SR-01435-018
MW: 276.67
"1-Methyl-5-(2-pyridinyl)-2-pyrrolidinone Monoperchlorate;(+/-)-N-Methyl-5-(2-pyridyl)pyrrolidin-2-one Perchlorate;"
(+/-)-THIOCTIC ACID
CAS:1077-28-7
Formula: C8H14O2S2
SA-02235-000
MW: 206.33
(+/-)-1 2-Dithiolane-3-pentanoic Acid; (+/-)-1 2-Dithiolane-3-valeric Acid; (RS)-?-Lipoic Acid; DL-Thioctic Acid; Liposan; Lipothion; NSC 628502; NSC 90788; Protogen A; Thioctsan;Tioctacid; rac ?-Lipoic Acid
(+/-)-THIOCTIC ACID-D5
CAS:1189471-66-6
Formula: C8H9D5O2S2
SI-02235-001
MW: 211.36
(+/-)-1 2-Dithiolane-3-pentanoic Acid-d5; (+/-)-1 2-Dithiolane-3-valeric Acid-d5; (RS)-?-Lipoic Acid-d5;DL-Thioctic Acid-d5; Liposan-d5; Lipothion-d5; NSC 628502-d5; NSC 90788-d5; Protogen A-d5; Thioctsan-d5; Tioctacid-d5; rac ?-Lipoic Acid-d5
(-)- -ACETYLMETHADOL HYDROCHLORIDE
CAS:43033-72-3
Formula: C23H32ClNO2
SR-01236-023
MW: 389.96
###############################################################################################################################################################################################################################################################
(-)- -ACETYLMETHADOL-D3 HYDROCHLORIDE
Formula: C23H29D3ClNO2
SI-01236-024
MW: 392.98
###############################################################################################################################################################################################################################################################
(-)- -METHADOL
CAS:14019-10-4
Formula: C21H29NO
SR-01236-013
MW: 311.46
(?S)-?-[(2S)-2-(dimethylamino)propyl]-?-ethyl-?-phenylbenzeneethanol; (S S)-(-)-6-(Dimethylamino)-4 4-diphenyl-3-heptanol; [S-(R* R*)]-?-[2-(dimethylamino)propyl]-?-ethyl-?-phenylbenzeneethanol; (3S 6S)-Methadol; L-?-Methadol; ?-l-Methadol;
(-)- -NARCOTINEDIOL
CAS:23942-99-6
Formula: C22H27NO7
SR-01357-011
MW: 417.45
###############################################################################################################################################################################################################################################################
(-)- -NORACETYLMETHADOL HYDROCHLORIDE
CAS:55096-75-8
Formula: C22H30ClNO2
SR-01236-025
MW: 375.93
###############################################################################################################################################################################################################################################################
(-)- -NORACETYLMETHADOL-D3 HYDROCHLORIDE
Formula: C22H27D3ClNO2
SI-01236-026
MW: 378.95
###############################################################################################################################################################################################################################################################
(-)-(14 )-DIHYDROVINPOCETINE-D5
Formula: C22H23D5N2O2
SI-02231-012
MW: 357.5
###############################################################################################################################################################################################################################################################
(-)-(3S)-3-HYDROXY QUININE
CAS:78549-61-8
Formula: C20H24N2O3
SM-01417-001
MW: 340.42
(8? 9R)-
(-)-(3S)-3-HYDROXY QUININE-VINYL-D3
Formula: C20H21D3N2O3
SI-01417-003
MW: 343.43
(3S)-3-Hydroxyquinine-d3; (3S)-Hydroxyquinine-d3; 3-Hydroxyquinine
(-)-11- 9-TETRAHYDRO CANNABINOL-9-METHANOL
CAS:36557-05-8
Formula: C21H30O3
SM-01324-009
MW: 330.46
(6aR 10aR)-
(-)-11- 9-TETRAHYDRO CANNABINOL-9-METHANOL-D9
Formula: C21H21D9O3
SI-01324-010
MW: 339.52
(6aR 10aR)-
(-)-11-HYDROXY- 8-TETRAHYDROCANNABINOL
CAS:28646-40-4
Formula: C21H30O3
SM-01324-002
MW: 330.46
###############################################################################################################################################################################################################################################################
(-)-11-NOR- 9-TETRAHYDRO CANNABINOL-9-CARBOXYLIC ACID
CAS:56354-06-4
Formula: C21H28O4
SM-01324-016
MW: 344.44
###############################################################################################################################################################################################################################################################
(-)-2-AMINO-6-PROPIONAMIDO-TETRAHYDROBENZOTHIAZOLE
CAS:106006-84-2
Formula: C10H15N3OS
SR-01145-005
MW: 225.31
N-(2-Amino-4 5 6 7-tetrahydro-benzothiazol-6-yl)propionamide; (S)-Pramipexole amide Pramipexole related compound B
(-)-3 4-DIHYDROXY NOREPHEDRINE
CAS:829-74-3
Formula: C9H13NO3
SR-01489-006
MW: 183.2
4-[(1R 2S)-2-Amino-1-hydroxypropyl]-1 2-benzenediol; BA 2818; Corbadrine; D-(-)-Cobefrin; L-?-Methylnoradrenaline; Levonordefrin; Neo-cobefrin; l-Cobefrin; (-)-Nordefrin;
(-)-CARBOVIR
CAS:120443-30-3
Formula: C11H13N5O2
SM-02073-001
MW: 247.25
(1R-cis)-2-Amino-1 9-dihydro-9-[4-(hydroxymethyl)-2-cyclopenten-1-yl]-6H-Purin-6-one;
(-)-CARBOVIR-5 -TRIPHOSPHATE
CAS:138284-89-6
Formula: C11H23N8O11P3
SR-02073-006
MW: 538.28
((1S 4R)-4-(2-Amino-6-oxo-3H-purin-9(6H)-yl)cyclopent-2-en-1-yl)methyl Tetrahydrogen Triphosphate Ammonium Salt
(-)-DEHYDRO GRISEOFULVIN
CAS:3573-90-8
Formula: C17H15ClO6
SR-01193-005
MW: 350.75
(1 S)-7-Chloro-2 4 6-trimethoxy-6 -methylspiro[benzofuran-2(3H) 1 -[2 5]cyclohexadiene]-3 4 -dione; Amudene; Dehydrogriseofulvin;
(-)-DIHYDROAPOVINCAMINIC ACID ETHYL ESTER
CAS:57327-92-1
Formula: C22H28N2O2
SR-02231-011
MW: 352.47
###############################################################################################################################################################################################################################################################
(-)-DONEPEZIL HYDROCHLORIDE
CAS:142057-78-1
Formula: C24H30ClNO3
SA-01229-005
MW: 415.95
(S)-2 3-Dihydro-5 6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-Inden-1-one Hydrochloride;
(-)-EPIGALLOCATECHIN
CAS:970-74-1
Formula: C15H14O7
SA-02374-000
MW: 306.27
###############################################################################################################################################################################################################################################################
(-)-EPIGALLOCATECHIN GALLATE
CAS:989-51-5
Formula: C22H18O11
SM-02374-002
MW: 458.37
"Teavigo; epi-Gallocatechin 3-O-Gallate; epi-Gallocatechin Gallate;EGCG; Epigallocatechin-3-monogallate; L-Epigallocatechin Gallate; 3-O-Galloyl-(-)-epigallocatechin;"
(-)-EPIGALLOCATECHIN GALLATE-D3/D4
Formula: C22H15D3O11
SI-02374-001 
MW: 461.39
"Teavigo-d3; epi-Gallocatechin 3-O-Gallate-d3; epi-Gallocatechin Gallate-d3;EGCG-d3; Epigallocatechin-3-monogallate-d3; L-Epigallocatechin Gallate-d3; 3-O-Galloyl-(-)-epigallocatechin-d3;"
(-)-EPIGALLOCATECHIN-13C3
Formula: C1213C3H14O7
SI-02374-008
MW: 309.25
###############################################################################################################################################################################################################################################################
(-)-GALLOCATECHIN
CAS:3371-27-5
Formula: C15H14O7
SR-02374-003
MW: 306.27
(2S 3R)-3 4-dihydro-2-(3 4 5-trihydroxyphenyl)-2H-1-benzopyran-3 5 7-triol; (2S-trans)-3 4-Dihydro-2-(3 4 5-trihydroxyphenyl)-2H-1-benzopyran-3 5 7-triol; (-)-Gallocatechol; l-Gallocatechin;
(-)-GALLOCATECHIN GALLATE
CAS:4233-96-9
Formula: C22H18O11
SR-02374-006
MW: 458.37
###############################################################################################################################################################################################################################################################
(-)-GEOSMIN
CAS:19700-21-1
Formula: C12H22O
SR-02214-002
MW: 182.3
"(4S 4aS 8aR)-Octahydro-4 8a-dimethyl-4a(2H)-naphthalenol;[4S-(4? 4a? 8a?)]-Octahydro-4 8a-dimethyl-4a(2H)-naphthalenol; Octahydro-4? 8a?-dimethyl-4a?(2H)-naphthol; Geosmin "
(-)-HYCOSAMINE
CAS:101-31-5
Formula: C17H23NO3
SA-02160-000
MW: 289.37
###############################################################################################################################################################################################################################################################
(-)-HYCOSAMINE-D3
Formula: C17H20D3NO3
SI-02160-001
MW: 292.39
###############################################################################################################################################################################################################################################################
(-)-N O-DIDESMETHYL TRAMADOL
CAS:144830-19-3
Formula: C14H21NO2
SR-01178-010
MW: 235.32
"3-[(1S 2S)-1-Hydroxy-2-[(methylamino)methyl]cyclohexyl]-phenol;(1S-cis)-3-[1-Hydroxy-2-[(methylamino)methyl]cyclohexyl]-phenol;"
(-)-N-DESMETHYL TRAMADOL
CAS:147762-58-1
Formula: C15H23NO2
SM-01178-016
MW: 249.35
"(1S 2S)-(-)-1-(3-Methoxyphenyl)-2-[(methylamino)methyl]cyclohexanol;cis-(-)-1-(3-Methoxyphenyl)-2-[(methylamino)methyl]cyclohexanol;"
(-)-NEBIVOLOL
CAS:118457-16-2
Formula: C22H25F2NO4
SR-01260-006
MW: 405.44
"(?S ??S 2R 2?S)-? ??-[Iminobis(methylene)]bis[6-fluoro-3 4-dihydro-2H-1-benzopyran-2-methanol]; [2S-[2R*[R*[R*(S*)]]]]-? ? -[Iminobis(methylene)]bis[6-fluoro-3 4-dihydro-2H-1-benzopyran-2-methanol; ?R-67145; Levonebivolol; ?l-Nebivolol; "
(-)-NEBIVOLOL O- -D-GLUCURONIDE(MIXTURE OF 2 DIASTEREOMERS)
Formula: C28H33F2NO10
SM-01260-018
MW: 581.56
"(1S)-1-[(2R)-6-Fluoro-3 4-dihydro-2H-1-benzopyran-2-yl]-2-[[(2S)-2-[(2S)-6-fluoro-3 4-dihydro-2H-1-benzopyran-2-yl]-2-hydroxyethyl]amino]ethyl ?-D-Glucopyrano-siduronic Acid; "
(-)-NEBIVOLOL-D4 HYDROCHLORIDE
Formula: C22H22D4ClF2NO4
SI-01260-007
MW: 445.92
###############################################################################################################################################################################################################################################################
(-)-NORGESTREL-D6
Formula: C21H22D6O2
SI-01539-001
MW: 318.48
(-)-Norgestrel-2 2 4 6 6 10-d6; 17-Ethynyl-18-methyl-
(-)-O-DESMETHYL TRAMADOL HYDROCHLORIDE
CAS:148218-19-3
Formula: C15H24ClNO2
SM-01178-006 
MW: 285.81
"3-[(1S 2S)-2-[(Dimethylamino)methyl]-1-hydroxycyclohexyl]phenol Hydrochloride;(1S-cis)-3-[2-[(Dimethylamino)methyl]-1-hydroxycyclohexyl]phenol Hydrochloride;EM 724;"
(-)-PSEUDO NOREPHEDRINE
CAS:37577-07-4
Formula: C9H13NO
SR-01489-005
MW: 151.21
###############################################################################################################################################################################################################################################################
(-)-RIBOFLAVIN
CAS:83-88-5
Formula: C17H20N4O6
SR-02421-002
MW: 376.36
1-Deoxy-1-(3 4-dihydro-7 8-dimethyl-2 4-dioxobenzo[g]pteridin-10(2H)-yl)-D-ribitol;
(-)-TIANEPTINE MONOSODIUM SALT
Formula: C21H24ClN2NaO4S
SM-01365-003
MW: 458.93
(-)-7-[(3-Chloro-6 11-dihydro-6-methyl-5 5-dioxidodibenzo[c f][1 2]thiazepin-11-yl)amino]heptanoic Acid Monosodium Salt
(-)-TRAMADOL HYDROCHLORIDE
CAS:148229-79-2
Formula: C16H26ClNO2
SA-01178-003
MW: 299.84
(1S 2S)-(-)-2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Hydrochloride; (1S-cis)-2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Hydrochloride; (-)-(1S 2S)-Tramadol Hydrochloride; E 381;
(±)-17-HYDROXY-7 7-DIMETHYL-19-NOR-17 -PREGN-5(10)-EN-20-YN-3-ONE
CAS:26674-51-1
Formula: C22H30O2
SR-01383-018
MW: 326.47
(±)-17-HYDROXY-7 7-DIMETHYL-19-NOR-17 -PREGN-5(10)-EN-20-YN-3-ONE-D6
Formula: C22H24D6O2
SI-01383-019
MW: 332.51
(±)-ATOVAQUONE IMPURITY C
Formula: C22H17ClO3
SR-01408-005
MW: 364.82
2-(4 -Chloro-2 3 4 5-tetrahydro-[1 1 -biphenyl]-4-yl)-3-hydroxynaphthalene-1 4-dione
(±)-ATOVAQUONE IMPURITY C-D5
Formula: C22H12D5ClO3
SI-01408-006
MW: 369.85
2-(4 -Chloro-2 3 4 5-tetrahydro-[1 1 -biphenyl]-4-yl)-3-hydroxynaphthalene-1 4-dione-d5;
(±)-CETIRIZINE-D4 DIHYDROCHLORIDE
Formula: C21H23D4Cl3N2O3
SA-01032-004
MW: 465.83
###############################################################################################################################################################################################################################################################
(±)-IBUPROFEN METHYL ESTER
CAS:61566-34-5
Formula: C14H20O2
SR-01282-006
MW: 220.31
###############################################################################################################################################################################################################################################################
(±)-P-FLUORO PSEUDOEPHEDRINE HYDROCHLORIDE
CAS:7799-73-7
Formula: C10H15ClFNO
SR-01468-009
MW: 219.68
(?S)-rel-4-Fluoro-?-[(1S)-1-(methylamino)ethyl]benzenemethanol Hydrochloride (1:1); (±)-p-Fluoro-?-[1-(methylamino)ethyl]benzyl Alcohol Hydrochloride
(±)-PRAMIPEXOLE
CAS:104617-86-9
Formula: C10H17N3S
SR-01145-006
MW: 211.33
2-Amino-6-propylamino-4 5 6 7-tetrahydrobenzothiazole; 4 5 6 7-tetrahydro-N6-propyl-2 6-Benzothiazolediamine
(±)-SIBUTRAMINE
CAS:106650-56-0
Formula: C17H26ClN
SA-01164-000
MW: 279.85
Didemethyl sibutramine hydrochloride; Medaria; Meridia; Racemic Sibutramine; Sibutramine
(±)-VANILMANDELIC-D3 ACID
CAS:74495-70-8
Formula: C9H7D3O5
SI-01293-003
MW: 201.19
"? 4-Dihydroxy-3-(methoxy-d3)benzeneacetic Acid; (+/-)-Vanilmandelic Acid-d3; [4-Hydroxy-3-(methoxy-d3)phenyl]glycolic Acid; 3-(Methoxy-d3)-4-hydroxyphenylhydroxyacetic Acid; HMMA-d3; VMA-d3;"
(1 11-SECO)-CYCLOSPORIN A OXAZOLIDINONE METHYLAMIDE
Formula: C65H114N12O14
SR-01493-012
MW: 1234.608
(1 2 4-TRIAZOL-4-YL) ITRACONAZOLE
CAS:854372-77-3
Formula: C35H38Cl2N8O4
SR-01083-010
MW: 705.63
rel-4-[4-[4-[4-[[(2R 4S)-2-(2 4-Dichlorophenyl)-2-(4H-1 2 4-triazol-4-ylmethyl)-1 3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2 4-dihydro-2-(1-methylpropyl)-
(1 S 2 S)-NICOTINE 1 -OXIDE
CAS:51095-86-4
Formula: C10H14N2O
SM-02211-003
MW: 178.23
###############################################################################################################################################################################################################################################################
(10E)-3-O-DE( -L-CLADINOSE)-10-DEHYDRO-11-DEHYDROXY-6-O-METHYL-ERYTHROMYCIN
CAS:198782-59-1
Formula: C30H53NO9
SR-02066-022
MW: 571.74
(10E)-3-O-De(2 6-dideoxy-3-C-methyl-3-O-methyl-?-L-ribo-hexopyranosyl)-10 11-didehydro-11-deoxy-6-O-methyl-erythromycin
(10E)-3-O-DE( -L-CLADINOSE)-10-DEHYDRO-11-DEHYDROXY-6-O-METHYL-ERYTHROMYCIN 2 -ACETATE
CAS:198782-60-4
Formula: C32H55NO10
SR-02066-013
MW: 613.78
(10E)-3-O-De(2 6-dideoxy-3-C-methyl-3-O-methyl-?-L-ribo-hexopyranosyl)-10 11-didehydro-11-deoxy-6-O-methyl-erythromycin 2 -Acetate
(11 16 )-11 21-BIS(ACETYLOXY)-2 -METHYL-5 H-PREGNA-1 4-DIENO[17 16-D]OXAZOLE-3 20-DIONE(DEFLAZACORT IMPURITY)
CAS:710951-92-1
Formula: C27H33NO7
SR-01277-003
MW: 483.55
Deflazacort Impurity C;
(11 16 17 )-9-CHLORO-17-(2 2-DIOXIDO-5H-1 2-OXATHIOL-4-YL)-17-[(2-FURANYLCARBONYL)OXY]-11-HYDROXY-16-METHYL-ANDROSTA-1 4-DIEN
CAS:223776-49-6
Formula: C28H31ClO8S
SR-01498-013
MW: 563.06
Mometasone Furoate Impurity
(11 17 ) -17- [(ETHOXYCARBONYL) OXY] - 11- HYDROXY- 3- OXO- ANDROSTA- 1 4- DIENE- 17- CARBOXYLIC ACID
CAS:133991-63-6
Formula: C23H30O7
SR-01579-007
MW: 418.48
PJ 91; Dechloromethyl Loteprednol Etabonate
(11 17 ) -17- [(ETHOXYCARBONYL) OXY] - 11- HYDROXY- 3- OXO- ANDROSTA- 1 4- DIENE- 17- CARBOXYLIC ACID-D5
Formula: C23H25D5O7
SI-01579-008
MW: 423.51
PJ 91-d5; Dechloromethyl Loteprednol Etabonate-d5
(11-CIS 13-CIS)-4-OXORETINOIC ACID
CAS:112924-95-5
Formula: C20H26O3
SM-01156-007
MW: 314.42
11-cis 13-cis-4-Oxoretinoic Acid; (2Z 4Z 6E 8E)-3 7-Dimethyl-9-(2 6 6-trimethyl-3-oxocyclohex-1-en-1-yl)nona-2 4 6 8-tetraenoic Acid
(13S)-ETHYL-18 19-DINORPREGNA-4 14 16-TRIENE-3 20-DIONE
CAS:932388-88-0
Formula: C21H26O2
SR-01265-009
MW: 310.43
(13S)-17-Acetyl-13-ethyl-6 7 8 9 10 11 12 13-octahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
(13S)-ETHYL-18 19-DINORPREGNA-5 14 16-TRIENE-3 20-DIONE
Formula: C21H26O2
SR-01265-010
MW: 310.43
(13S)-17-Acetyl-13-ethyl-4 6 7 8 9 11 12 13-octahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
(15R)-BIMATOPROST
CAS:1163135-92-9
Formula: C25H37NO4
SR-02067-004
MW: 415.57
"(5Z)-7-[(1R 2R 3R 5S)-3 5-Dihydroxy-2-[(1E 3R)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide; "
(15R)-BIMATOPROST ACID
CAS:41639-71-8
Formula: C23H32O5
SR-02067-009
MW: 388.5
(5Z)-7-[(1R 2R 3R 5S)-3 5-Dihydroxy-2-[(1E 3R)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-5-heptenoic Acid; [1R-[1?(Z) 2?(1E 3R*) 3? 5?]]-7-[3 5-Dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl]-5-heptenoic Acid
(15R)-BIMATOPROST ACID-D4
Formula: C23H28D4O5
SI-02067-010
MW: 392.52
(5Z)-7-[(1R 2R 3R 5S)-3 5-Dihydroxy-2-[(1E 3R)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-5-heptenoic Acid-d4; [1R-[1?(Z) 2?(1E 3R*) 3? 5?]]-7-[3 5-Dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl]-5-heptenoic Acid-d4
(16 )-16-METHYL-17 21-BIS(1-OXOPROPOXY)PREGNA-1 4 9(11)-TRIENE-3 20-DIONE
CAS:52092-12-3
Formula: C27H34O6
SR-01520-031
MW: 454.56
(16 )-17 21-DIHYDROXY-16 -METHYL-PREGNA-1 4 9(11)-TRIENE-3 20-DIONE
CAS:13504-15-9
Formula: C22H28O4
SR-01412-047
MW: 356.46
USP Betamethasone Related Compound C
(16 )-21-CHLORO-17-[(2-FURANYLCARBONYL)OXY]-16-METHYL-PREGNA-1 4-DIENE-3 11 20-TRIONE
CAS:1305334-31-9
Formula: C27H29ClO6
SR-01498-012
MW: 484.97
Mometasone Furoate Impurity
(17 )-13-ETHYL-18 19-DINORPREGNA-3 5(10)-DIEN-20-YNE-3 17-DIOL DIACETATE
CAS:62855-59-8
Formula: C25H32O4
SR-01124-005
MW: 396.52
(8R 9S 13S 14S 17R)-13-Ethyl-17-ethynyl-2 6 7 8 9 11 12 13 14 15 16 17-dodecahydro-1H-cyclopenta[a]phenanthrene-3 17-diyl Diacetate
(17 )-13-ETHYL-3-METHOXY-18 19-DINORPREGNA-3 5-DIEN-20-YN-17-OL
CAS:176254-10-7
Formula: C22H30O2
SR-01124-006
MW: 326.47
(17 )-13-ETHYL-3-METHOXY-GONA-2 5(10) 15-TRIEN-17-OL
CAS:119054-15-8
Formula: C20H28O2
SR-01265-011
MW: 300.44
(13S 17S)-13-Ethyl-3-methoxy-4 6 7 8 9 11 12 13 14 17-decahydro-1H-cyclopenta[a]phenanthren-17-ol
(17 )-13-ETHYL-3-METHOXYGONA-1 3 5(10) 15-TETRAEN-17-OL
CAS:59126-63-5
Formula: C20H26O2
SR-01265-013
MW: 298.42
(17 )-13-ETHYL-3-METHOXYGONA-1 3 5(10) 8-TETRAEN-17-OL
CAS:7443-72-3
Formula: C20H26O2
SR-01539-006
MW: 298.42
13-Ethyl-3-methoxygona-1 3 5(10) 8-tetraen-17?-ol; 3-Methoxy-18-methyl-1 3 5(10) 8-estratetraen-17?-ol
(17 )-17-HYDROXY-3-OXO-19-NORPREGNA-5(10) 9(11)-DIENE-21-NITRILE
CAS:106111-42-6
Formula: C20H25NO2
SR-02097-008
MW: 311.42
(17 )-19-NORPREGNA-3 5-DIEN-20-YNE-3 17-DIOL 3 17-DIACETATE
CAS:2205-78-9
Formula: C24H30O4
SR-01410-002
MW: 382.49
(17?)-19-Norpregna-3 5-dien-20-yne-3 17-diol Diacetate; 17-Ethynyl-19-norandrosta-3 5-diene-3 17?-diol Diacetate; 19-Nor-17?-pregna-3 5-dien-20-yne-3 17?-diol Diacetate; SC 6091
(17 )-3-ETHYNYL-19-NORPREGNA-3 5-DIEN-20-YN-17-OL
CAS:79727-03-0
Formula: C22H26O
SR-01410-005
MW: 306.44
(17 )-N-[2 5-BIS(TRIFLUOROMETHYL)PHENYL]-3-OXO-4-AZAANDROST-5-ENE-17-CARBOXAMIDE
CAS:164656-21-7
Formula: C27H30F6N2O2
SR-01217-019
MW: 528.53
###############################################################################################################################################################################################################################################################
(17A )-HYDROXY-6 17A-DIMETHYL-D-HOMOANDROST-4-ENE-3 17-DIONE
Formula: C22H32O3
SR-02161-004
MW: 344.49
(17a?)-17?-hydroxy-6 17a-dimethyl-D-homoandrost-4-ene-3 17-dione; Medroxyprogesterone Acetate Impurity I;
(17A )-HYDROXY-6 17A-DIMETHYL-D-HOMOANDROST-4-ENE-3 17-DIONE 17-ACETATE
Formula: C24H34O4
SR-02161-002
MW: 386.52
6 17a-Dimethyl-3 17-dioxo-D-homoandrost-4-en-17a-yl Acetate; Medroxyprogesterone Acetate Impurity C;
(19E/Z)-SECO RAPAMYCIN SODIUM SALT >85% BY HPLC
Formula: C51H78NNaO13
SR-01155-002
MW: 936.15
###############################################################################################################################################################################################################################################################
(19E/Z)-SECO-[4-O-(2-HYDROXYETHYL)] RAPAMYCIN SODIUM SALT >80%
Formula: C53H82NNaO14
SR-01155-005
MW: 980.21
###############################################################################################################################################################################################################################################################
(19E/Z)-SECO-[4-O-[2-HYDROXY(ETHYL)-D4]] RAPAMYCIN SODIUM SALT
Formula: C53H78D4NNaO14
SI-01155-006
MW: 984.23
###############################################################################################################################################################################################################################################################
(1AS 4S 6AR 7AS)-6-AMINO-1 1A 4 6A 7 7A-HEXAHYDRO-4-(3-HYDROXYTRICYCLO[3.3.1.13 7]DEC-1-YL)-3H-CYCLOPROPA[4 5]PYRROLO[1 2-A]PYRA
CAS:1350800-76-8
Formula: C18H25N3O2
SR-02276-020
MW: 315.41
(1R 2R)-BORTEZOMIB
CAS:1132709-15-9
Formula: C19H25BN4O4
SR-01529-002
MW: 384.24
"B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid; [(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid;"
(1R 2R)-BORTEZOMIB-D5
Formula: C19H20D5BN4O4
SI-01529-003
MW: 389.27
"B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic-d5 Acid; [(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic-d5 Acid;"
(1R 2S 5R)-MENTHOL-5R-HYDROXY-[1 3]-OXATHIOLANE-2R-CARBOXYLATE
CAS:147126-62-3
Formula: C14H24O4S
SR-01436-003
MW: 288.4
"(2R 5R)-5-Hydroxy[1 3]oxathiolane-2-carboxylic Acid L-Menthol Ester (1R 2S 5R)-Menthol-5R-hydroxy Acid 2-Isopropyl-5-methyl-cyclohexyl Ester; HME; "
(1R 2S)-ERYTHRO-DIHYDRO BUPROPION HYDROCHLORIDE
Formula: C13H21Cl2NO
SM-01018-016
MW: 278.22
(?R)-3-Chloro-?-[(1S)-1-[(1 1-dimethylethyl)amino]ethyl]benzenemethanol Hydrochloride
(1R 2S)-ERYTHRO-DIHYDRO BUPROPION MALEATE
Formula: C17H24ClNO5
SM-01018-005
MW: 357.83
(?R)-3-Chloro-?-[(1S)-1-[(1 1-dimethylethyl)amino]ethyl]benzenemethanol Maleate; (1R 2S)-2-(tert-Butylamino)-1-(3-chlorophenyl)propan-1-ol Maleate
(1R 2S)-M-NITRO-ERYTHRO-CHLORAMPHENICOL
CAS:1327173-91-0
Formula: C11H12Cl2N2O5
SR-02182-016
MW: 323.13
"2 2-dichloro-N-[(1R 2S)-2-hydroxy-1-(hydroxymethyl)-2-(3-nitrophenyl)ethyl]acetamide"
(1R 2S)-NOREPHEDRINE
CAS:492-41-1
Formula: C9H13NO
SM-01489-003
MW: 151.21
(?R)-
(1R 2S)-NOREPHEDRINE-D3 HYDROCHLORIDE
CAS:352438-64-3
Formula: C9H11D3ClNO
SI-01489-004
MW: 190.69
(?R)-
(1R 2S)-REL-2-PHENYLCYCLOPROPANAMINE DISULFATE
CAS:13492-01-8
Formula: C18H22N2?H2SO4
SR-01180-005
MW: 364.46
###############################################################################################################################################################################################################################################################
(1R 3R 4R)-ENTECAVIR
CAS:1367369-76-3
Formula: C12H15N5O3
SR-01502-017
MW: 277.28
2-Amino-1 9-dihydro-9-[(1R 3R 4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; Entecavir Impurity ETY-2;
(1R 3R)-METHYL-1 2 3 4-TETRAHYDRO-2-CHLOROACETYL-1-(3 4-METHYLENEDIOXYPHENYL)-9H-PYRIDO[3 4-B]INDOLE-3-CARBOXYLATE (CHLOROPRETA
CAS:171489-59-1
Formula: C22H19ClN2O5
SR-01484-004
MW: 426.85
(1R 3R)-1-(1 3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2 3 4 9-tetrahydro-1H-pyrido[3 4-b]indole-3-carboxylic Acid Methyl Ester;
(1R 3S 4S)-ENTECAVIR
Formula: C12H15N5O3
SR-01502-012
MW: 277.28
2-Amino-1 9-dihydro-9-[(1R 3S 4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one;
(1R 3S 5S)-3-(2-HYDROXY-2 2-DI(THIOPHEN-2-YL)ACETOXY)-8 8-DIMETHYL-8-AZABICYCLO[3.2.1]OCT-6-EN-8-IUM BROMIDE
Formula: C19H22BrNO3S2
SR-01415-004
MW: 456.42
(1R 3S)-1-(1 3-BENZODIOXOL-5-YL)-2-(2-CHLOROACETYL)-2 3 4 9-TETRAHYDRO-1H-PYRIDO[3 4-B]INDOLE-3-CARBOXYLIC ACID METHYL ESTER
CAS:629652-44-4
Formula: C22H19ClN2O5
SR-01484-031
MW: 426.85
(1R 3S)-3-[2-AMINO-6-(CYCLOPROPYLAMINO)-9H-PURIN-9-YL]CYCLOPENTANEMETHANOL
CAS:208762-35-0
Formula: C14H20N6O
SR-01464-014
MW: 288.35
Abacavir Impurity E
(1R 3S)-3-[2-AMINO-6-(CYCLOPROPYLAMINO)-9H-PURIN-9-YL]CYCLOPENTANEMETHANOL-D4
Formula: C14H16D4N6O
SI-01464-015
MW: 292.37
Abacavir Impurity E
(1R 3S)-SOLIFENACIN HYDROCHLORIDE
CAS:180468-40-0
Formula: C23H27ClN2O2
SR-01413-012
MW: 398.93
(1R)-3 4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic Acid (3S)-1-Azabicyclo-[2.2.2]oct-3-yl Ester Hydrochloride;
(1R 3S-)SOLIFENACIN-D5 HYDROCHLORIDE
Formula: C23H22D5ClN2O2
SI-01413-013
MW: 403.96
(1R)-3 4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic-d5 Acid (3S)-1-Azabicyclo-[2.2.2]oct-3-yl Ester Hydrochloride;
(1R 4S)-(R)-BICALUTAMIDE SULFIDE CAMPHANIC ACID ESTER
CAS:113299-39-1
Formula: C28H26F4N2O5S
SR-01014-007
MW: 578.58
###############################################################################################################################################################################################################################################################
(1R 4S)-(S)-BICALUTAMIDE SULFIDE CAMPHANIC ACID ESTER
CAS:113181-03-6
Formula: C28H26F4N2O5S
SR-01014-008
MW: 578.58
[1R-[1?(S*) 4?]]-4 7 7-Trimethyl-3-oxo-1-[[[4-cyano-3-(trifluoromethyl)phenyl]amino]carbonyl]-2-[(4-fluorophenyl)thio]-1-methylethyl Ester 2-Oxabicyclo[2.2.1]heptane-1-carboxylic Acid
(1R 4S)-SERTRALINE HYDROCHLORIDE
CAS:79896-32-5
Formula: C17H18Cl3N
SR-01163-005
MW: 342.69
(1R 4S)-4-(3 4-Dichlorophenyl)-1 2 3 4-tetrahydro-N-methyl-1-naphthalenamine
(1R 5S)-4-[(2-BROMO-4 5-DIMETHOXYPHENYL)METHYL]-4-[2-[2-(6 6-DIMETHYLBICYCLO[3.1.1]HEPT-2-EN-2-YL)ETHOXY]ETHYL]MORPHOLINIUM BROM
CAS:1235355-01-7
Formula: C26H39Br2NO4
SR-01223-002
MW: 589.4
(1R)-(1S 2S 3R 5S)-PINANEDIOL-N-(N-PYRAZINYLPHENYLALANINOYL)-1-AMINO-3-METHYL-BUTANE-1-BORONATE
CAS:205393-22-2
Formula: C29H39BN4O4
SR-01529-013
MW: 518.46
N-[(1S)-2-[[(1R)-1-[(3aS 4S 6S 7aR)-Hexahydro-3a 5 5-trimethyl-4 6-methano-1 3 2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide;
(1R)-(1S 2S 3R 5S)-PINANEDIOL-N-(N-PYRAZINYLPHENYLALANINOYL)-1-AMINO-3-METHYLBUTANE-1-BORONATE-D8
Formula: C29H31D8BN4O4
SI-01529-014
MW: 526.5
N-[(1S)-2-[[(1R)-1-[(3aS 4S 6S 7aR)-Hexahydro-3a 5 5-trimethyl-4 6-methano-1 3 2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide;
(1R-CIS)-MILNACIPRAN HYDROCHLORIDE
CAS:175131-61-0
Formula: C15H23ClN2O
SA-01231-006
MW: 282.81
(1R 2S)-2-(Aminomethyl)-N N-diethyl-1-phenylcyclopropanecarboxamide Hydrochloride; Levomilnacipran; Savella; cis-(-)-Milnacipran Hydrochloride;
(1R-CIS)-MILNACIPRAN-D10 HYDROCHLORIDE
Formula: C15H13D10ClN2O
SI-01231-003
MW: 292.87
(1R 2S)-2-(Aminomethyl)-N N-diethyl-1-phenylcyclopropanecarboxamide-d10 Hydrochloride; Levomilnacipran-d10; Savella-d10; cis-(-)-Milnacipran Hydrochloride-d10;
(1RS)-1-(6-METHOXY-2-NAPHTHYL)ETHANOL (NAPROXEN IMPURITY K)
CAS:77301-42-9
Formula: C13H14O2
SR-01115-008
MW: 202.25
6-Methoxy-?-methyl-
(1S 2R 4S)-2-(((4-METHOXYPHENYL)DIPHENYLMETHOXY)METHYL)-4-(2-(((4-METHOXYPHENYL)DIPHENYLMETHYL)AMINO)-6-OXO-1H-PURIN-9(6H)-YL)-3
Formula: C59H50N6O8
SR-01502-028
MW: 971.06
(1S 2R)-BORTEZOMIB
CAS:1132709-16-0
Formula: C19H25BN4O4
SR-01529-006
MW: 384.24
B-[(1S)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
(1S 2R)-BORTEZOMIB-D5
Formula: C19H20D5BN4O4
SI-01529-007
MW: 389.27
B-[(1S)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid-d5
(1S 2R)-M-NITRO-ERYTHRO-CHLORAMPHENICOL
CAS:1327173-88-5
Formula: C11H12Cl2N2O5
SR-02182-015
MW: 323.13
2 2-dichloro-N-[(1S 2R)-2-hydroxy-1-(hydroxymethyl)-2-(3-nitrophenyl)ethyl]acetamide
(1S 2R)-NOREPHEDRINE HYDROCHLORIDE
CAS:40626-29-7
Formula: C9H14ClNO
SR-01489-007
MW: 187.67
###############################################################################################################################################################################################################################################################
(1S 2S 3S 4R)-3-[(1S)-1-AMINO-2-ETHYLBUTYL]-4-[[(1 1-DIMETHYLETHOXY)CARBONYL]AMINO]-2-HYDROXYCYCLOPENTANECARBOXYLIC ACID METHYL
CAS:316173-29-2
Formula: C18H34N2O5
SR-02373-004
MW: 358.47
(1S 2S 5S)-4-[2-[2-(6 6-DIMETHYLBICYCLO[3.1.1]HEPT-2-YL)ETHOXY]ETHYL]MORPHOLINE
CAS:38284-47-8
Formula: C17H31NO2
SR-01223-003
MW: 281.43
(1S 2S 5S)-2-[2-(2-Morpholinoethoxy)ethyl]-6 6-dimethylnorpinane; (1S 2S 5S)-6 6-Dimethyl-2-[2-(2-morpholinoethoxy)ethyl]norpinane;
(1S 2S)-BORTEZOMIB
CAS:1132709-14-8
Formula: C19H25BN4O4
SR-01529-004
MW: 384.24
B-[(1S)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic Acid;
(1S 2S)-BORTEZOMIB-D5
Formula: C19H20D5BN4O4
SI-01529-005
MW: 389.27
B-[(1S)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic Acid-d5;
(1S 3R)-1-(1 3-BENZODIOXOL-5-YL)-2 3 4 9-TETRAHYDRO-N-METHYL-1H-PYRIDO[3 4-B]INDOLE-3-CARBOXAMIDE
CAS:951661-85-1
Formula: C20H19N3O3
SR-01484-023
MW: 349.38
(1S 3R)-1-(Benzo[d][1 3]dioxol-5-yl)-N-methyl-2 3 4 9-tetrahydro-1H-pyrido[3 4-b]indole-3-carboxamide
(1S 3R)-1-(1 3-BENZODIOXOL-5-YL)-2 3 4 9-TETRAHYDRO-N-METHYL-1H-PYRIDO[3 4-B]INDOLE-3-CARBOXAMIDE-D3
Formula: C20H16D3N3O3
SI-01484-024
MW: 352.4
(1S 3R)-1-(Benzo[d][1 3]dioxol-5-yl)-N-methyl-2 3 4 9-tetrahydro-1H-pyrido[3 4-b]indole-3-carboxamide-d3
(1S 3S 4R)-ENTECAVIR
CAS:1367369-79-6
Formula: C12H15N5O3
SR-01502-019
MW: 277.28
2-Amino-1 9-dihydro-9-[(1S 3S 4R)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one;
(1S 3S)-SOLIFENACIN HYDROCHLORIDE
CAS:180468-38-6
Formula: C23H27ClN2O2
SR-01413-009
MW: 398.93
(1S)-3 4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic Acid (3S)-1-Azabicyclo-[2.2.2]oct-3-yl Ester Hydrochloride;
(1S 3S-)SOLIFENACIN HYDROCHLORIDE-D5
Formula: C23H22D5ClN2O2
SI-01413-010
MW: 403.96
(1S)-3 4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic-d5 Acid (3S)-1-Azabicyclo-[2.2.2]oct-3-yl Ester Hydrochloride;
(1S 4R) SERTRALINE HYDROCHLORIDE
CAS:79896-31-4
Formula: C17H18Cl3N
SR-01163-006
MW: 342.69
"(1S 4R)-4-(3 4-Dichlorophenyl)-1 2 3 4-tetrahydro-N-methyl-1-naphthalenamine Hydrochloride; (1S-trans)-4-(3 4-Dichlorophenyl)-1 2 3 4-tetrahydro-N-methyl-1--naphthalenamine Hydrochloride;"
(1S 4R)-4-AMINO-2-CYCLOPENTENE-1-CARBOXYLIC ACID METHYL ESTER L-TARTRATE
CAS:419563-22-7
Formula: C11H17NO8
SR-02373-002
MW: 291.25
(1S 4R)-4-Amino-2-cyclopentene-1-carboxylic Acid Methyl Ester (2R 3R)-2 3-Dihydroxybutanedioate
(1S)-N-TERT-BUTYLOXYCARBONYL-1-(4-BENZYLOXYPHENYL)-3-[(3-EXO)-3-[3-METHYL-5-(1-METHYLETHYL)-4H-1 2 4-TRIAZOL-4-YL]-8-AZABICYCLO[
Formula: C34H47N5O3
SM-02017-015
MW: 573.77
N-Des1-(4 4-difluorocyclohexanecarbonyl) N-tert-Butyloxycarbonyl 4-Benzyloxyphenyl Maraviroc
(1S-CIS)-MILNACIPRAN HYDROCHLORIDE
CAS:175131-60-9
Formula: C15H23ClN2O
SA-01231-007
MW: 282.81
"(1S 2R)-2-(Aminomethyl)-N N-diethyl-1-phenylcyclopropanecarboxamide Hydrochloride; cis-(+)-Milnacipran Hydrochloride; (1S 2R)-Milnacipran Hydrochloride"
(2 )-METHYL MEGESTROL ACETATE
CAS:907193-65-1
Formula: C25H34O4
SR-01320-009
MW: 398.54
(2?)-17-(Acetyloxy)-2 6-dimethylpregna-4 6-diene-3 20-dione;
(2 3 5 16 17 )-17-ACETOXY-3-HYDROXY-2-(4-MORPHOLINYL)-16-(1-PYRROLIDINYL)ANDROSTANE
CAS:119302-24-8
Formula: C29H48N2O4
SR-02388-013
MW: 488.7
2?-(4-Morpholinyl)-16?-(1-pyrrolidinyl)-5?-androstane-3? 17?-diol 17-Acetate; (2? 3? 5? 16? 17?)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstane-3 17-diol 17-Acetate; Desallyl Rocuronium
(2 3 5 16 17 )-2 16-DI-1-PYRROLIDINYLANDROSTANE-3 17-DIOL 3 17-DIACETATE
Formula: C31H50N2O4
SR-02388-009
MW: 514.74
(2 3 5 16 17 )-2 3-EPOXY-16-(1-PYRROLIDINYL)ANDROSTAN-17-OL
CAS:119302-19-1
Formula: C23H37NO2
SR-02388-011
MW: 359.55
2 3-Epoxy-1H-cyclopenta[a]phenanthrene androstan-17-ol deriv.; 2? 3?-Epoxy-16?-(1-pyrrolidinyl)-5?-androstan-17?-ol;
(2 3 5 16 17 )-2-(4-MORPHOLINYL)-16-(1-PYRROLIDINYL)ANDROSTANE-3 17-DIOL
CAS:119302-20-4
Formula: C27H46N2O3
SR-02388-012
MW: 446.67
2?-(4-Morpholinyl)-16?-(1-pyrrolidinyl)-5?-androstane-3? 17?-diol; (2? 3? 5? 16? 17?)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstan-3 17-diol; Desacetyl Desallyl Rocuronium
(2 R 2R CIS)-SAXAGLIPTIN
CAS:1564265-95-7
Formula: C18H25N3O2
SR-02276-014
MW: 315.41
(1R 3R 5R)-2-[(2R)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13 7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
(2 R 2S CIS)-SAXAGLIPTIN
CAS:1564265-93-5
Formula: C18H25N3O2
SR-02276-012
MW: 315.41
(1S 3S 5S)-2-[(2R)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13 7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
(2 S 2R TRANS)-SAXAGLIPTIN
CAS:1564266-00-7
Formula: C18H25N3O2
SR-02276-013
MW: 315.41
(1S 3R 5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13 7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
(2,6-XYLYLOXY) ACETYL LOPINAVIR
CAS:943250-65-5
Formula: C47H58N4O7
SR-02403-005
MW: 790.99
(1S 3S)-1-[(1S)-1-[[2-(2 6-Dimethylphenoxy)acetyl]amino]-2-phenylethyl]-3-[[(2S)-3-methyl-1-oxo-2-(tetrahydro-2-oxo-1(2H)-pyrimidinyl)butyl]amino]-4-phenylbutyl Ester 2-(2 6-dimethylphenoxy)-Acetic Acid
(2-[(E)-2 6-DICHLOROPHENYLIMINO]-1-(1-{2-[(E)-2 6-DICHLOROPHENYLIMINO]-IMIDAZOLIDIN-1-YL}-ETHYL)-IMIDAZOLIDINE
Formula: C20H20Cl4N6
SR-01427-007
MW: 486.22
USP Clonidine Related Compound B; (N N E N N E)-N N -(1 1 -(ethane-1 1-diyl)bis(imidazolidin-1-yl-2-ylidene))bis(2 6-dichloroaniline)
(20 RS)-15 20 -DIHYDRO VINORELBINE DITARTARATE
Formula: C53H68N4O20
SR-01416-002
MW: 1081.12
(2? 3? 4? 5? 12R 19?)-4-(acetyloxy)-6 7-didehydro-15-[(2S 4RS 6S 8S)-4-ethyl-1 3 4 5 6 7 8 9-octahydro-8-(methoxycarbonyl)-2 6-methano-2H-azecino[4 3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methylaspidospermidine-3-carboxylic Acid Methyl Ester Ditartarate;
(2E)-1-(2-HYDROXYPHENYL)-3-(PHENYL-D5)-2-PROPEN-1-ONE
CAS:146196-93-2
Formula: C15H7D5O2
SI-01148-016
MW: 229.29
(E)-2 -Hydroxy-chalcone-d5; (E)-o-Hydroxyphenyl Styryl Ketone-d5; NSC 170284-d5; trans-2 -Hydroxychalcone-d5;
(2E)-2-BUTENEDIOIC ACID 1-[[3-[(1R)-3-[BIS(1-METHYLETHYL)AMINO]-1-PHENYLPROPYL]-4-(2-METHYL-1-OXOPROPOXY)PHENYL]METHYL] ESTER
CAS:1254942-29-4
Formula: C30H39NO6
SR-01510-014
MW: 509.63
(2E)-DEMETHOXY CURCUMIN
CAS:22608-11-3
Formula: C20H18O5
SR-02219-009
MW: 338.35
###############################################################################################################################################################################################################################################################
(2R 3 R)-GLYCOPYRROLATE BROMIDE
CAS:475468-09-8
Formula: C19H28BrNO3
SR-02053-006
MW: 398.33
(3R)-3-[[(2R)-Cyclopentylhydroxyphenylacetyl]oxy]-1 1-dimethylpyrrolidinium Bromide; (3R)-3-[[(2R)-2-Cyclopentyl-2-hydroxy-2-phenylacetyl]oxy]-1 1-dimethylpyrrolidinium Bromide (1:1)
(2R 3 S)-GLYCOPYRROLATE BROMIDE
CAS:129784-12-9
Formula: C19H28BrNO3
SR-02053-007
MW: 398.33
###############################################################################################################################################################################################################################################################
(2R 3S 5S)-3-(BENZYLOXY)-5-(6-(BENZYLOXY)-2-(((4-METHOXYPHENYL)DIPHENYLMETHYL)AMINO)-9H-PURIN-9-YL)-2-((BENZYLOXY)METHYL)CYCLOPE
CAS:1263274-06-1
Formula: C52H49N5O5
SR-01502-003
MW: 823.98
(2R 3S 5S)-rel-5-[2-[[(4-Methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]cyclopentanol
(2R 4R 5S)-LOPINAVIR
Formula: C37H48N4O5
SR-02403-006
MW: 628.8
(S)-N-((2R 4R 5S)-5-(2-(2 6-Dimethylphenoxy)acetamido)-4-hydroxy-1 6-diphenylhexan-2-yl)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide
(2R 5S)-5-(4-AMINO-5-FLUORO-2-OXO-1(2H)-PYRIMIDINYL)-1 3-OXATHIOLANE-2-CARBOXYLIC ACID (1R 2S 5R)-5-METHYL-2-(1-METHYLETHYL)CYCL
CAS:764659-72-5
Formula: C18H26FN3O4S
SR-01436-026
MW: 399.48
Emtricitabine Menthyl Ester
(2R 6S)-REL-2 6-DIMETHYL-4-(2-METHYL-3-PHENYLPROPYL)MORPHOLINE HYDROCHLORIDE
CAS:922734-43-8
Formula: C16H26ClNO
SR-01334-002
MW: 283.84
(±)-2 6-cis-Dimethyl-4-(2-methyl-3-phenylpropyl)-morpholine Hydrochloride
(2R)-DARUNAVIR-D9
Formula: C27H28D9N3O7S
SI-02209-003
MW: 547.66
[(1R 2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenyl-methyl)propyl]carabamic Acid (3R 3aR 6aR)-Hexahydrofuro[2 3-b]-furan-3-yl Ester-d9; TMC-114-d9; UIC-94017-d9;
(2R)-VILDAGLIPTIN
CAS:1036959-27-9
Formula: C17H25N3O2
SR-02275-006
MW: 303.4
(R)-1-(2-(((1r 3S 5R 7S)-3-Hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile; (2R)-1-[2-[(3-Hydroxytricyclo[3.3.1.13 7]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile
(2R-CIS)-1-[2-(HYDROXYMETHYL)-1 3-OXATHIOLAN-5-YL]-2 4(1H 3H)-PYRIMIDINEDIONE
CAS:145986-07-8
Formula: C8H10N2O4S
SR-01436-024
MW: 230.24
Lamivudine Impurity J; Lamivudine Uridine Analog
(2R-CIS)-1-[2-(HYDROXYMETHYL)-1 3-OXATHIOLAN-5-YL]-2 4(1H 3H)-PYRIMIDINEDIONE-13C 15N2
Formula: C713CH1015N2O4S
SI-01436-025
MW: 233.22
Lamivudine Impurity J-13C 15N2
(2S 2 S)-1 1 -[[(3-HYDROXYTRICYCLO[3.3.1.13 7]DEC-1-YL)IMINO]BIS(1-OXO-2 1-ETHANEDIYL)]BIS-2-PYRROLIDINECARBONITRILE
CAS:1036959-23-5
Formula: C24H33N5O3
SR-02275-009
MW: 439.55
Vildagliptin
(2S 2R TRANS)-SAXAGLIPTIN
CAS:1564265-98-0
Formula: C18H25N3O2
SR-02276-009
MW: 315.41
(1R 3S 5R)-2-[(2R)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13 7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
(2S 2S TRANS)-SAXAGLIPTIN
CAS:1564265-96-8
Formula: C18H25N3O2
SR-02276-008
MW: 315.41
(1R 3S 5R)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13 7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
(2S 3 Z)-CEFPROZIL
CAS:110764-35-7
Formula: C18H19N3O5S
SR-02058-002
MW: 389.43
USP Cefprozil L-Epimer; [6R-[3(Z) 6? 7?(S*)]]-7-[[Amino(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(1-propenyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
(2S 3R 6RS)-2-(3-OXOBUTYL)-3-METHYL-6-[(R)-2-PROPANAL]CYCLOHEXANONE
CAS:1093625-96-7
Formula: C14H22O3
SR-02143-007
MW: 238.32
(2S 3R 6RS)-
(2S 3R)-5-(3-(((6R 7S)-6 7-DIHYDROXY-5 6 7 8-TETRAHYDRONAPHTHALEN-1-YL)OXY)-2-HYDROXYPROPOXY)-1 2 3 4-TETRAHYDRONAPHTHALENE-2 3
Formula: C23H28O7
SR-01445-003
MW: 416.46
Nadolol Impurity C
(2S 3S 5S)-2-(2 6-DIMETHYLPHENOXYACETYL)AMINO-3-HYDROXY-5-TRIFLUROMETHYLCARBONYLAMINO-1 6-DIPHENYLHEXANE
Formula: C30H33F3N2O4
SR-01490-022
MW: 542.59
Lopinavir Impurity
(2S 3S 5S)-5-AMINO-1 6-DIPHENYL-2-([[THIAZOL-5-YLMETHOXY)CARBONYL]AMINO]HEXAN-3-YL 2-(3-((2-ISOPROPYLTHIAZOL-4-YL)METHYL)-3-METH
Formula: C37H48N6O5S2?xHCl
SR-01490-021
MW: 720.94
(2S 3S)-2-[[(2Z)-2-(2-AMINO-4-THIAZOLYL)-2-[(1-CARBOXY-1-METHYLETHOXY)IMINO]ACETYL]AMINO]-3-(SULFOAMINO)BUTANOIC ACID
CAS:87500-74-1
Formula: C13H19N5O9S2
SM-01272-007
MW: 453.45
[S-[R* R*-(Z)]]-2-[[(2-Amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-3-(sulfoamino)-butanoic Acid; SQ26992; USP Open Ring Aztreonam
(2S 3S)-3-AMINO-2-[[(2Z)-2-(2-AMINO-4-THIAZOLYL)-2-[(1-CARBOXY-1-METHYLETHOXY)IMINO]ACETYL]AMINO]BUTANOIC ACID
CAS:102586-36-7
Formula: C13H19N5O6S
SR-01272-006
MW: 373.38
[S-[R* R*-(Z)]]-3-Amino-2-[[(2-amino-4-thiazolyl)[(1-carboxy-1-methylethoxy)imino]acetyl]amino]butanoic Acid; (2S 3S)-3-Amino-2-((Z)-2-(2-aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)butanoic Acid
(2S 4R 5S)-LOPINAVIR
Formula: C37H48N4O5
SR-02403-007
MW: 628.8
(S)-N-((2S 4R 5S)-5-(2-(2 6-Dimethylphenoxy)acetamido)-4-hydroxy-1 6-diphenylhexan-2-yl)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide
(2S 4R)-4-HYDROXY-1 2-PYRROLIDINEDICARBOXYLIC ACID 1-(4-NITROBENZYL) ESTER
CAS:96034-57-0
Formula: C13H14N2O7
SR-02117-006
MW: 310.26
(2S-trans)-4-Hydroxy-1 2-pyrrolidinedicarboxylic Acid 1-[(4-Nitrophenyl)methyl] Ester; (2S 4R)-1-(p-Nitrobenzyloxycarbonyl)-4-hydroxyproline; trans-4-Hydroxy-1-(4-nitrobenzyloxycarbonyl)-L-proline;
(2S)-2-AMINOMETHYL-1-ETHYLPYRROLIDINE
CAS:22795-99-9
Formula: C7H16N2
SR-02165-014
MW: 128.22
(2S)-1-Ethyl-2-pyrrolidinemethanamine; (-)-2-(Aminomethyl)-1-ethyl-pyrrolidine; (-)-1-Ethyl-2-(aminomethyl)pyrrolidine; (-)-2-(Aminomethyl)-1-ethylpyrrolidine; (S)-(-)-1-Ethyl-2-pyrrolidinemethanamine; S-(-)-2-(Aminomethyl)-N-ethylpyrrolidine;
(2S)-2-AMINOMETHYL-1-ETHYLPYRROLIDINE-D5
Formula: C7H11D5N2
SI-02165-015
MW: 133.25
###############################################################################################################################################################################################################################################################
(2S)-4 -DEPROPYL-4 -PROPYLIDENELINCOMYCIN
CAS:37744-65-3
Formula: C18H32N2O6S
SR-01558-014
MW: 404.52
###############################################################################################################################################################################################################################################################
(2S)-4 -DEPROPYL-4 -PROPYLIDENELINCOMYCIN-D3
Formula: C18H29D3N2O6S
SI-01558-015
MW: 407.54
###############################################################################################################################################################################################################################################################
(3 )-7-DEHYDRO CHOLESTEROL
CAS:434-16-2
Formula: C27H44O
SR-02215-017
MW: 384.64
Cholesta-5 7-dien-3?-ol; 7 8-Didehydrocholesterol; 7-Dehydrocholesterin; Provitamin D3.
(3 )-7-DEHYDRO CHOLESTEROL-D7
Formula: C27H37D7O
SI-02215-018
MW: 391.68
Cholesta-5 7-dien-3?-ol-d7; 7 8-Didehydrocholesterol-d7; 7-Dehydrocholesterin-d7; Provitamin D3-d7
(3 )-7-DEHYDRO CHOLESTEROL-D7 (MAJOR)
Formula: C27H37D7O
SI-02215-019
MW: 391.68
Cholesta-5 7-dien-3?-ol-d7; 7 8-Didehydrocholesterol-d7; 7-Dehydrocholesterin-d7; Provitamin D3-d7
(3 )-ALLOPREGNANOLONE
CAS:516-54-1
Formula: C21H34O2
SA-02425-000
MW: 318.49
###############################################################################################################################################################################################################################################################
(3 )-ALLOPREGNANOLONE 3- -D-GLUCURONIDE
CAS:31300-87-5
Formula: C27H42O8
SM-02425-002
MW: 494.62
"(3? 5?)-20-Oxopregnan-3-yl ?-D-Glucopyranosiduronic Acid; 20-Oxo-5?-pregnan-3?-yl ?-D-Glucopyranosiduronic Acid; 20-Oxo-5?-pregnan-3?-yl Glucosiduronic Acid; 3?-Hydroxy-5?-pregnan-20-one Glucuronide;"
(3 )-ALLOPREGNANOLONE P-NITROBENZOATE
Formula: C28H37NO5
SR-02425-006
MW: 467.6
(3 )-ALLOPREGNANOLONE SULFATE PYRIDINIUM SALT
CAS:1177357-94-6
Formula: C26H39NO5S
SM-02425-003
MW: 477.66
(3? 5?)-3-(Sulfooxy)pregnan-20-one Pyridinium Salt; 3?-Hydroxy-5?-pregnan-20-one Sulfate Pyridinium Salt;
(3 )-ALLOPREGNANOLONE SULFATE SODIUM SALT
CAS:215996-42-2
Formula: C21H33NaO5S
SM-02425-004
MW: 420.54
(3? 5?)-3-(Sulfooxy)pregnan-20-one Sodium Salt; 3?-Hydroxy-5?-pregnan-20-one Sulfate Sodium Salt;
(3 )-ALLOPREGNANOLONE-D5
Formula: C21H29D5O2
SI-02425-001
MW: 323.52
###############################################################################################################################################################################################################################################################
(3 22R)-DIHYDROXY CHOLESTEROL
CAS:596-94-1
Formula: C27H46O3
SM-02215-049
MW: 418.65
(3? 22R)-Cholest-5-ene-3 20 22-triol; (22R)-Cholest-5-ene-3? 20 22-triol; (20R 22R)-20 22-Dihydroxycholesterol; (20R 22R)-Dihydroxycholesterol; (22R)-20? 22-Dihydroxycholesterol; (22R)-5-Cholesten-3? 20? 22-triol; 20? 22(R)-Dihydroxycholesterol;
(3 22S)-DIHYDROXY CHOLESTEROL
CAS:26649-05-8
Formula: C27H46O3
SR-02215-048
MW: 418.65
(3? 22S)-Cholest-5-ene-3 20 22-triol; (22S)-Cholest-5-ene-3? 20 22-triol; (20R 22S)-20 22-Dihydroxycholesterol; 20? 22S-Dihydroxycholesterol;
(3 5 7 )-7-HYDROXY-3-(SULFOOXY)-CHOLAN-24-OIC ACID DISODIUM SALT
CAS:60237-34-5
Formula: C24H38Na2O7S
SR-02179-008
MW: 516.6
(3 5 7 )-7-HYDROXY-3-(SULFOOXY)-CHOLAN-24-OIC ACID-D5 DISODIUM SALT
Formula: C24H33D5Na2O7S
SR-02179-009
MW: 521.63
(3-(3-CHLOROPHENETHYL)PYRIDIN-2-YL-D5)(1-METHYLPIPERIDIN-4-YL)METHANONE
Formula: C20H18D5ClN2O
SI-01093-013
MW: 347.89
[3-[2-(3-Chlorophenyl)ethyl]-2-pyridinyl-d5](1-methyl-4-piperidinyl)methanone
(3-(BENZO[D]ISOTHIAZOL-3-YL)-5-(2-(4-(BENZO[D]ISOTHIAZOL-3-YL)PIPERAZIN-1-YL)ETHYL)-6-CHLOROINDOLIN-2-ONE)
Formula: C28H24ClN5OS2
SR-01242-021
MW: 546.11
Ziprasidone Related Compound D
(3-BENZOYLPHENYL)ACETONITRILE
CAS:21288-34-6
Formula: C15H11NO
SR-01084-005
MW: 221.25
3-Benzoylbenzeneacetonitrile;
(3-DES-TRIFLUOROMETHYL-3-METHYL) SITAGLIPTIN
Formula: C16H18F3N5O
SR-02014-012
MW: 353.34
(3AR 4R 6S 6AS)-4-[[(1 1-DIMETHYLETHOXY)CARBONYL]AMINO]-3-(1-ETHYLPROPYL)-3A 5 6 6A-TETRAHYDRO-4H-CYCLOPENT[D]ISOXAZOLE-6-CARBOX
CAS:229613-93-8
Formula: C18H30N2O5
SR-02373-003
MW: 354.44
(3AS 4S 6AR)-TETRAHYDRO-4-METHOXYFURO[3 4-B]FURAN-2(3H)-ONE
CAS:866594-60-7
Formula: C7H10O4
SR-02209-014
MW: 158.15
(3aS 4S 6aR)-4-Methoxytetrahydrofuro[3 4-b]furan-2(3H)-one;
(3R 3AS 6AR)-HEXAHYDROFURO[2 3-B]FURAN-3-YL-4-(N-((2R 3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL)-N-ISOBUTYL-D9-SULFAMOYL)PHENYLCARBAM
Formula: C27H28D9N3O7S
SI-02209-005
MW: 556.72
*
(3R 3AS 6AR)-HEXAHYDROFURO[2 3-B]FURAN-3-YL-4-(N-((2R 3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL)-N-ISOBUTYLSULFAMOYL)PHENYLCARBAMATE
Formula: C27H37N3O7S
SR-02209-004
MW: 547.66
*
(3R 4R 4AS 7R 8S 8AR)-HEXAHYDRO-3-HYDROXY-4 7-DIMETHYL-8-(3-OXOBUTYL)-1 2-BENZODIOXIN-8A(3H)-CARBOXALDEHYDE
CAS:149588-86-3
Formula: C15H24O5
SR-01332-003
MW: 284.35
[3R-(3? 4? 4a? 7? 8? 8a?)]-Hexahydro-3-hydroxy-4 7-dimethyl-8-(3-oxobutyl)-1 2-benzodioxin-8a(3H)-carboxaldehyde;
(3R 5R 6E)-7-[2-CYCLOPROPYL-4-(4-FLUOROPHENYL)-3-QUINOLINYL]-3 5-DIHYDROXY-6-HEPTENOIC ACID CALCIUM SALT
CAS:254452-96-5
Formula: C25H24FNO4 ?1/2Ca
SR-02208-005
MW: 440.49
5-epi-NK-104
(3R 5R)-ROSUVASTATIN SODIUM SALT
Formula: C22H27FN3NaO6S
SR-01161-009 
MW: 503.52
(3R 5R 6E)-
(3R 5S)-FLUVASTATIN SODIUM SALT
CAS:94061-80-0
Formula: C24H25FNNaO4
SA-01071-002
MW: 433.45
(3R 5S)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3 5-dihydroxy-6-heptenoic Acid Sodium Salt;
(3R 5S)-FLUVASTATIN TERT-BUTYL ESTER
CAS:194934-96-8
Formula: C28H34FNO4
SM-01071-012
MW: 467.57
(3R 5S 6E)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3 5-dihydroxy-6-heptenoic Acid 1 1-Dimethylethyl Ester
(3R 5S)-FLUVASTATIN-D7 SODIUM SALT
Formula: C24H18D7FNNaO4
SI-01071-008
MW: 440.49
(3R 5S)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl-d7)-1H-indol-2-yl]-3 5-dihydroxy-6-heptenoic Acid Sodium Salt;
(3R 8R 9S 12R)-ATAZANAVIR
Formula: C38H52N6O7
SR-02113-014
MW: 704.86
(3R 8R 9S 12R)-3 12-Bis(1 1-dimethylethyl)-8-hydroxy-4 11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]- 2 5 6 10 13-pentaazatetradecanedioic Acid 1 14-Dimethyl Ester;
(3R 8S 9S 12R)-ATAZANAVIR
CAS:1292296-11-7
Formula: C38H52N6O7
SR-02113-008
MW: 704.86
(3R 8S 9S 12R)-3 12-Bis(1 1-dimethylethyl)-8-hydroxy-4 11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]- 2 5 6 10 13-pentaazatetradecanedioic Acid 1 14-Dimethyl Ester;
(3R 8S 9S 12S)-ATAZANAVIR
CAS:1332981-14-2
Formula: C38H52N6O7
SR-02113-004
MW: 704.86
(3R 8S 9S 12S)-3 12-Bis(1 1-dimethylethyl)-8-hydroxy-4 11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2 5 6 10 13-pentaazatetradecanedioic Acid 1 14-Dimethyl Ester
(3R)- -DIPHENYL-3-PYRROLIDINEACETAMIDE
CAS:134002-27-0
Formula: C18H20N2O
SR-01418-003
MW: 280.36
(R)-(+)-3-(1-Carbamoyl-1 1-diphenylmethyl)pyrrolidine
(3R)-2 3-DIHYDRO-3-(2-PROPYN-1-YLAMINO)-1H-INDEN-1-ONE
CAS:1312077-05-6
Formula: C12H11NO
SR-02034-019
MW: 185.22
3-keto-Npropargyl-1-aminoindan
(3R)-5-OXO-3-[(TRIETHYLSILYL)OXY]
CAS:118456-54-5
Formula: C19H34O4Si
SR-01110-010
MW: 326.47
Methyl-7-[5-oxo-3(R)-[triethylsilyl)oxy]-1-cyclopenten-1-yl]heptanoate;
(3S 5R E)-TERT-BUTYL 7-(3-(4-FLUOROPHENYL)-1-ISOPROPYL-1H-INDOL-2-YL)-3 5-DIHYDROXYHEPT-6-ENOATE
CAS:194935-03-0
Formula: C28H34FNO4
SR-01071-013
MW: 467.57
[R-[R* S*-(E)]]-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3 5-dihydroxy-6-heptenoic Acid 1 1-Dimethylethyl Ester
(3S 5R)-ATORVASTATIN SODIUM SALT
Formula: C33H34FN2NaO5
SR-01009-011
MW: 580.62
(?S ?R)-2-(4-Fluorophenyl)-? ?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Sodium Salt; Atorvastatin Impurity AT10;
(3S 5R)-FLUVASTATIN SODIUM SALT
CAS:94061-81-1
Formula: C24H25FNNaO4
SA-01071-003
MW: 433.45
(3S 5R)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3 5-dihydroxy-6-heptenoic Acid Sodium Salt;
(3S 5S 6E)-O-TERT-BUTYL FLUVASTATIN
CAS:194935-00-7
Formula: C28H34FNO4
SR-01071-019
MW: 467.57
###############################################################################################################################################################################################################################################################
(3S 5S) (3R 5R) (3S 5R) (3R 5S)-FLUVASTATIN SODIUM SALT(MIXTURES OF ISOMERS)
Formula: C24H25FNNaO4
SA-01071-001
MW: 433.45
XU 62-320; Lescol; Lipaxan; Primexin;
(3S 8R 9R 12S)-ATAZANAVIR
Formula: C38H52N6O7
SR-02113-006
MW: 704.86
(3S 8R 9R 12S)-3 12-Bis(1 1-dimethylethyl)-8-hydroxy-4 11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2 5 6 10 13-pentaazatetradecanedioic Acid 1 14-Dimethyl Ester
(3S 8S 9S 12R)-ATAZANAVIR
CAS:1332981-16-4
Formula: C38H52N6O7
SR-02113-005
MW: 704.86
(3S 8S 9S 12R)-3 12-Bis(1 1-dimethylethyl)-8-hydroxy-4 11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2 5 6 10 13-pentaazatetradecanedioic Acid 1 14-Dimethyl Ester
(3S)
CAS:103733-66-0
Formula: C12H15NO4
SR-01111-008
MW: 237.25
(S)-1 2 3 4-Tetrahydro-6 7-dimethoxy-3-isoquinolinecarboxylic Acid
(3S)-1-TOSYL- -DIPHENYL
CAS:133099-09-9
Formula: C25H24N2O2S
SR-01418-002
MW: 416.54
(S)-1-[(4-Methylphenyl)sulfonyl]-? ?-diphenyl-3-pyrrolidineacetonitrile; (S)-2 2-Diphenyl-2-(1-tosyl-3-pyrrolidinyl)acetonitrile; 2 2-Diphenyl-2-((3S)-1-tosyl-3-pyrrolidinyl)acetonitrile; (S)-2 2-Diphenyl-2-(1-tosylpyrrolidin-3-yl)acetonitrile
(3S)-3-HYDROXY QUINIDINE
CAS:53467-23-5
Formula: C20H24N2O3
SM-01417-005
MW: 340.42
(9S)-6?-Methoxy-Cinchonan-3 9-diol; (3S)-Hydroxyquinidine; 3-Hydroxyquinidine;
(4-BROMO-2-(HYDROXYMETHYL) PHENYL)(4-FLUOROPHENYL-D4)METHANONE
Formula: C14H6D4BrFO2
SI-01040-022
MW: 313.16
(4-CHLORO-3 5-DIMETHYLPYRIDIN-2-YL)METHANOL HYDROCHLORIDE
CAS:143016-70-0
Formula: C8H11Cl2NO
SR-01127-016
MW: 208.09
4-Chloro-3 5-dimethyl-2-pyridinemethanol Hydrochloride
(4-CHLOROPHENYL)[4-(1-METHYLETHOXY)PHENYL]METHANONE(FENOFIBRATE IMPURITY)
CAS:154356-96-4
Formula: C16H15ClO2
SR-01062-009
MW: 274.74
(4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone; 3-[4-(4-Chlorobenzoyl)phenoxy]-2-propane; Fenofibrate Impurity F;
(4-CHLOROPHENYL)[4-(1-METHYLETHOXY)PHENYL]METHANONE-D7(FENOFIBRATE IMPURITY)
Formula: C16H8D7ClO2
SR-01062-010
MW: 281.79
(4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone-D7; 3-[4-(4-Chlorobenzoyl)phenoxy]-2-propane-D7; Fenofibrate Impurity F-D7
(4-DESNITRO-2-NITROPHENYL)-(R R)-CHLORAMPHENICOL
CAS:22933-62-6
Formula: C11H12Cl2N2O5
SR-02182-012
MW: 323.13
[R-(R* R*)]-2 2-Dichloro-N-[2-hydroxy-1-(hydroxymethyl)-2-(2-nitrophenyl)ethyl]-acetamide; D-threo-2 2-Dichloro-N-[?-hydroxy-?-(hydroxymethyl)-o-nitrophenethyl]-acetamide; D-threo-(1R 2R)-1-o-Nitrophenyl-2-dichloroacetamido-1 3-propanediol
(4-DESNITRO-2-NITROPHENYL)-(R S)-CHLORAMPHENICOL
Formula: C11H12Cl2N2O5
SR-02182-018
MW: 323.13
2 2-Dichloro-N-((1R 2S)-1 3-dihydroxy-1-(2-nitrophenyl)propan-2-yl)acetamide
(4-DESNITRO-2-NITROPHENYL)-(S R)-CHLORAMPHENICOL
Formula: C11H12Cl2N2O5
SR-02182-017
MW: 323.13
2 2-Dichloro-N-((1S 2R)-1 3-dihydroxy-1-(2-nitrophenyl)propan-2-yl)acetamide
(4-DESNITRO-2-NITROPHENYL)-(S S)-CHLORAMPHENICOL
Formula: C11H12Cl2N2O5
SR-02182-019
MW: 323.13
2 2-Dichloro-N-((1S 2S)-1 3-dihydroxy-1-(2-nitrophenyl)propan-2-yl)acetamide
(4-METHOXY-3,5-DIMETHYLPYRIDIN-2-YL) METHANOL HYDROCHLORIDE
CAS:96300-88-8
Formula: C9H14ClNO2
SR-01127-018
MW: 203.67
4-Methoxy-3 5-dimethyl-2-pyridinemethanol Hydrochloride
(4-PIPERIDYL)BENZHYDROL-D10
Formula: C18H11D10NO
SI-01063-008
MW: 277.43
###############################################################################################################################################################################################################################################################
(4R 6R)-6-(CYANOMETHYL)-2 2-DIMETHYL-1 3-DIOXANE-4-ACETIC ACID 1 1-DIMETHYLETHYL ESTER
CAS:125971-94-0
Formula: C14H23NO4
SR-01009-020
MW: 269.34
6-(Cyanomethyl)-2 2-dimethyl-1 3-dioxane-4-acetic acid 1 1-Dimethylethyl Ester (4R-cis)-; ((4R 6R)-6-(Cyanomethyl)-2 2-dimethyl-[1 3]dioxan-4-yl)acetic Acid tert-Butyl Ester; (6R-Cyanomethyl-2 2-dimethyl-[1 3]dioxan-4R-yl)acetic Acid tert-Butyl Ester
(4R 6R)-6-[2-[(2S)-1 2-DIHYDRO-6-HYDROXY-2-METHYL-1-NAPHTHALENYL]ETHYL]TETRAHYDRO-4-HYDROXY-2H-PYRAN-2-ONE
Formula: C18H22O4
SR-01146-023
MW: 302.36
(4R 6S)-5 6-DIHYDRO-6-METHYL-4H-THIENO[2 3-B]THIOPYRAN-4-OL 7 7-DIOXIDE
CAS:147128-77-6
Formula: C8H10O3S2
SR-01458-003
MW: 218.29
(4R-cis)-4H-Thieno[2 3-b]thiopyran-4-ol 5 6-dihydro-6-methyl-7 7-dioxide; (4R 6S)-5 6-Dihydro-4-hydroxy-6-methylthieno[2 3-b]thiopyran-7 7-dioxide
(4R 6S)-6-HYDROXYMETHYL-2 2-DIMETHYL-1 3-DIOXANE-4-ACETIC ACID 1 1-DIMETHYLETHYL ESTER
CAS:124655-09-0
Formula: C13H24O5
SR-01161-018
MW: 260.33
2 4-Dideoxy-3 5-O-(1-methylethylidene)-D-erythro-hexonic Acid 1 1-Dimethylethyl Ester; 2-[(4R 6S)-6-(Hydroxymethyl)-2 2-dimethyl-1 3-dioxan-4-yl]acetic Acid tert-Butyl Ester;
(4R)-(3 4 -DICHLOROPHENYL)-3 4-DIHYDRO-2H-NAPHTHALEN-1-ONE
CAS:155748-61-1
Formula: C16H12Cl2O
SR-01163-015
MW: 291.17
(R)-4-(3 4-Dichlorophenyl)-1-tetralone;
(4S CIS)-1 1-DIMETHYLETHYL-6-AMINOETHYL-2 2-DIMETHYL-1 3-DIOXANE-4-ACETATE
CAS:947586-93-8
Formula: C14H27NO4
SR-01009-046
MW: 273.37
(4S 6S)-6-(2-Aminoethyl)-2 2-dimethyl-1 3-dioxane-4-acetic Acid 1 1-Dimethylethyl Ester
(4S)-4-(PHENYLTHIO)-L-PROLINE HYDROCHLORIDE
CAS:105107-84-4
Formula: C11H14ClNO2S
SR-02122-008
MW: 259.75
cis-4-(Phenylthio)-L-proline Hydrochloride;
(4S)-4-(PHENYLTHIO)-L-PROLINE-D5 HYDROCHLORIDE
Formula: C11H9D5ClNO2S
SI-02122-009
MW: 264.78
cis-4-(Phenylthio)-L-proline-d5 Hydrochloride
(4S)-4-CYCLOHEXYL-1-[[HYDROXY(4-PHENYLBUTYL)PHOSPHINYL]ACETYL]-L-PROLINE PHENYLMETHYL ESTER
CAS:474382-58-6
Formula: C30H40NO5P
SI-01074-013
MW: 525.62
(2-((2S 4S)-2-((Benzyloxy)carbonyl)-4-cyclohexylpyrrolidin-1-yl)-2-oxoethyl)(4-phenylbutyl)phosphinic Acid
(4S)-4-ETHYL-7 8-DIHYDRO-4-HYDROXY-1H-PYRANO[3 4-F]INDOLIZINE-3 6 10(4H)-TRIONE
CAS:110351-94-5
Formula: C13H13NO5
SR-01248-018
MW: 263.25
(S)-4-Ethyl-7 8-dihydro-4-hydroxy-1H-pyrano[3 4-f]indolizine-3 6 10(4H)-trione
(5 )-4 5-EPOXY-3 14-DIHYDROXY-6-OXO-MORPHINAN-17-CARBOXALDEHYDE
CAS:1007856-83-8
Formula: C17H17NO5
SM-01294-016
MW: 315.32
(5 )-ANDROSTA-2 16-DIEN-17-OL 17-ACETATE
CAS:50588-42-6
Formula: C21H30O2
SR-02388-010
MW: 314.46
17-Acetoxy-5?-androsta-2 16-diene
(5 5 -BIS(2-(4-(BENZO[D]ISOTHIAZOL-3-YL)PIPERAZIN-1-YL)ETHYL)-6 6 -DICHLORO-3-HYDROXY-3 3 -BIINDOLINE-2 2 -DIONE)
CAS:1303996-68-0
Formula: C42H40Cl2N8O3S2
SR-01242-018
MW: 839.85
Ziprasidone Related Compound C;
(5 5 -BIS(2-(4-(BENZO[D]ISOTHIAZOL-3-YL)PIPERAZIN-1-YL)ETHYL)-6 6 -DICHLORO-3-HYDROXY-3 3 -BIINDOLINE-2 2 -DIONE)-D8
Formula: C42H32D8Cl2N8O3S2
SI-01242-019
MW: 847.9
Ziprasidone Related Compound C-d8; 5 5 -bis[2-[4-(1 2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6 6 -dichloro-1 1 3 3 -tetrahydro-3-hydroxy-[3 3 -bi-2H-indole]-2 2 -dione-d8
(5-(2-(4-(BENZO[D]ISOTHIAZOL-3-YL)PIPERAZIN-1-YL)ETHYL)-6-CHLOROINDOLINE-2 3-DIONE)
Formula: C21H19ClN4O2S
SR-01242-017
MW: 426.92
Ziprasidone Related Compound B;
(5-METHYL-3-PYRIDINYL)METHYL RUPATADINE
CAS:1422960-88-0
Formula: C33H34ClN4
SR-02398-004
MW: 522.1
(5E)-6-(4-HYDROXY-3-METHOXYPHENYL)-5-HEXENE-2 4-DIONE
CAS:189181-53-1
Formula: C13H14O4
SR-02219-023
MW: 234.25
(E)-6-(4-Hydroxy-3-methoxyphenyl)hex-5-ene-2 4-dione
(5E)-BIMATOPROST
CAS:1163135-95-2
Formula: C25H37NO4
SR-02067-002
MW: 415.57
"(5E)-7-[(1R 2R 3R 5S)-3 5-Dihydroxy-2-[(1E 3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide; 5-trans-Bimatoprost; "
(5E)-BIMATOPROST-D5
Formula: C25H32D5NO4
SI-02067-003
MW: 420.6
(5E)-7-[(1R 2R 3R 5S)-3 5-Dihydroxy-2-[(1E 3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide-d5; 5-trans-Bimatoprost-d5;
(5R 6S)-2-[(4-CHLOROPHENYL)AMINO]-5-HYDROXY-6-[(1R 2R)-1 2 3-TRIHYDROXYPROPYL]-5 6-DIHYDRO-4H-1 3-OXAZIN-4-ONE
Formula: C13H15ClN2O6
SR-02220-016
MW: 330.72
(5R 6S)-2-[(4-CHLOROPHENYL)AMINO]-5-HYDROXY-6-[(1R 2R)-1 2 3-TRIHYDROXYPROPYL]-5 6-DIHYDRO-4H-1 3-OXAZIN-4-ONE-D4
Formula: C13H11D4ClN2O6
SI-02220-017
MW: 334.75
(5R) -2- OXO- 3- [4- (3- OXO- 4- MORPHOLINYL) PHENYL] - 5- OXAZOLIDINECARBOXALD EHYDE
CAS:1160170-03-5
Formula: C14H14N2O5
SR-02052-020
MW: 290.27
(5R) -2- OXO- 3- [4- (3- OXO- 4- MORPHOLINYL) PHENYL] - 5- OXAZOLIDINECARBOXYLI C ACID
CAS:1160170-07-9
Formula: C14H14N2O6
SR-02052-022
MW: 306.27
(5R)-FLUCLOXACILLIN N4-[N-[[3-(2-CHLORO-6-FLUORO-PHENYL)-5-METHYL-4-ISOXAZOLYL]CARBONYL]-GLYCINYL] PENILLOIC ACID
Formula: C32H27Cl2F2N5O9S
SR-01444-006
MW: 766.55
(5R)-FLUCLOXACILLIN N4-ACETYL PENILLOIC ACID
Formula: C21H21ClFN3O7S
SR-01444-005
MW: 513.92
(5R)-FLUCLOXACILLIN PENILLOIC ACID
CAS:42947-70-6
Formula: C19H19ClFN3O6S
SR-01444-003
MW: 471.89
###############################################################################################################################################################################################################################################################
(5S 6R)-6-[(1R)-1-[3 5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY]-5-(4-FLUOROPHENYL)-3-MORPHOLINONE[APREPITANT-M3]
CAS:419574-04-2
Formula: C20H16F7NO3
SM-01376-002
MW: 451.33
Aprepitant-M3 Metabolite;
(5S 7S)-5-AMINO-7-ISOPROPYL-N-BENZYLOXYCARBONYL-8-[4-METHOXY-5-(3-METHOXYPROPOXY)BENZYL]OCTAN-1 4-DIOL (MIXTURE OF DIASTEREOMERS
Formula: C30H45NO7
SR-02048-010
MW: 531.68
(5Z 9Z 13E)-GERANYLGERANYLACETONE
CAS:3879-24-1
Formula: C23H38O
SR-01460-008
MW: 330.55
(Z Z E)-6 10 14 18-Tetramethyl-5 9 13 17-nonadecatetraen-2-one; (5Z 9Z 13E)-6 10 14 18-Tetramethylnonadeca-5 9 13 17-tetraen-2-one
(5Z 9Z 13Z)-GERANYLGERANYLACETONE
CAS:3796-67-6
Formula: C23H38O
SR-01460-007
MW: 330.55
(5Z 9Z 13Z)-6 10 14 18-Tetramethylnonadeca-5 9 13 17-tetraen-2-one; all-Z-Geranylgeranylacetone
(6 11 )-6 9-DIFLUORO-11-HYDROXYPREGNA-1 4 16-TRIENE-3 20-DIONE
CAS:1027011-66-0
Formula: C21H24F2O3
SR-02336-009
MW: 362.41
(6 11 16 )-6 9-DIFLUORO-11 21-DIHYDROXY-21-METHOXY-16 17-[(1-METHYLETHYLIDENE)BIS(OXY)]-PREGNA-1 4-DIENE-3 20-DIONE
CAS:62013-83-6
Formula: C25H32F2O7
SR-01457-006
MW: 482.51
(6 11 16 17 )-(6 11 16 17 )-17 17 -(TRITHIODICARBONYL)BIS[6 9-DIFLUORO-11-HYDROXY-16-METHYL-17-(1-OXOPROPOXY)-ANDROSTA
CAS:960071-64-1
Formula: C48H58F4O10S3
SR-01070-023
MW: 967.16
Fluticasone Impurity
(6 11 16 17 )-6 9-DIFLUORO-11-HYDROXY-16-METHYL-SPIRO[ANDROSTA-1 4-DIENE-17 5 -[1 3]OXATHIOLANE]-2 3 4 -TRIONE
CAS:219719-95-6
Formula: C22H24F2O5S
SR-02336-010
MW: 438.48
(6-AMINOHEXYL) TRIMETHYLAMMONIUM BROMIDE HYDROBROMIDE
CAS:33968-67-1
Formula: C9H24Br2N2
SR-01577-003
MW: 320.11
6-Amino-N N N-trimethyl-1-hexanaminium Bromide Hydrobromide;
(6-AMINOHEXYL) TRIMETHYLAMMONIUM CHLORIDE HYDROCHLORIDE
Formula: C9H24Cl2N2
SR-01577-006
MW: 231.21
6-Amino-N N N-trimethyl-1-hexanaminium Chloride Hydrochloride;
(6BR 12R)-12-(BENZO[D][1 3]DIOXOL-5-YL)-12A-HYDROXY-8-METHYL-8 9 12 12A-TETRAHYDROPYRAZINO[1 2 :1 2]PYRROLO[3 4-C]QUINOLINE-6 7
Formula: C22H19N3O6
SR-01484-021
MW: 421.4
Tadalafil Impurity D
(6R 12AR)-REL-6-(1 3-BENZODIOXOL-5-YL)-2 3 6 6A 7 11B 12 12A-OCTAHYDRO-2-METHYLPYRAZINO[1 2 :1 6]PYRIDO[3 4-B]INDOLE-1 4-DIONE
CAS:1217533-14-6
Formula: C22H19N3O6
SR-01484-022
MW: 421.4
(6R 7R)-7-AMINO-8-OXO-3-(1Z)-1-PROPEN-1-YL-5--THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID (>90%)
CAS:106447-44-3
Formula: C10H12N2O3S
SR-02058-007
MW: 240.28
USP Cefprozil Related Compound D;
(6R 7S)-CEFOPERAZONE
CAS:1315481-36-7
Formula: C25H27N9O8S2
SR-02316-002
MW: 645.67
(6R 7S)-7-[[(2R)-2-[[(4-Ethyl-2 3-dioxo-1-piperazinyl)carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;
(6R 7S)-CEFOPERAZONE-D4
Formula: C25H23D4N9O8S2
SI-02316-003
MW: 649.69
(6R 7S)-7-[[(2R)-2-[[(4-Ethyl-2 3-dioxo-1-piperazinyl)carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;
(6R)-TETRAHYDRO-L-BIOPTERIN-D3 SULFATE(MIXTURE OF DIASTEREOMERS)
Formula: C9H14D3N5O7S
SI-01448-011
MW: 342.34
(6R)-2-Amino-6-[(1R 2S)-1 2-dihydroxypropyl]-5 6 7 8-tetrahydro-
(6S)-TETRAHYDRO-L-BIOPTERIN DISULFATE
CAS:103130-45-6
Formula: C9H19N5O11S2
SR-01448-005
MW: 437.4
(6S)-
(6S)-TETRAHYDRO-L-BIOPTERIN-D3 DISULFATE(MIXTURE OF DIASTEREOMERS)
Formula: C9H16D3N5O11S2
SI-01448-006
MW: 440.42
(6S)-
(7 11)-DIHYDROXY-5-KETO-12 12-DIFLUOROTETRANORPROSTA-1 16-DIOIC ACID
Formula: C16H24F2O7
SM-02006-009
MW: 366.35
(8 )-9 10-DIDEHYDRO-8-[[[(1 1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]METHYL]-6-METHYLERGOLINE
CAS:1075250-72-4
Formula: C22H32N2OSi
SR-01020-016
MW: 368.59
(8 )-N-[[[3-(DIMETHYLAMINO)PROPYL]AMINO]CARBONYL]-N-ETHYL-6-(2-PROPEN-1-YL)-ERGOLINE-8-CARBOXAMIDE
CAS:81409-91-8
Formula: C26H37N5O2
SM-01020-015
MW: 451.6
(8?)-N-[[[3-(Dimethylamino)propyl]amino]carbonyl]-N-ethyl-6-(2-propenyl)-ergoline-8-carboxamide; Indolo[4 3-fg]quinoline Ergoline-8-carboxamide deriv.
(8R 11R 12R 16RS)-MISOPROSTOL ACID-D5
Formula: C21H31D5O5
SI-01110-002
MW: 373.54
"(11? 13E)-11 16-Dihydroxy-16-methyl-9-oxo-prost-13-en-1-oic Acid-d5; Misoprostol-d5 Free Acid; (+/-)-15-Deoxy-(16RS)-16-hydroxy-16-methylprogestaglandin E1-d5; "
(8R 11R 12R 16RS)-MISOPROSTOL-D5
Formula: C22H33D5O5
SI-01110-004
MW: 387.56
(11? 13E)-11 16-Dihydroxy-16-methyl-9-oxoprost-13-en-1-oic Acid-d5 Methyl Ester; Cytotec-d5; Misogon-d5; Misoprostil-d5; SC 29333-d5;
(8S 13S 14S 17R)-3-CYANOMETHYL-3-17-DIHYDROXY-13-METHYL-2 3 4 6 7 8 12 13 14 15 16 17-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17
Formula: C22H28N2O2
SR-02097-006
MW: 352.47
2-((13S 17R)-3 17-Dihydroxy-13-methyl-2 3 4 6 7 8 12 13 14 15 16 17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)acetonitrile
(9 10 13 14 )-17-METHYL-MORPHINAN-3 10-DIOL
CAS:133381-58-5
Formula: C17H23NO2
SR-01201-013
MW: 273.37
(9E)-ERYTHROMYCIN A OXIME
CAS:111321-02-9
Formula: C37H68N2O13
SR-01483-007
MW: 748.94
(9E)-Erythromycin 9-Oxime; (E)-Erythromycin A Oxime; (E)-Erythromycin Oxime
(9Z)-ERYTHROMYCIN A OXIME
CAS:134931-01-4
Formula: C37H68N2O13
SR-01483-008
MW: 748.94
(9Z)-Erythromycin 9-Oxime
(DECARBOXY) -1-OXO FEXOFENADINE-D10 METHANOL
Formula: C32H29D10NO3
SI-01063-015
MW: 495.72
1-(4-(1-Hydroxy-2-methylpropan-2-yl)phenyl)-4-(4-(hydroxydiphenyl-d5-methyl)piperidin-1-yl)butan-1-one;
(E E)-BIS(2-HYDROXYBENZYLIDENE)ACETONE(2-HBA)
CAS:131359-24-5
Formula: C17H14O3
SR-02219-021
MW: 266.29
"(1E 4E)-1 5-Bis(2-hydroxyphenyl)-1 4-pentadien-3-one; 2-HBA; (E E)-1 5-Bis(2-hydroxyphenyl)-1 4-pentadien-3-one;"
(E E)-BISDEMETHOXYCURCUMIN
CAS:33171-05-0
Formula: C19H16O4
SR-02219-011
MW: 308.33
(1E 6E)-1 7-Bis(4-hydroxyphenyl)-1 6-heptadiene-3 5-dione; (E E)-1 7-Bis(4-hydroxyphenyl)-1 6-heptadiene-3 5-dione; Bisdemethoxycurcumin; Bisdesmethoxycurcumin; Curcumin III; Didemethoxycurcumin
(E E)-BISDEMETHOXYCURCUMIN-D8
Formula: C19H8D8O4
SI-02219-012
MW: 316.38
(1E 6E)-1 7-Bis(4-hydroxyphenyl)-1 6-heptadiene-3 5-dione-d8; (E E)-1 7-Bis(4-hydroxyphenyl)-1 6-heptadiene-3 5-dione-d8; Bisdemethoxycurcumin-d8; Bisdesmethoxycurcumin-d8; Curcumin III-d8; Didemethoxycurcumin-d8;
(E)-2 3 -DEHYDRO-CINACALCET
CAS:955373-56-5
Formula: C22H20F3N
SR-01029-006
MW: 355.4
(?R)-?-Methyl-N-[(2E)-3-[3-(trifluoromethyl)phenyl]-2-propen-1-yl]-1-naphthalenemethanamine; Cinacalcet Impurity C
(E)-3 5 4 -TRIBENZYLOXYSTILBENE
CAS:89946-06-5
Formula: C35H30O3
SR-01262-026
MW: 498.61
###############################################################################################################################################################################################################################################################
(E)-3 5 4 -TRIBENZYLOXYSTILBENE-D21
Formula: C35H9D21O3
SI-01262-027
MW: 519.74
###############################################################################################################################################################################################################################################################
(E)-3-(3-(4-FLUOROPHENYL)-1-ISOPROPYL-1H-INDOL-2-YL)ACRYLALDEHYDE
CAS:93957-50-7
Formula: C20H18FNO
SR-01071-020
MW: 307.36
(E)-3-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-2-propenal; (2E)-3-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-2-propenal
(E)-3-(4-((2-HYDROXY-3-(METHOXYCARBONYL)PHENYL)DIAZENYL)BENZAMIDO)PROPANOIC ACID
Formula: C18H17N3O6
SR-02370-013
MW: 371.34
(E)-3-[(2-CYANO-3-ETHOXY-3-OXO-1-PROPENYL)AMINO]-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
CAS:52632-17-4
Formula: C12H14N4O4
SR-02090-007
MW: 278.26
Ethyl (E)-3-[(2-cyano-3-ethoxy-3-oxo-1-propenyl)amino]-1H-pyrazole-4-carboxylate; Ethyl 3-(2-carbethoxy-2-cyanoethenyl)amino-1H-pyrazole-4-carboxylate;
(E)-3-O-METHYL ENTACAPONE
CAS:857629-78-8
Formula: C15H17N3O5
SR-01054-005
MW: 319.31
"(2E)-2-Cyano-N N-diethyl-3-(4-hydroxy-3-methoxy-5-nitrophenyl)-2-propenamide; Entacapone 3-Methyl Ether; "
(E)-4-HYDROXY TOREMIFENE
CAS:177748-22-0
Formula: C26H28ClNO2
SR-01358-007
MW: 421.96
"(E)-4-[4-Chloro-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]phenol; (E)-4-Hydroxytoremifene;"
(E)-5-[(P-CARBOXYPHENYL)AZO]-2-SALICYLIC ACID DISODIUM SALT
Formula: C14H8N2Na2O5
SR-01011-016
MW: 330.2
USP Balsalazide Related Compound A;
(E)-5-[(P-CARBOXYPHENYL)AZO]-2-SALICYLIC ACID-D4
Formula: C14H6D4N2O5
SI-01011-017
MW: 290.26
(E)-6 6-DIMETHYLHEPT-2-EN-4-YN-1-OL
CAS:173200-56-1
Formula: C9H14O
SR-01173-007
MW: 138.21
(2E)-6 6-Dimethyl-2-hepten-4-yn-1-ol
(E)-AZTREONAM
CAS:99341-02-3
Formula: C13H17N5O8S2
SI-01272-005
MW: 435.43
2-[[(E)-[1-(2-Amino-4-thiazolyl)-2-[[(2S 3S)-2-methyl-4-oxo-1-sulfo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methyl-propanoic Acid; SQ 28429
(E)-CEFDINIR
CAS:178601-88-2
Formula: C14H13N5O5S2
SR-01027-003
MW: 395.41
(6R 7R)-7-[[(2E)-(2-Amino-4-thiazolyl)(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;
(E)-CEFIXIME (CEFIXIME EP IMPURITY D)
CAS:97164-56-2
Formula: C16H15N5O7S2
SR-01028-005
MW: 453.45
###############################################################################################################################################################################################################################################################
(E)-CEFPODOXIME PROXETIL
CAS:947692-13-9
Formula: C21H27N5O9S2
SR-01522-009
MW: 557.6
(6R 7R)-7-[[(2E)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 1-[[(1-Methylethoxy)carbonyl]oxy]ethyl Ester
(E)-CEFPODOXIME PROXETIL-D3
Formula: C21H24D3N5O9S2
SI-01522-010
MW: 560.62
(6R 7R)-7-[[(2E)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 1-[[(1-Methylethoxy)carbonyl]oxy]ethyl Ester-d3
(E)-CEFTIBUTEN DIHYDRATE
CAS:97519-40-9
Formula: C15H18N4O8S2
SR-02262-002
MW: 446.46
[6R-[6? 7?(E)]]-7-[[2-(2-Amino-4-thiazolyl)-4-carboxy-1-oxo-2-butenyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Dihydrate;
(E)-CEFTRIAXONE
CAS:92143-31-2
Formula: C18H18N8O7S3
SR-01028-012
MW: 554.58
"(6R 7R)-7-[[(2E)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[(1 2 5 6-tetrahydro-2-methyl-5 6-dioxo-1 2 4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; Ro 15-2254; "
(E)-CEFTRIAXONE DISODIUM
Formula: C18H16N8Na2O7S3
SR-01028-015
MW: 598.54
Sodium (6R 7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(((2-methyl-6-oxido-5-oxo-2 5-dihydro-1 2 4-triazin-3-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;
(E)-CEFTRIAXONE SODIUM
Formula: C18H17N8NaO7S3
SR-01028-013
MW: 576.56
(6R 7R)-7-[[(2E)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-3-[[(1 2 5 6-tetrahydro-2-methyl-5 6-dioxo-1 2 4-triazin-3-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium
(E)-CINNAMALDEHYDE DIMETHYL ACETAL
CAS:63511-93-3
Formula: C11H14O2
SR-02081-003
MW: 178.23
[(1E)-3 3-Dimethoxy-1-propen-1-yl]-benzene; (E)-(3 3-Dimethoxy-1-propenyl)-benzene; trans-Cinnamaldehyde Dimethyl Acetal; (1E)-(3 3-Dimethoxy-1-propenyl)-benzene
(E)-CINNAMALDEHYDE DIMETHYL ACETAL-D5
Formula: C11H9D5O2
SI-02081-004
MW: 183.26
[(1E)-3 3-Dimethoxy-1-propen-1-yl]-benzene-d5; (E)-(3 3-Dimethoxy-1-propenyl)-benzene-d5; trans-Cinnamaldehyde Dimethyl Acetal-d5; (1E)-(3 3-Dimethoxy-1-propenyl)-benzene-d5
(E)-DESCHLOROPHENYL FLUOXASTROBIN
CAS:852429-78-8
Formula: C15H13FN4O5
SM-02201-004
MW: 348.29
"6-[2-[(E)-(5 6-Dihydro-1 4 2-dioxazin-3-yl)(methoxyimino)methyl]phenoxy]-5-fluoro-4(3H)-pyrimidinone; "
(E)-DESCHLOROPHENYL FLUOXASTROBIN-D4
Formula: C15H9D4FN4O5
SI-02201-003
MW: 352.31
"6-[2-[(E)-(5 6-Dihydro-1 4 2-dioxazin-3-yl-d4)(methoxyimino)methyl]phenoxy]-5-fluoro-4(3H)-pyrimidinone; "
(E)-DIHYDRO EFAVIRENZ
CAS:440124-96-9
Formula: C14H11ClF3NO2
SR-01280-002
MW: 317.69
(4S)-6-Chloro-4-[(1E)-2-cyclopropylethenyl]-1 4-dihydro-4-(trifluoromethyl)-2H-3 1-Benzoxazin-2-one; SR 695; USP Efavirenz Related Compound B
(E)-ETHYL 4-(8-CHLORO-5H-BENZO[5 6]CYCLOHEPTA[1 2-B]PYRIDIN-11(6H)-YLIDENE)-3 4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE
Formula: C22H21ClN2O2
SR-01093-016
MW: 380.87
Dehydro Loratadine Isomer-A (Loratidine Impurity)
(E)-FLUVOXAMINE MALEATE
CAS:61718-82-9
Formula: C19H25F3N2O6
SA-01072-001
MW: 434.41
(E)-5-Methoxy-1-[4-(triflurormethyl)phenyl]-1-pentanone O-(2-Aminoethyl)oxime Maleate; DU-23000; MK-264; Dumirox; Faverin; Fevarin; Floxyfral; Luvox; Maveral;
(E)-FLUVOXAMINE-D4 MALEATE
Formula: C19H21D4F3N2O6
SI-01072-002
MW: 438.43
(E)-5-Methoxy-1-[4-(triflurormethyl)phenyl]-1-pentanone O-(2-Aminoethyl-d4)oxime Maleate; DU-23000-d4; MK-264-d4; Dumirox-d4; Faverin-d4; Fevarin-d4; Floxyfral-d4; Luvox-d4; Maveral-d4
(E)-N-(3-(3-(DIMETHYLAMINO)ACRYLOYL)PHENYL)-N-ETHYLACETAMIDE
CAS:1227694-96-3
Formula: C15H20N2O2
SR-01190-002
MW: 260.33
N-[3-[(2E)-3-(Dimethylamino)-1-oxo-2-propen-1-yl]phenyl]-N-ethyl-acetamide
(E)-N-(3-(3-(DIMETHYLAMINO)ACRYLOYL)PHENYL)-N-ETHYLACETAMIDE-D5
Formula: C15H15D5N2O2
SI-01190-003
MW: 265.36
N-[3-[(2E)-3-(Dimethylamino)-1-oxo-2-propen-1-yl]phenyl]-N-ethyl-acetamide-d5
(E)-N-(3-(3-(DIMETHYLAMINO)ACRYLOYL)PHENYL)ACETAMIDE
CAS:1227694-86-1
Formula: C13H16N2O2
SR-01190-004
MW: 232.28
N-[3-[(2E)-3-(Dimethylamino)-1-oxo-2-propen-1-yl]phenyl]-acetamide
(E)-N-BENZYL SERTRALINE
CAS:335627-22-0
Formula: C23H19Cl2N
SR-01163-026
MW: 380.31
N-[4-(3 4-Dichlorophenyl)-3 4-dihydro-1(2H)-naphthalenylidene]-benzenemethanamine; (E)-N-(4-(3 4-dichlorophenyl)-3 4-dihydronaphthalen-1(2H)-ylidene)-1-phenylmethanamine
(E)-OLOPATADINE HYDROCHLORIDE
CAS:949141-22-4
Formula: C21H24ClNO3
SA-02107-005
MW: 373.87
(11E)-
(E)-TAMOXIFEN
CAS:13002-65-8
Formula: C26H29NO
SM-01172-008
MW: 371.51
2-[4-[(1E)-1 2-Diphenyl-1-buten-1-yl]phenoxy]-N N-dimethyl-ethanamine; 2-[p-(1 2-Diphenyl-1-butenyl)phenoxy]-N N-dimethyl-ethylamine; cis-Tamoxifen;
(E/Z)-3-[(2-CYANO-3-ETHOXY-3-OXO-1-PROPENYL)AMINO]-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
CAS:321571-07-7
Formula: C12H14N4O4
SR-02090-006
MW: 278.26
"3-[(2-Cyano-3-ethoxy-3-oxo-1-propen-1-yl)amino]-1H-pyrazole-4-carboxylic Acid Ethyl Ester; (Ethyl-(E/Z)-3-(2-carbethoxy-2-cyanoethenyl)amino-1H-pyrazole-4-carboxylate); Allopurinol Related Compound F; "
(E/Z)-3-O-METHYL ENTACAPONE
CAS:146698-91-1
Formula: C15H17N3O5
SR-01054-004
MW: 319.31
"2-Cyano-N N-diethyl-3-(4-hydroxy-3-methoxy-5-nitrophenyl)-2-propenamide;(E/Z)-Entacapone 3-Methyl Ether"
(E/Z)-FK-506 26 28-ALLYLIC ESTER REARRANGEMENT IMPURITY
CAS:131944-48-4
Formula: C44H69NO12
SR-01333-009
MW: 804.02
[3R-[3R*(1R* 3R* 4R*) 4E 6S* 7S* 10R* 11E 14S* 16S* 17R* 18S* 20R* 21R* 28aS*]]-
(E/Z)-FLUOXASTROBIN-D4(MIXTURE)
Formula: C21H12D4ClFN4O5
SI-02201-002
MW: 462.85
(E/Z)-[2-[[6-(2-Chlorophenoxy)-5-fluoro-4-pyrimidinyl]oxy]phenyl](5 6-dihydro-1 4 2-dioxazin-3-yl-d4)methanone O-Methyloxime; (E/Z)-HEC 5725-d4;
(N -(BENZISOXAZOL-3-YLMETHYLSULFONYL) -N N-DIMETHYLFORMIMIDAMIDE
Formula: C11H13N3O3S
SR-01192-009
MW: 267.3
Zonisamide Related Compound C
(N 4-O)-DIACETYL-D-GLUCOSAMINE
Formula: C10H17NO7
SR-01516-015
MW: 263.24
2-(Acetylamino)-2-deoxy-D-glucose 4-Acetate; D-Glucosamine (N 4-O)-Diacetate; N-Acetyl Glucosamine 4-Acetate;
(N N 3-TRIDEMETHYL) SIBUTRAMINE HYDROCHOLRIDE
CAS:84484-93-5
Formula: C14H20ClN
SM-01164-016 
MW: 237.77
1-(1-(4-Chlorophenyl)cyclobutyl)butan-1-amine Hydrocholride; 1-?(4-?Chlorophenyl)?-??-?propylcyclobutanemethanami?ne Hydrocholride
(N N-DIDEMETHYL) 1-HYDROXY SIBUTRAMINE HYDROCHOLRIDE
CAS:186521-88-0
Formula: C15H23Cl2NO
SM-01164-014 
MW: 304.26
?-?Amino-?1-?(4-?chlorophenyl)?-??-?methylcyclobutanebutanol Hydrocholride
(N-METHYL-N-ETHYLAMINO)BUTYROPHENONE-D3 HYDROCHLORIDE
Formula: C13H17D3ClNO
SI-02342-004
MW: 244.78
2-[N-(Methyl-d3)-N-ethylamino]-1-phenyl-1-butanone Hydrochloride;
(R R S R)-NEBIVOLOL
CAS:920275-20-3
Formula: C23H27F2NO3
SR-01260-020
MW: 403.46
(?R ? S 2R 2 R)-? ? -[Iminobis(methylene)]bis[6-fluoro-3 4-dihydro-2H-1-benzopyran-2-methanol;
(R R S R)-NEBIVOLOL HYDROCHLORIDE-D4
Formula: C23H23D4F2NO3
SI-01260-021
MW: 407.49
(?R ? S 2R 2 R)-? ? -[Iminobis(methylene)]bis[6-fluoro-3 4-dihydro-2H-1-benzopyran-2-methanol-d4;
(R R S S)-NEBIVOLOL
CAS:1360598-84-0
Formula: C22H25F2NO4
SR-01260-019
MW: 405.44
(?R ? S 2R 2 S)-? ? -[Iminobis(methylene)]bis[6-fluoro-3 4-dihydro-2H-1-benzopyran-2-methanol; (R)-1-((R)-6-Fluorochroman-2-yl)-2-(((S)-2-((S)-6-fluorochroman-2-yl)-2-hydroxyethyl)amino)ethanol
(R R)-(-)-PSEUDOEPHEDRINE GLYCINAMIDE
CAS:170115-98-7
Formula: C12H18N2O2
SR-01468-010
MW: 222.28
[R-(R* R*)]-2-Amino-N-(2-hydroxy-1-methyl-2-phenylethyl)-N-methyl-acetamide; 2-Amino-N-((1R 2R)-1-hydroxy-1-phenylpropan-2-yl)-N-methylacetamide
(R R)-(-)-PSEUDOEPHEDRINE GLYCINAMIDE-D3
Formula: C12H12D6N2O2
SR-01468-011
MW: 228.32
[R-(R* R*)]-2-Amino-N-(2-hydroxy-1-methyl-2-phenylethyl)-N-methy-d3-acetamide; 2-Amino-N-((1R 2R)-1-hydroxy-1-phenylpropan-2-yl-)-N-methyl-d3-acetamide
(R R)-ETHAMBUTOL DIHYDROCHLORIDE
CAS:134566-79-3
Formula: C10H24N2O2
SR-01573-003
MW: 204.31
(2R 2 R)-2 2 -(1 2-Ethanediyldiimino)bis-1-butanol Dihydrochloride
(R R)-HYDROXY DES(BORIC ACID) BORTEZOMIB
Formula: C19H24N4O3
SR-01529-010
MW: 356.42
N-((R)-1-(((R)-1-Hydroxy-3-methylbutyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
(R R)-LABETALOL HYDROCHLORIDE
CAS:75659-08-4
Formula: C19H25ClN2O3
SR-02355-003
MW: 364.87
2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-1-methyl-3-phenylpropyl]amino]ethyl]benzamide Hydrochloride; Dilevalol Hydrochloride; Dilevalon Hydrochloride; Levadil Hydrochloride; Sch 19927 HCl; Unicard Hydrochloride
(R R)-LABETALOL-D3 HYDROCHLORIDE
Formula: C19H22D3ClN2O3
SI-02355-004
MW: 367.88
2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-1-methyl-3-phenylpropyl]amino]ethyl]benzamide-d3 Hydrochloride; Dilevalol-d3 Hydrochloride; Dilevalon-d3 Hydrochloride; Levadil-d3 Hydrochloride; Sch 19927-d3 Hydrochloride; Unicard-d3 Hydrochloride;
(R R)-SERTRALINE HYDROCHLORIDE
CAS:79645-15-1
Formula: C17H18Cl3N
SR-01163-007 
MW: 342.69
(1R 4R)-4-(3 4-Dichlorophenyl)-1 2 3 4-tetrahydro-N-methyl-1-naphthalenamine Hydrochloride; (1R-cis)-4-(3 4-Dichlorophenyl)-1 2 3 4-tetrahydro-N-methyl-1-naphthalenamine Hydrochloride
(R R)-SOLIFENACIN SUCCINATE
CAS:862207-70-3
Formula: C27H32N2O6
SR-01413-008
MW: 480.55
"(1R)-(3R)-1-Azabicyclo[2.2.2]oct-3-yl 3 4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate Butanedioic Acid; (1R 3 R)-Solifenacin Succinate; "
(R R)-TRANS-1-DESHYDROXY RASAGILINE
CAS:1276516-73-4
Formula: C12H13NO
SR-02034-012
MW: 187.24
(1R 3R)-2 3-Dihydro-3-(2-propyn-1-ylamino)-1H-inden-1-ol
(R S R S)-NEBIVOLOL
CAS:119365-24-1
Formula: C22H25F2NO4
SR-01260-022
MW: 405.44
[2R-[2R*[S*[R*(S*)]]]]-? ? -[Iminobis(methylene)]bis[6-fluoro-3 4-dihydro-2H-1-benzopyran-2-methanol; R 74829
(R S S S)-NEBIVOLOL HYDROCHLORIDE
CAS:920299-33-8
Formula: C22H26ClF2NO4
SR-01260-003
MW: 441.9
(?S ? S 2R 2 S)-? ? -[Iminobis(methylene)]bis[6-fluoro-3 4-dihydro-2H-1-benzopyran-2-methanol Hydrochloride (1:1)
(R S S)-ENALAPRIL MALEATE
CAS:1356932-13-2
Formula: C24H32N2O9
SR-01053-006
MW: 492.52
N-[(1R)-1-(Ethoxycarbonyl)-3-phenylpropyl]-L-alanyl-L-proline (2Z)-2-Butenedioate; (R)-1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-L-proline Maleate;
(R S)-4-HYDROXY CYCLOPHOSPHAMIDE PREPARATION KIT
CAS:61903-30-8
Formula: C7H15Cl2N2O3P
SM-02098-003
MW: 277.09
(2R 4S)-rel-2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1 3 2-oxazaphosphorin-4-ol 2-Oxide;
(R S)-EQUOL
CAS:94105-90-5
Formula: C15H14O3
SM-01438-023
MW: 242.27
"3 4-Dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol;4? 7-Isoflavandiol; (+/-)-Equol; 7 4 -Homoisoflavane; NV 07?; "
(R S)-EQUOL 7- -D-GLUCURONIDE SODIUM SALT
Formula: C21H21NaO9
SM-01438-019
MW: 440.38
3 4-Dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-yl-?-D-glucopyranosiduronic Acid Sodium Salt; Equol Glucuronide Sodium Salt
(R S)-EQUOL-D4 (MAJOR)(MIXTURE OF DIASTEREOMERS)
Formula: C15H10D4O3
SI-01438-024
MW: 246.29
"3 4-Dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol-d4;4? 7-Isoflavandiol-d4; (+/-)-Equol-d4; 7 4 -Homoisoflavane-d4; NV 07?-d4; "
(R S)-ETHAMBUTOL
CAS:10054-06-5
Formula: C10H24N2O2
SR-01573-002
MW: 204.31
(R* S*)-2 2 -(1 2-Ethanediyldiimino)bis-1-butanol ; (R S)-Ethambutol; meso-N N -Bis[1-(hydroxymethyl)propyl]ethylenediamine; USP Ethambutol Related Compound A;
(R S)-N-ETHYL NORCOTININE
CAS:359435-41-9
Formula: C11H14N2O
SR-01435-021
MW: 190.25
1-Ethyl-5-(3-pyridinyl)-2-pyrrolidinone;
(R S)-NORCOTININE
CAS:17708-87-1
Formula: C9H10N2O
SM-01435-019
MW: 162.19
5-(3-Pyridinyl)-2-pyrrolidinone; (+/-)-Demethylcotinine;
(R S)-NORCOTININE N-OXIDE
CAS:101708-63-8
Formula: C9H10N2O2
SM-01435-023
MW: 178.19
5-(1-Oxido-3-pyridinyl)-
(R S)-NORCOTININE-PYRIDYL-D4
CAS:1020719-70-3
Formula: C9H6D4N2O
SI-01435-020
MW: 166.21
5-(3-Pyridinyl)-2-pyrrolidinone-pyridyl-d4; (RS)-Norcotinine-d4; (+/-)-Demethylcotinine-d4; (+/-)-Norcotinine-d4;
(R) - (- ) - APOMORPHINE
CAS:58-00-4
Formula: C17H17NO2
SA-01343-004
MW: 267.32
4H-?Dibenzo[de ?g]?quinoline-?10 ?11-?diol 5 ?6 ?6a ?7-?tetrahydro-?6-?methyl-? (R)?-; 6a?-?Aporphine-?10 ?11-?diol; (-?)?-?10 ?11-?Dihydroxyaporphine; (-?)?-?Apomorphine; Apokyn; Apomorphin; Apomorphine; Ixense; l-?Apomorphine
(R) - DARIFENACIN
CAS:133099-05-5
Formula: C28H30N2O2
SA-01418-000
MW: 426.55
(R)?-1-?[2-?(2 ?3-?Dihydro-?5-?benzofuranyl)?ethyl]?-?? ??-?diphenyl-?3-?pyrrolidineacetamide?; (R)?-?(+)?-?3-?(1-?Carbamoyl-?1 ?1-?diphenylmethyl)?-?1-?[2-(2 3-dihydrobenzofuran-?5-?yl)ethyl]pyrrolidine; ent-?Darifenacin
(R) - DARIFENACIN-D4
CAS:1261734-81-9
Formula: C28H26D4N2O2
SI-01418-001
MW: 430.57
(R)?-1-?[2-?(2 ?3-?Dihydro-?5-?benzofuranyl)?ethyl]?-?? ??-?diphenyl-?3-?pyrrolidineacetamide?; (R)-(+)-3-(1-Carbamoyl-1 1-diphenylmethyl)-1-[2-(2 3-dihydrobenzofuran-5-yl)ethyl]pyrrolidine; ent-?Darifenacin
(R) - DESMETHYL SIBUTRAMINE HYDROCHLORIDE
CAS:259731-40-3
Formula: C16H25Cl2N
SM-01164-010
MW: 302.28
(?R)?-1-?(4-?Chlorophenyl)?-?N-?methyl-??-?(2-?methylpropyl)?-cyclobutanemethanami?ne Hydrochloride; (R)?-?Desmethylsibutramine Hydrochloride
(R)-(+)-4 -HYDROXYPHENYL CARVEDILOL
CAS:1217770-29-0
Formula: C24H26N2O5
SM-01025-007
MW: 422.47
"(R)-4-[2-[[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]amino]ethoxy]-3-methoxyphenol;(R)-4-Hydroxycarvedilol; (R)-BM 140686; (R)-BM 14686;"
(R)-(+)-BUPIVACAINE HYDROCHLORIDE
CAS:27262-46-0
Formula: C18H29ClN2O
SA-01017-002
MW: 324.89
1-Butyl-N-(2 6-dimethylphenyl)-2-piperidinecarboxamide Monohydrochloride; 1-Butyl-N-(2 6-dimethylphenyl)-2-piperidinecarboxamide Hydrochloride; 1-Butyl-2 6 -pipecoloxylidide Monohydrochloride;
(R)-(+)-CARVEDILOL
CAS:95093-99-5
Formula: C24H26N2O4
SA-01025-005
MW: 406.47
(+)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol; (+)-Carvedilol; (R)-Carvedilol;
(R)-(+)-DROPROPIZINE
CAS:99291-24-4
Formula: C13H20N2O2
SR-02123-004
MW: 236.31
(2R)-3-(4-Phenyl-1-piperazinyl)-1 2-propanediol; (R)-3-(4-Phenyl-1-piperazinyl)-1 2-propanediol; (+)-Dropropizine; Dextrodropropizine; d-Dropropizine;
(R)-(+)-DROPROPIZINE-D4
Formula: C13H16D4N2O2
SI-02123-005
MW: 240.33
(2R)-3-(4-Phenyl-1-piperazinyl)-1 2-propanediol-d4; (R)-3-(4-Phenyl-1-piperazinyl)-1 2-propanediol-d4; (+)-Dropropizine-d4; Dextrodropropizine-d4; d-Dropropizine-d4;
(R)-(+)-FELODIPINE
CAS:119945-59-4
Formula: C18H19Cl2NO4
SR-01060-013
MW: 384.25
(4R)-4-(2 3-Dichlorophenyl)-1 4-dihydro-2 6-dimethyl-3 5-pyridinedicarboxylic Acid 3-Ethyl 5-Methyl Ester; (+)-Felodipine; (R)-Felodipine;
(R)-(+)-FELODIPINE-D5
Formula: C18H14D5Cl2NO4
SI-01060-014
MW: 389.28
(4R)-4-(2 3-Dichlorophenyl)-1 4-dihydro-2 6-dimethyl-3 5-pyridinedicarboxylic Acid 3-Ethyl-d5 5-Methyl Ester; (+)-Felodipine-d5; (R)-Felodipine-d5
(R)-(+)-MEQUITAZINE
CAS:147780-50-5
Formula: C20H22N2S
SR-02083-002
MW: 322.47
(R)-10-(1-Azabicyclo[2.2.2]oct-3-ylmethyl)
(R)-(+)-NOR VERAPAMIL HYDROCHLORIDE
CAS:123932-43-4
Formula: C26H37ClN2O4
SM-01187-004
MW: 477.04
(?R)-?-[3-[[2-(3 4-Dimethoxyphenyl)ethyl]amino]propyl]-3 4-dimethoxy-?-(1-methylethyl)-benzeneacetonitrile Hydrochloride; (R)-Norverapamil Hydrochloride;
(R)-(+)-O-DESMETHYL CARVEDILOL
CAS:123372-14-5
Formula: C23H24N2O4
SM-01025-010
MW: 392.45
"(R)-2-[2-[[3-(9H-Carbazol-4-yloxy)-2-hydroxypropyl]amino]ethoxy]phenol;R)-(+)-O-Desmethylcarvedilol;"
(R)-(+)-PANTOPRAZOLE
CAS:142706-18-1
Formula: C16H15F2N3O4S
SA-01134-004
MW: 383.37
5-(Difluoromethoxy)-2-[(R)-[(3 4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; (+)-5-(Difluoromethoxy)-2-[[(3 4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; (+)-Pantoprazole; R-Pantoprazole
(R)-(+)-THALIDOMIDE
CAS:2614-06-4
Formula: C13H10N2O4
SR-01301-002
MW: 258.23
(R)-(+)-2-(2 6-Dioxo-3-piperidinyl)-1H-iso-indole-1 3(2H)-dione; (R)-Thalidomide; NSC 91729;
(R)-(+)-TIMOLOL MALEATE
CAS:26839-77-0
Formula: C17H28N4O7S
SA-01443-002
MW: 432.49
(2R)-1-[(1 1-Dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1 2 5-thiadiazol-3-yl]oxy]-
(R)-(+)-VERAPAMIL HYDROCHLORIDE
CAS:38176-02-2
Formula: C27H39ClN2O4
SR-01187-008
MW: 491.06
(?R)-?-[3-[[2-(3 4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3 4-dimethoxy-?-(1-methylethyl)-benzeneacetonitrile Hydrochloride; (R)-Verapamil Hydrochloride; Dexverapamil Hydrochloride; LU 33925; NSC 632821;
(R)-(-)-CLENBUTEROL
CAS:50306-03-1
Formula: C12H18Cl2N2O
SR-01524-004
MW: 277.19
"(?R)-4-Amino-3 5-dichloro-?-[[(1 1-dimethylethyl)amino]methyl]benzenemethanol; (-)-Clenbuterol; (R)-Clenbuterol;"
(R)-(-)-ETODOLAC
CAS:87226-41-3
Formula: C17H21NO3
SR-01058-008
MW: 287.35
"(1R)-1 8-Diethyl-1 3 4 9-tetrahydropyrano[3 4-b]indole-1-acetic Acid; (-)-(R)-Etodolac; (-)-Etodolac; (-)-Etodolic Acid; R-Etodolac; RAK 593; SDX 101; "
(R)-(-)-ETODOLAC-D3
Formula: C17H18D3NO3
SI-01058-006
MW: 290.37
"(1R)-1 8-(Diethyl-d3)-1 3 4 9-tetrahydropyrano[3 4-b]indole-1-acetic Acid; (-)-(R)-Etodolac-d3; (-)-Etodolac-d3; (-)-Etodolic Acid-d3; R-Etodolac-d3; RAK 593-d3; SDX 101-d3; "
(R)-(-)-FENFLURAMINE HYDROCHLORIDE
CAS:3616-78-2
Formula: C12H17ClF3N
SR-01061-004
MW: 267.72
(?R)-N-Ethyl-?-methyl-3-(trifluoromethyl)benzeneethanamine Hydrochloride; (-)-N-Ethyl-?-methyl-m-(trifluoromethyl)phenethylamine Hydrochloride; (-)-Fenfluramine Hydrochloride; l-Fenfluramine Hydrochloride;
(R)-(-)-HYDROXY CHLOROQUINE DIPHOSPHATE
CAS:158749-75-8
Formula: C18H32ClN3O9P2
SM-01033-012
MW: 531.86
(R)-2-[[4-[(7-Chloro-4-quinolinyl)amino]pentyl]ethylamino]ethanol Phosphate;
(R)-(-)-HYDROXY CHLOROQUINE-D4 DIPHOSPHATE
Formula: C18H28D4ClN3O9P2
SI-01033-013
MW: 535.89
(R)-2-[[4-[(7-Chloro-4-quinolinyl)amino]pentyl]ethylamino]ethanol-d4 Phosphate;
(R)-(-)-IBUPROFEN
CAS:51146-57-7
Formula: C13H18O2
SR-01282-014
MW: 206.28
(?R)-
(R)-(-)-IBUPROFEN-D3
Formula: C13H15D3O2
SI-01282-004
MW: 209.3
(?R)-
(R)-(-)-KETOPROFEN
CAS:56105-81-8
Formula: C16H14O3
SR-01084-022
MW: 254.28
(?R)-
(R)-(-)-KETOPROFEN-13C D3
CAS:1329496-52-7
Formula: C1513CH11D3O3
SI-01084-023
MW: 258.29
(?R)-
(R)-1-[N-[1-(ETHOXYCARBONYL)-3-PHENYLPROPYL]-L-ALANYL]-L-PROLINE PHENYLMETHYL ESTER
CAS:139492-22-1
Formula: C27H34N2O5
SM-01053-022
MW: 466.57
(R S S)-Enalapril 2?-Carboxybenzyl Ester
(R)-1-AMINOINDANE 90% EE
CAS:10277-74-4
Formula: C9H11N
SR-02157-002
MW: 133.19
(1R)-2 3-Dihydro-1H-inden-1-amine; (R)-(-)-1-Indanamine; (R)-1-Aminoindan; (R)-1-Indanylamine; (R)-2 3-Dihydro-1-Indenamine; (R)-2 3-Dihydro-1H-inden-1-amine; R-(-)-1-Aminoindane; TV 136; [(1R)-2 3-Dihydro-1H-inden-1-yl]amine;
(R)-1-AMINOINDANE-D3 HYDROCHLORIDE
Formula: C9H9D3ClN
SI-02157-001
MW: 172.67
(1R)-2 3-Dihydro-1H-inden-1-amine-d3; (R)-(-)-1-Indanamine-d3; (R)-1-Aminoindan-d3; (R)-1-Indanylamine-d3; (R)-2 3-Dihydro-1-Indenamine-d3; (R)-2 3-Dihydro-1H-inden-1-amine-d3; R-(-)-1-Aminoindane-d3; TV 136-d3; [(1R)-2 3-Dihydro-1H-inden-1-yl]amine-d3;
(R)-10-MONOHYDROXY-10 11-DIHYDRO CARBAMAZEPINE
CAS:104746-03-4
Formula: C15H14N2O2
SM-01130-004
MW: 254.28
(10R)-
(R)-2 -O-DESETHYL-2 -O-DESMETHYL TAMSULOSIN HYDROCHLORIDE(IMPURITY)
Formula: C19H27ClN2O5S
SR-01238-009
MW: 430.95
2-Methoxy-5-[(2R)-2-[(2-(2-methoxyphenoxy)ethyl)propyl]benzenesulphonamide Hydrochloride;
(R)-2 -O-DESETHYL-2 -O-DESMETHYL TAMSULOSIN-D3 HYDROCHLORIDE(IMPURITY)
Formula: C19H24D3ClN2O5S
SR-01238-010
MW: 433.96
2-Methoxy-5-[(2R)-2-[(2-(2-methoxyphenoxy)ethyl)propyl]benzenesulphonamide Hydrochloride-D3;
(R)-2-CYCLOHEXYL-2-HYDROXYPHENYLACETIC ACID
CAS:20585-39-1
Formula: C14H18O3
"SR-01131-018"
MW: 234.29
(R)-2 -Cyclohexylmandelic Acid; (R)-Cyclohexylhydroxyphenylacetic Acid
(R)-3 -HYDROXY PRAVASTATIN SODIUM SALT
CAS:722504-46-3
Formula: C23H35NaO8
SR-01146-014
MW: 462.51
(?R ?R 1S 2S 6S 8S 8aR)-1 2 6 7 8 8a-Hexahydro-? ? 6-trihydroxy-8-[(2S 3R)-3-hydroxy-2-methyl-1-oxobutoxy]-2-methyl-1-naphthaleneheptanoic Acid Sodium;
(R)-3-((TERT-BUTOXYCARBONYL)AMINO)-4-(2 4 5-TRIFLUOROPHENYL)BUTANOIC ACID
CAS:486460-00-8
Formula: C15H18F3NO4
SR-02014-002
MW: 333.3
###############################################################################################################################################################################################################################################################
(R)-3-(4-CHLOROPHENYL)-4-HYDROXYBUTYRIC ACID SODIUM SALT
Formula: C10H10ClNaO3
SR-02241-008
MW: 236.63
(R)-4-Chloro-?-(hydroxymethyl)-benzenepropanoic Acid Sodium Salt; (R)-?-(p-Chlorophenyl)-?-hydroxybutyric Acid Sodium Salt;
(R)-3-CHLORO-1-PHENYL-1-(2-METHYLPHENOXY)PROPANE
CAS:114446-47-8
Formula: C16H17ClO
SR-01472-015
MW: 260.76
1-[(1R)-3-Chloro-1-phenylpropoxy]-2-methylbenzene;
(R)-3-CHLORO-1-PHENYL-1-(2-METHYLPHENOXY-D7)PROPANE
CAS:1217765-70-2
Formula: C16H10D7ClO
SI-01472-016
MW: 267.8
1-[(1R)-3-Chloro-1-phenylpropoxy]-2-methylbenzene-d7;
(R)-4 4 -[OXYBIS(METHYLENE)]BIS[2-[(1R)-3-[BIS(1-METHYLETHYL)AMINO]-1-PHENYLPROPYL]-PHENOL DIFUMARATE
Formula: C52H68N2O11
SR-01510-013
MW: 897.1
"Fesoterodine Diol Dimer Difumarate"
(R)-4-METHYL KETOPROFEN
Formula: C17H16O3
SM-01084-031
MW: 268.31
(R)-4-METHYL KETOPROFEN-D3
Formula: C17H13D3O3
SI-01084-032
MW: 271.33
(R)-5-HYDROXYMETHYL TOLTERODINE FORMATE
CAS:380636-49-7
Formula: C23H33NO4
SM-01249-001
MW: 387.51
(R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol Formate;
(R)-5-HYDROXYMETHYL TOLTERODINE METHACRYLATE
CAS:1390644-37-7
Formula: C26H35NO3
SR-01510-010
MW: 409.56
2-Methyl-2-propenoic Acid 2-[(1R)-3-[bis(1-Methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl Ester; (R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl Methacrylate
(R)-8-HYDROXY WARFARIN
CAS:63740-77-2
Formula: C19H16O5
SM-01188-010
MW: 324.33
4 8-Dihydroxy-3-[(1R)-3-oxo-1-phenylbutyl]-2H-1-benzopyran-2-one; (R)-4 8-dihydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-Benzopyran-2-one; (R)-8-Hydroxywarfarin; 8-Hydroxy-R-warfarin; R-8-Hydroxywarfarin;
(R)-9-[2-(HYDROXYPROPYL] ADENINE(DESPHOSPHORYL TENOFOVIR)
CAS:14047-28-0
Formula: C8H11N5O
SR-02018-002
MW: 193.21
D-(-)-9-(2-Hydroxypropyl)adenine; (?R)-6-Amino-?-methyl-9H-purine-9-ethanol;
(R)-9-HYDROXY RISPERIDONE
CAS:130049-85-3
Formula: C23H27FN4O3
SM-01159-005
MW: 426.48
"(9R)-3-[2-[4-(6-Fluoro-1 2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6 7 8 9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1 2-a]pyrimidin-4-one; "
(R)-ACENOCOUMAROL
CAS:66556-77-2
Formula: C19H15NO6
SR-02198-004
MW: 353.33
(R)-4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-1-benzopyran-2-one; (+)-3-(?-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin; (+)-Acenocoumarin; (R)-(+)-Acenocoumarol; (R)-(+)-Nicoumalone;
(R)-ALBUTEROL HYDROCHLORIDE
CAS:50293-90-8
Formula: C13H22ClNO3
SA-01002-003
MW: 275.77
"(?1R)-?1-[[(1 1-Dimethylethyl)amino]methyl]-4-hydroxy-1 3-benzenedimethanol Hydrochloride; (-)-Salbutamol Hydrochloride; (R)-Salbutamol Hydrochloride; Levalbuterol Hydrochloride; Levosalbutamol Hydrochloride; Xopenex;"
(R)-ALBUTEROL-D9 HYDROCHLORIDE
Formula: C13H13D9ClNO3
SI-01002-004
MW: 284.83
"(?1R)-?1-[[(1 1-Dimethylethyl)amino]methyl]-4-hydroxy-1 3-benzenedimethanol-d9 Hydrochloride; (-)-Salbutamol-d9 Hydrochloride; (R)-Salbutamol-d9 Hydrochloride; Levalbuterol-d9 Hydrochloride; Levosalbutamol-d9 Hydrochloride; Xopenex-d9;"
(R)-AMLODIPINE-D4
Formula: C20H21D4ClN2O5
SI-01005-005
MW: 412.9
(4R)-2-[[2-Amino(ethoxy-d4)]ethyl]-4-(2-chlorophenyl)-1 4-dihydro-6-methyl-3 5-pyridinedicarboxylic Acid 3-Ethyl 5-Methyl Ester; (+)-Amlodipine-d4; (R)-(+)-Amlodipine-d4; d-Amlodipine-d4;
(R)-AMPHETAMINE HYDROCHLORIDE
CAS:41820-21-7
Formula: C9H14ClN
SR-01420-001
MW: 171.67
(?R)-?-Methyl-benzeneethanamine Hydrochloride; (-)-(R)-Amphetamine Hydrochloride; (-)-Amphetamine Hydrochloride; (-)-Phenaminum Hydrochloride; Levamfetamine Hydrochloride; l-(-)-Amphetamine Hydrochloride; l-?-Methylphenethylamine Hydrochloride
(R)-APOMORPHINE-D5 HYDROCHLORIDE (MAJOR)
CAS:76787-63-8
Formula: C17H13D5ClNO2
SI-01343-005
MW: 308.81
(R)-5 6 6a 7-Tetrahydro-6-methyl-4H-dibenzo[de g]quinoline-1 2 3 8 9-d5-10 11-diol-d5 Hydrochloride
(R)-ATENOLOL
CAS:56715-13-0
Formula: C14H22N2O3
SR-01008-002
MW: 266.34
"4-[(2R)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide; (+)-(R)-Atenolol; (+)-Atenolol; (R)-(+)-Atenolol; "
(R)-ATENOLOL-D7
CAS:1309283-25-7
Formula: C14H15D7N2O3
SI-01008-003
MW: 273.38
"4-[(2R)-2-Hydroxy-3-[(1-methylethyl-d7)amino]propoxy]benzeneacetamide; (+)-(R)-Atenolol-d7; (+)-Atenolol-d7; (R)-(+)-Atenolol-d7; "
(R)-AZELASTINE HYDROCHLORIDE
CAS:153408-28-7
Formula: C22H25Cl2N3O
SR-01360-003
MW: 418.36
(R)-4-[(4-Chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinone Hydrochloride; (-)-Azelastine Hydrochloride;
(R)-AZELASTINE N-OXIDE (MIXTURE OF DIASTEREOMERS)
Formula: C22H24ClN3O2
SM-01360-009
MW: 397.9
(R)-4-[(4-Chlorophenyl)methyl]-2-(hexahydro-1-methyl-1-oxido-1H-azepin-4-yl)-1(2H)-phthalazinone; (-)-Azelastine N-Oxide;
(R)-BACLOFEN
CAS:69308-37-8
Formula: C10H12ClNO2
SR-02241-002
MW: 213.66
(?R)-?-(Aminomethyl)-4-chlorobenzenepropanoic Acid; (-)-Baclofen; (R)-(-)-Baclofen; (R)-4-Amino-3-(4-chlorophenyl)butanoic Acid; (R)-4-Amino-3-(4-chlorophenyl)butyric Acid; D-Baclofen; R-(-)-Baclofen; l-Baclofen; AGI 006; Arbaclofen
(R)-BENDROFLUMETHIAZIDE
CAS:1087345-31-0
Formula: C15H14F3N3O4S2
SR-01326-002
MW: 421.41
(3R)-3 4-Dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-2H-1 2 4-benzothiadiazine-7-sulfonamide 1 1-Dioxide;
(R)-BETAXOLOL HYDROCHLORIDE
CAS:91878-54-5
Formula: C18H30ClNO3
SR-02259-002
MW: 343.89
"(2R)-1-[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanolHydrochloride; (+)-Betaxolol Hydrochloride; (R)-(+)-Betaxolol Hydrochloride; Dextrobetaxolol Hydrochloride; "
(R)-BETAXOLOL-D7 HYDROCHLORIDE
Formula: C18H23D7ClNO3
SI-02259-003
MW: 350.93
"(2R)-1-[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]-3-[(1-methylethyl-d7)amino]-2-propanolHydrochloride; (+)-Betaxolol-d7 Hydrochloride; (R)-(+)-Betaxolol-d7 Hydrochloride; Dextrobetaxolol-d7 Hydrochloride; "
(R)-BICALUTAMIDE
CAS:113299-40-4
Formula: C18H14F4N2O4S
SA-01014-001
MW: 430.37
(2R)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide; (R)-Casodex;
(R)-BICALUTAMIDE-D4
Formula: C18H10D4F4N2O4S
SI-01014-003
MW: 434.4
(2R)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl-d4)sulfonyl]-2-hydroxy-2-methylpropanamide; (R)-Casodex-d4;
(R)-BUFURALOL HYDROCHLORIDE
CAS:57704-11-7
Formula: C16H24ClNO2
SR-01386-004
MW: 297.82
(?R)-?-[[(1 1-Dimethylethyl)amino]methyl]-7-ethyl-2-benzofuranmethanol; (+)-Bufuralol Hydrochloride; d-Bufuralol Hydrochloride;
(R)-BUPROPION D-TARTARIC ACID SALT
Formula: C17H24ClNO7
SR-01018-012
MW: 389.83
(2R)-
(R)-CARISBAMATE
CAS:194085-74-0
Formula: C9H10ClNO3
SR-02145-003
MW: 215.63
(1R)-1-(2-Chlorophenyl)-
(R)-CARISBAMATE -D-O-GLUCURONIDE
CAS:940279-83-4
Formula: C15H18ClNO9
SM-02145-006
MW: 391.76
(1R)-2-[(Aminocarbonyl)oxy]-1-(2-chlorophenyl)ethyl ?-D-Glucopyranosiduronic Acid;
(R)-CARISBAMATE-D4
Formula: C9H6D4ClNO3
SI-02145-004
MW: 219.66
(1R)-1-(2-Chlorophenyl-d4)-1 2-ethanediol 2-Carbamate;
(R)-CETIRIZINE DIHYDROCHLORIDE
CAS:130018-77-8
Formula: C21H27Cl3N2O3
SM-01032-006
MW: 461.81
2-[2-[4-[(R)-(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic Acid Dihydrochloride; (-)-Cetirizine Dihydrochloride; Levocetirizine Dihydrochloride;
(R)-CETIRIZINE-D4 DIHYDROCHLORIDE
Formula: C21H23D4Cl3N2O3
SI-01032-003
MW: 465.83
2-[2-[4-[(R)-(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy-d4]acetic Acid Dihydrochloride; (-)-Cetirizine-d4 Dihydrochloride; Levocetirizine-d4 Dihydrochloride;
(R)-CITADIOL
CAS:481047-48-7
Formula: C20H23FN2O2
SR-01040-026
MW: 342.41
###############################################################################################################################################################################################################################################################
(R)-CITALOPRAM OXALATE
CAS:219861-53-7
Formula: C22H23FN2O5
SA-01040-003
MW: 414.43
1-(3-Dimethylaminopropyl)-1-(4-fluoro-phenyl)-1 3-dihydro-isobenzofuran-5-carbonitrile Oxalate;
(R)-DE(AMINOSULFONYL) TAMSULOSIN
CAS:1329611-47-3
Formula: C20H27NO3
SR-01238-006
MW: 329.43
(2R)-N-[2-(2-Ethoxyphenoxy)ethyl)-1-(4-methoxyphenyl)propan-2-amine;
(R)-DESMETHYL CITALOPRAM HYDROCHLORIDE
CAS:144010-85-5
Formula: C19H20ClFN2O
SM-01040-014
MW: 346.83
(1R)-1-(4-Fluorophenyl)-1 3-dihydro-1-[3-(methylamino)propyl]-5-isobenzofurancarbonitrile Hydrochloride; (R)-(-)-N-Demethylcitalopram Hydrochloride;
(R)-DOXYLAMINE-D5
Formula: C17H17D5N2O
SI-02032-011
MW: 275.4
N N-Dimethyl-2-[(1R)-1-phenyl-d5-1-(2-pyridinyl)ethoxy]ethanamine; (R)-N N-Dimethyl-2-(1-phenyl-d5-1-(pyridin-2-yl)ethoxy)ethanamine
(R)-ESMOLOL ACID
CAS:910651-37-5
Formula: C15H23NO4
SR-01055-006
MW: 281.35
"4-[(2R)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzenepropanoic Acid; "
(R)-ESMOLOL HYDROCHLORIDE
CAS:118629-36-0
Formula: C16H26ClNO4
SR-01055-004
MW: 331.83
4-[(2R)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzenepropanoic Acid Methyl Ester Hydrochloride;
(R)-FESOTERODINE FUMARATE
CAS:286930-03-8
Formula: C30H41NO7
SA-01510-001
MW: 527.65
"2-Methylpropanoic Acid 2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl Ester (2E)-2-Butenedioate; SMP 8272; SPM 907;"
(R)-HYDROXY DES(BORIC ACID) BORTEZOMIB
CAS:289472-78-2
Formula: C19H24N4O3
SR-01529-008
MW: 356.42
N-[(1S)-2-[[(1R)-1-Hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide; N-[(1S)-2-[[(1R)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]pyrazinecarboxamide;
(R)-HYDROXY ILOPERIDONE
CAS:501373-87-1
Formula: C24H29FN2O4
SR-02271-010
MW: 428.5
(?R)-4-[3-[4-(6-Fluoro-1 2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-?-methyl-benzenemethanol;
(R)-HYDROXY ILOPERIDONE-D3
Formula: C24H26D3FN2O4
SI-02271-011
MW: 431.51
(?R)-4-[3-[4-(6-Fluoro-1 2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-?-methyl-benzenemethanol-d3;
(R)-HYDROXYMELPHALAN TRIFLUOROACETIC ACID SALT
Formula: C15H20ClF3N2O5
SR-01491-007
MW: 400.78
4-[(2-Chloroethyl)(2-hydroxyethyl)amino]-D-phenylalanine Trifluoroacetic Acid Salt
(R)-HYDROXYMELPHALAN-D4 TRIFLUOROACETIC ACID SALT
Formula: C15H16D4ClF3N2O5
SI-01491-008
MW: 404.8
4-[(2-Chloroethyl)(2-hydroxyethyl)amino]-D-phenylalanine-d4 Trifluoroacetic Acid Salt
(R)-IRINOTECAN HYDROCHLORIDE TRIHYDRATE
Formula: C33H45ClN4O9?3H2O
SR-01248-012
MW: 677.18
(4R)-4 11-Diethyl-3 4 12 14-tetrahydro-4-hydroxy-3 14-dioxo-1H-pyrano[3? 4?:6 7]indolizino[1 2-b]quinolin-9-yl Ester [1 4?-Bipiperidine]-1?-carboxylic Acid Hydrochloride Trihydrate; USP Irinotecan Related Compound D;
(R)-IRINOTECAN HYDROCHLORIDE-D10 TRIHYDRATE
Formula: C33H29D10ClN4O6
SI-01248-013
MW: 633.2
[1 4 -Bipiperidine]-1 -carboxylic acid (4R)-4 11-diethyl-3 4 12 14-tetrahydro-4-hydroxy-3 14-dioxo-1H-pyrano[3 4 :6 7]indolizino[1 2-b]quinolin-9-yl ester
(R)-KETAMINE HYDROCHLORIDE
CAS:33795-24-3
Formula: C13H17Cl2NO
SR-01392-005
MW: 274.19
(2R)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone Hydrochloride; (+)- 2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone Hydrochloride; (-)-(R)-Ketamine Hydrochloride; (R)-(+)-Ketamine Hydrochloride;
(R)-KETAMINE-D6 HYDROCHLORIDE
Formula: C13H11D6Cl2NO
SI-01392-006
MW: 280.22
(2R)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone-d6 Hydrochloride; (+)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone-d6 Hydrochloride; (-)-(R)-Ketamine-d6 Hydrochloride; (R)-(+)-Ketamine-d6 Hydrochloride
(R)-KETOPROFEN -D-GLUCURONIDE ALLYL ESTER
Formula: C25H26O9
SM-01084-038
MW: 470.47
(R)-1-(3-Benzoly-?-methylbenzeneacetate)-?-D-glucopyranuronic Acid Allyl Ester; (R)-Ketoprofen Glucuronide Allyl Ester; (R)-Ketoprofen Allyl Glucuronate
(R)-KETOPROFEN ACYL- -D-GLUCURONIDE
CAS:140148-25-0
Formula: C22H22O9
SM-01084-024
MW: 430.4
1-[(?R)-3-Benzoyl-?-methylbenzeneacetate]
(R)-LANSOPRAZOLE
CAS:138530-94-6
Formula: C16H14F3N3O2S
SA-01087-006
MW: 369.36
2-[(R)-[[3-Methyl-4-(2 2 2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-
(R)-LANSOPRAZOLE-D4
Formula: C16H10D4F3N3O2S
SI-01087-007
MW: 373.39
2-[(R)-[[3-Methyl-4-(2 2 2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-
(R)-LERCANIDIPINE HYDROCHLORIDE
CAS:187731-34-6
Formula: C36H42ClN3O6
SR-02267-005
MW: 648.19
(4R)-1 4-Dihydro-2 6-dimethyl-4-(3-nitrophenyl)-3 5-pyridinedicarboxylic Acid 2-[(3 3-Diphenylpropyl)methylamino]-1 1-dimethylethyl Methyl Ester Hydrochloride;
(R)-LEVETIRACETAM
CAS:103765-01-1
Formula: C8H14N2O2
SR-01196-004
MW: 170.21
"(?R)-?-Ethyl-2-oxo-1-pyrrolidineacetamide; (R)-?-ethyl-2-oxo-1-pyrrolidineacetamide; (2R)-2-(2-Oxo-pyrrolidin-1-yl)butanamide; UCB-L 060; "
(R)-LINEZOLID
CAS:872992-20-6
Formula: C16H20FN3O4
SM-01227-002
MW: 337.35
N-[[(5R)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;
(R)-LOFEXIDINE
CAS:81447-78-1
Formula: C11H12Cl2N2O
SR-02084-002
MW: 259.13
2-[(1R)-1-(2 6-Dichlorophenoxy)ethyl]-4 5-dihydro-
(R)-LORAZEPAM
CAS:91402-80-1
Formula: C15H10Cl2N2O2
SR-02410-005
MW: 321.16
(R)-7-Chloro-5-(2-chlorophenyl)-1 3-dihydro-3-hydroxy-2H-1 4-benzodiazepin-2-one; (-)-Lorazepam;
(R)-METHADONE HYDROCHLORIDE
CAS:5967-73-7
Formula: C21H28CLNO
SM-01236-001
MW: 345.91
(6R)-6-(Dimethylamino)-4 4-diphenyl-3-heptanone Hydrochloride; L-6-(Dimethylamino)-4 4-diphenyl-3-heptanone Hydrochloride; (-)-Methadone Hydrochloride; Levomethadone Hydrochloride; Levothyl Hydrochloride; Polamivet Hydrochloride;
(R)-METHOTRIMEPRAZINE
CAS:60-99-1
Formula: C19H24N2OS
SR-01377-006
MW: 328.47
###############################################################################################################################################################################################################################################################
(R)-METOPROLOL
CAS:81024-43-3
Formula: C15H25NO3
SA-01103-003
MW: 267.36
(2R)-
(R)-MODAFINIL
CAS:112111-43-0
Formula: C15H15NO2S
SA-01349-004
MW: 273.35
2-[(R)-(diphenylmethyl)sulfinyl]acetamide; (-)-Modafinil; (R)-(-)-Modafinil; Armodafinil;
(R)-MODAFINIL-D10
Formula: C15H5D10NO2S
SI-01349-005
MW: 283.41
"2-[(R)-(Diphenylmethyl)sulfinyl]acetamide-d10; (-)-Modafinil-d10; (R)-(-)-Modafinil-d10; Armodafinil-d10; CEP 10952-d10; CRL 40982-d10;"
(R)-N-((R)-1-(NAPHTHALEN-1-YL)ETHYL)-2-(3-(TRIFLUOROMETHYL)PHENYL)PROPAN-1-AMINE
Formula: C22H22F3N
SR-01029-014
MW: 357.41
(R)-N-(1-(NAPHTHALEN-1-YL)ETHYL)-3-(M-TOLYL)PROPANAMIDE
Formula: C22H23NO
SR-01029-012
MW: 317.42
(R)-N-BENZYL-1-(1-NAPHTHYL)ETHYLAMINE
CAS:66469-40-7
Formula: C19H19N
SR-01029-008
MW: 261.36
(?R)-?-Methyl-N-(phenylmethyl)-1-naphthalenemethanamine; (R)-?-Methyl-N-(phenylmethyl)-1-naphthalenemethanamine; (R)-(-)-N-Benzyl-1-(1-naphthyl)ethylamine; Cinacalcet Impurity B
(R)-N-DEMETHYL DAPOXETINE
CAS:1202160-36-8
Formula: C20H21NO
SM-02110-008
MW: 291.39
(?R)-N-Methyl-?-[2-(1-naphthalenyloxy)ethyl]benzenemethanamine;
(R)-N-DESETHYL OXYBUTYNIN HYDROCHLORIDE
CAS:181647-12-1
Formula: C20H28ClNO3
SM-01131-006
MW: 365.89
"(?R)-?-Cyclohexyl-?-hydroxybenzeneacetic Acid 4-(Ethylamino)-2-butyn-1-yl Ester Hydrochloride; "
(R)-N-ETHYL-N N-DIMETHYL-2-(PHENYL(O-TOLYL)METHOXY)ETHANAMINIUM CHLORIDE
Formula: C20H28ClNO
SR-01350-011
MW: 333.9
USP Orphenadrine Related Compound B;
(R)-O-DESMETHYL NAPROXEN
CAS:123050-98-6
Formula: C13H12O3
SR-01115-010
MW: 216.23
(?R)-6-Hydroxy-?-methyl-2-naphthaleneacetic Acid; (R)-2-(6-Hydroxy-2-naphthyl)propionic Acid;
(R)-OMEPRAZOLE
CAS:119141-89-8
Formula: C17H19N3O3S
SA-01127-008
MW: 345.42
###############################################################################################################################################################################################################################################################
(R)-ORPHENADRINE CITRATE
Formula: C24H31NO8
SR-01350-008
MW: 461.5
USP Orphenadrine Related Compound A; (RS)-N N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine Citrate;
(R)-OXYBUTYNIN CHLORIDE
CAS:1207344-05-5
Formula: C22H32ClNO3
SR-01131-003
MW: 393.95
(R)-?-Phenylcyclohexaneglycolic Acid 4-(Diethylamino)-2-butynyl Ester Hydrochloride
(R)-PHENOXYBENZAMINE HYDROCHLORIDE
CAS:16053-59-1
Formula: C18H23Cl2NO
SR-01139-004
MW: 340.29
(R)-N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzenemethanamine Hydrochloride; (+)-N-Benzyl-N-(2-chloroethyl)-1-phenoxyisopropylamine Hydrochloride; (+)-Phenoxybenzamine Hydrochloride; d-Phenoxybenzamine Hydrochloride;
(R)-PHENPROCOUMON
CAS:599-27-9
Formula: C18H16O3
SM-02192-005
MW: 280.32
(R)-4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one; (R)-(+)-3-(?-Ethylbenzyl)-4-hydroxy-coumarin; (+)-Phenprocoumon; (R)-(+)-Phenprocoumon;
(R)-PHENYLEPHRINE -D-GLUCURONIDE
Formula: C15H21NO8
SM-01296-005
MW: 343.33
(R)-PRAMIPEXOLE DIHYDROCHLORIDE
CAS:104632-28-2
Formula: C10H19Cl2N3S
SA-01145-002
MW: 284.25
(R)-4 5 6 7-Tetrahydro-N6-propyl-2 6-benzothiazolediamine Dihydrochloride; R-(+)-Pramipexole Dihydrochloride
(R)-PRASUGREL THIOLACTONE
Formula: C18H18FNO2S
SM-02112-008
MW: 331.4
5-((R)-2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-5 6 7 7a-tetrahydrothieno[3 2-c]pyridin-2(4H)-one
(R)-PROPRANOLOL -D-GLUCURONIDE SODIUM SALT
CAS:87102-70-3
Formula: C22H28NNaO8
SM-01149-009
MW: 457.45
(R)-1-[[(1-Methylethyl)amino]methyl]-2-(1-naphthalenyloxy)ethyl ?-D-Glucopyranosiduronic Acid Monosodium Salt; (+)-Propranolol Glucuronide Sodium; (R)-Propranolol Glucuronide Sodium;
(R)-RABEPRAZOLE SODIUM SALT
CAS:171440-18-9
Formula: C18H21N3NaO3S
SR-01298-017
MW: 382.43
2-[(R)-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole Sodium Salt; R-(+)-Rabeprazole Sodium Salt;
(R)-RABEPRAZOLE-D3 SODIUM SALT
CAS:1216494-11-9
Formula: C18H18D3N3NaO3S
SI-01298-018
MW: 385.45
2-[(R)-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole-d3 Sodium Salt; R-(+)-Rabeprazole-d3 Sodium Salt;
(R)-RAMELTEON
CAS:196597-27-0
Formula: C16H21NO2
SR-02307-004
MW: 259.34
"N-[2-[(8R)-1 6 7 8-Tetrahydro-2H-indeno[5 4-b]furan-8-yl]ethyl]propanamide;(R)-N-[2-(1 6 7 8-tetrahydro-2H-indeno[5 4-b]furan-8-yl)ethyl]propanamide; "
(R)-RIVASTIGMINE TARTRATE SALT
Formula: C18H28N2O8
SM-01199-003
MW: 400.42
N-Ethyl-N-methylcarbamic Acid 3-[(1R)-1-(Dimethylamino)ethyl]phenyl Ester (2R 3R)-2 3-Dihydroxybutanedioate; SDZ 212712 Tartrate;
(R)-SERTACONAZOLE
CAS:583057-48-1
Formula: C20H15Cl3N2OS
SR-02164-004
MW: 437.77
1-[(2R)-2-[(7-Chlorobenzo[b]thien-3-yl)methoxy]-2-(2 4-dichlorophenyl)ethyl]-1H-Imidazole; Arasertaconazole;
(R)-SERTACONAZOLE-D6
Formula: C20H9D6Cl3N2OS
SI-02164-005
MW: 443.81
1-[(2R)-2-[(7-Chlorobenzo[b]thien-3-yl)methoxy]-2-(2 4-dichlorophenyl)ethyl]-1H-Imidazole-d6; Arasertaconazole-d6;
(R)-SIBUTRAMINE (R)-MANDELATE
Formula: C25H34ClNO3
SA-01164-018
MW: 432
(R)-1-(1-(4-Chlorophenyl)cyclobutyl)-N N 3-trimethylbutan-1-amine (R)-2-Hydroxy-2-phenylacetate
(R)-SIBUTRAMINE HYDROCHLORIDE
Formula: C17H27Cl2N
SA-01164-008 
MW: 316.31
(R)-1-?(4-?Chlorophenyl)?-?N ?N-?dimethyl-??-?(2-?methylpropyl)cyclobutanemethanami?ne Hydrochloride; (R)-BTS 54524; (R)-Reductil; (R)-Vazy
(R)-SN-38
CAS:647852-82-2
Formula: C22H20N2O5
SR-02130-002
MW: 392.4
(4R)-4 11-Diethyl-4 9-dihydroxy-1H-pyrano[3 4 :6 7]indolizino[1 2-b]quinoline-3 14(4H 12H)dione;
(R)-TAMSULOSIN HYDROCHLORIDE
CAS:106463-17-6
Formula: C20H29ClN2O5S
SA-01238-000
MW: 444.97
5-[(2R)-2-[[2-(-Ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride; Flomax; Harnal; Omnic; Pradif; YM 12617-1; YM 617; Yutanal;
(R)-TAMSULOSIN-D3 HYDROCHLORIDE
Formula: C20H26D3ClN2O5S
SI-01238-003
MW: 447.99
5-[(2R)-2-[[2-(-Ethoxyphenoxy)ethyl]amino]propyl-d3]-2-methoxybenzenesulfonamide Hydrochloride; Flomax-d3; Harnal-d3; Omnic-d3; Pradif-d3; YM 12617-1-d3; YM 617-d3; Yutanal-d3;
(R)-TAMSULOSIN-D4 HYDROCHLORIDE
Formula: C20H25D4ClN2O5S
SI-01238-001
MW: 449
5-[(2R)-2-[[2-(-Ethoxyphenoxy)ethyl-d4]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride; Flomax-d4; Harnal-d4; Omnic-d4; Pradif-d4; YM 12617-1-d4; YM 617-d4; Yutanal-d4
(R)-TIAGABINE 4-CARBOXY-O-ETHYL HYDROCHLORIDE
CAS:145821-60-9
Formula: C22H30ClNO2S2
SR-01302-008
MW: 440.06
(R)-1-[4 4-Bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic Acid Ethyl Ester Hydrochloride; Ethyl Tiagabinate Hydrochloride; USP Tiagabine Hydrochloride Related Compound A;
(R)-TIMOLOL
CAS:26839-76-9
Formula: C13H24N4O3S
SR-01443-003
MW: 316.42
(+)-Timolol; (R)-(+)-Timolol; L 714465; d-Timolol; (R)-1-[(1 1-Dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1 2 5-thiadiazol-3-yl]oxy]-2-propanol; (+)-1-(tert-Butylamino)-3-[(4-morpholino-1 2 5-thiadiazol-3-yl)oxy]-2-propanol
(R)-VALIOLAMINE VOGLIBOSE
CAS:1303996-67-9
Formula: C17H34N2O11
SR-01331-001
MW: 442.46
4 4 -[[(1R)-1-(Hydroxymethyl)-1 2-ethanediyl]diimino]bis[3 4-dideoxy-2-C-(hydroxymethyl)-D-epi-inositol;
(R)-VILOXAZINE HYDROCHLORIDE
CAS:56287-63-9
Formula: C13H20ClNO3
SR-02431-004
MW: 273.76
(R)-
(R)-VILOXAZINE-D5 HYDROCHLORIDE
CAS:1246815-04-2
Formula: C13H15D5ClNO3
SI-02431-005
MW: 278.79
(R)-
(R)-ZOPICLONE
CAS:138680-08-7
Formula: C17H17ClN6O3
SR-01309-009
MW: 388.81
"(R)-4-Methyl-6-(5-chloro-2-pyridinyl)-6 7-dihydro-7-oxo-5H-pyrrolo[3 4-b]pyrazin-5-yl-1-piperazinecarboxylic Acid; (-)-Zopiclone; ((-)-(5R)-6-(5-Chloropyridin-2-yl)-7-oxo-6 7-dihydro-5H-pyrrolo[3 4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate); "
(R* R*)-(±)-N N-DIETHYL NOREPHEDRINE HYDROCHLORIDE
CAS:58917-77-4
Formula: C13H22ClNO
SR-01468-001
MW: 243.77
(R* R*)-?-[1-(Diethylamino)ethyl]benzenemethanol Hydrochloride; (R* R*)-(±)-?-[1-(Diethylamino)ethyl]benzenemethanol Hydrochloride
(RAC SYN)-4-DESCHLORO-SERTRALINE
CAS:871838-58-3
Formula: C17H18ClN
SR-01163-014
MW: 271.78
Sertraline Impurity C
(RS)-N-DESPROPYL PRAMIPEXOLE
CAS:104617-49-4
Formula: C7H11N3S
SR-01145-013
MW: 169.25
4 5 6 7-Tetrahydrobenzo[d]thiazole-2 6-diamine; (RS)-2 6-Diamino-4 5 6 7-tetrahydrobenzothiazole; 2 6-Diamino-4 5 6 7-tetrahydro-1 3-benzothiazole; 2 6-Diamino-4 5 6 7-tetrahydrobenzothiazole; 4 5 6 7-Tetrahydrobenzothiazole-2 6-diamine
(S R S S)-ORLISTAT
CAS:111466-63-8
Formula: C29H53NO5
SR-01537-006
MW: 495.73
[2S-[2?(S*) 3?]]-N-Formyl-
(S S S)-ATAZANAVIR BENZYLIDENEHYDRAZINE CARBAMATE
Formula: C42H46N6O4
SR-02113-007
MW: 698.85
(S S S)-ENALAPRIL MALEATE
CAS:76095-16-4
Formula: C24H32N2O9
SA-01053-003
MW: 492.52
N-[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]-L-alanyl-L-proline (2Z)-2-Butenedioate; Acapril; Acetensil; Alphrin; Amprace;
(S S S)-ENALAPRIL-D5 MALEATE SALT
CAS:349554-02-5
Formula: C24H27D5N2O9
SI-01053-004
MW: 497.55
N-[(1S)-1-(Ethoxycarbonyl)-3-(phenyl-d5)propyl]-L-alanyl-L-proline (2Z)-2-Butenedioate; Acapril-d5; Acetensil-d5; Alphrin-d5; Amprace-d5;
(S S)-(+)-PSEUDOEPHEDRINE GLYCINAMIDE
CAS:170115-96-5
Formula: C12H18N2O2
SR-01468-012
MW: 222.28
[S-(R* R*)]-2-Amino-N-(2-hydroxy-1-methyl-2-phenylethyl)-N-methyl-acetamide
(S S)-(-)-PSEUDOEPHEDRINE GLYCINAMIDE-D6
Formula: C12H12D6N2O2
SI-01468-013
MW: 228.32
[S-(R* R*)]-2-Amino-N-(2-hydroxy-1-methyl-2-phenylethyl)-N-methyl-acetamide-d6
(S S)-META-NITRO-CHLORAMPHENICOL
CAS:1327173-85-2
Formula: C11H12Cl2N2O5
SR-02182-020
MW: 323.13
2 2-Dichloro-N-[(1S 2S)-2-hydroxy-1-(hydroxymethyl)-2-(3-nitrophenyl)ethyl]acetamide; 2 2-Dichloro-N-((1S 2S)-1 3-dihydroxy-1-(3-nitrophenyl)propan-2-yl)acetamide
(S S)-TRANS-1-DESHYDROXY RASAGILINE
Formula: C12H13NO
SR-02034-011
MW: 187.24
(S) - DESMETHYL SIBUTRAMINE HYDROCHLORIDE
CAS:259731-39-0
Formula: C16H25Cl2N
SM-01164-011
MW: 302.28
(?S)?-1-?(4-?Chlorophenyl)?-?N-?methyl-??-?(2-?methylpropyl)?cyclobutanemethanami?ne Hydrochloride; (S)?-?Desmethylsibutramine Hydrochloride
(S) FTY720 PHOSPHATE
CAS:402616-26-6
Formula: C19H34NO5P
SR-02265-016
MW: 387.45
2-(S)-Amino-2-[2-(4-octylphenyl)ethyl]-1 3-propanediol Mono(dihydrogen phosphate) Ester; (S)-FTY720-P; (S)-Fingolimod
(S)-(+)-CLENBUTEROL
CAS:50499-60-0
Formula: C12H18Cl2N2O
SR-01524-005
MW: 277.19
"(?S)-4-Amino-3 5-dichloro-?-[[(1 1-dimethylethyl)amino]methyl]benzenemethanol; (+)-Clenbuterol; (S)-Clenbuterol;"
(S)-(+)-ETODOLAC
CAS:87249-11-4
Formula: C17H21NO3
SR-01058-007
MW: 287.35
(1S)-1 8-Diethyl-1 3 4 9-tetrahydropyrano[3 4-b]indole-1-acetic Acid; (+)-(S)-Etodolac; (+)-Etodolac; (+)-Etodolic Acid; (S)-(+)-Etodolic Acid; RAK 592; S-Etodolac;
(S)-(+)-ETODOLAC-D3
Formula: C17H18D3NO3
SI-01058-009
MW: 290.37
(1S)-1 8-(Diethyl-d3)-1 3 4 9-tetrahydropyrano[3 4-b]indole-1-acetic Acid; (+)-(S)-Etodolac-d3; (+)-Etodolac-d3; (+)-Etodolic Acid-d3; (S)-(+)-Etodolic Acid-d3; RAK 592-d3; S-Etodolac-d3;
(S)-(+)-FENFLURAMINE HYDROCHLORIDE
CAS:3239-45-0
Formula: C12H17ClF3N
SR-01061-003
MW: 267.72
###############################################################################################################################################################################################################################################################
(S)-(+)-HYDROXY CHLOROQUINE DIPHOSPHATE
CAS:158749-76-9
Formula: C18H32ClN3O9P2
SM-01033-014
MW: 531.86
(S)-2-[[4-[(7-Chloro-4-quinolinyl)amino]pentyl]ethylamino]ethanol Phosphate;
(S)-(+)-HYDROXY CHLOROQUINE-D4 DIPHOSPHATE
CAS:137433-24-0
Formula: C18H28D4ClN3O9P2
SI-01033-015
MW: 535.89
(S)-2-[[4-[(7-Chloro-4-quinolinyl)amino]pentyl]ethylamino]ethanol-d4 Phosphate;
(S)-(+)-IBUPROFEN
CAS:51146-56-6
Formula: C13H18O2
SR-01282-013
MW: 206.28
(?S)-
(S)-(+)-IBUPROFEN (S)-(+)-LYSINATE
CAS:113403-10-4
Formula: C19H32N2O4
SR-01282-009
MW: 352.47
(?S)-
(S)-(+)-IBUPROFEN-D3
Formula: C13H15D3O2
SI-01282-005
MW: 209.3
(?S)-
(S)-(+)-KETOPROFEN
CAS:22161-81-5
Formula: C16H14O3
SR-01084-003
MW: 254.28
"(S)-(+)-3-Benzoyl-?-methylbenzeneacetic Acid; (+)-Ketoprofen; (S)-Ketoprofen; (S)-2-(3-Benzoylphenyl)propionic Acid; Dexketoprofen; Keral"
(S)-(+)-KETOPROFEN-13C D3
Formula: C1513CH11D3O3
SI-01084-004
MW: 258.29
(S)-(+)-3-Benzoyl-?-methylbenzeneacetic Acid-13C d3; (+)-Ketoprofen-13C d3; (S)-Ketoprofen-13C d3; (S)-2-(3-Benzoylphenyl)propionic Acid-d3; Dexketoprofen-d3;
(S)-(-)- -LIPOIC ACID
CAS:1077-27-6
Formula: C8H14O2S2
SR-02235-003
MW: 206.33
(3S)-
(S)-(-)-3-(BENZOYLTHIO)-2-METHYLPROPANOIC ACID
CAS:72679-02-8
Formula: C11H12O3S
SR-01024-006
MW: 224.28
(2S)-3-(Benzoylthio)-2-methylpropanoic Acid;
(S)-(-)-3-ACETYLTHIO-2-METHYLPROPIONIC ACID
CAS:76497-39-7
Formula: C6H10O3S
SR-01024-007
MW: 162.21
###############################################################################################################################################################################################################################################################
(S)-(-)-4 -HYDROXYPHENYL CARVEDILOL
CAS:1217853-93-4
Formula: C24H26N2O5
SM-01025-008
MW: 422.47
"(S)-4-[2-[[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]amino]ethoxy]-3-methoxyphenol;(S)-4-Hydroxycarvedilol; (S)-BM 140686; (S)-BM 14686;"
(S)-(-)-BUPIVACAINE
CAS:27262-47-1
Formula: C18H28N2O
SA-01017-007
MW: 288.43
(2S)-1-Butyl-N-(2 6-dimethylphenyl)-2-piperidinecarboxamide; L-(-)-Bupivacaine; Levobupivacaine;
(S)-(-)-BUPIVACAINE HYDROCHLORIDE
CAS:27262-48-2
Formula: C18H29ClN2O
SA-01017-001
MW: 324.89
###############################################################################################################################################################################################################################################################
(S)-(-)-CARBIDOPA
CAS:28860-95-9
Formula: C10H14N2O4
SR-01345-004
MW: 226.23
###############################################################################################################################################################################################################################################################
(S)-(-)-CARBIDOPA-D5
Formula: C10H9 D5N2O4
SI-01345-005
MW: 231.26
###############################################################################################################################################################################################################################################################
(S)-(-)-CARVEDILOL
CAS:95094-00-1
Formula: C24H26N2O4
SA-01025-006
MW: 406.47
(-)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol; (-)-Carvedilol; (S)-Carvedilol;
(S)-(-)-DROPROPIZINE
CAS:99291-25-5
Formula: C13H20N2O2
SR-02123-002
MW: 236.31
(2S)-
(S)-(-)-DROPROPIZINE-D4
Formula: C13H16D4N2O2
SI-02123-003
MW: 240.33
(2S)-
(S)-(-)-FELODIPINE
CAS:105618-03-9
Formula: C18H19Cl2NO4
SR-01060-015
MW: 384.25
(4S)-4-(2 3-Dichlorophenyl)-1 4-dihydro-2 6-dimethyl-3 5-pyridinedicarboxylic Acid 3-Ethyl 5-Methyl Ester; (-)-Felodipine; (S)-Felodipine;
(S)-(-)-FELODIPINE-D5
Formula: C18H14D5Cl2NO4
SI-01060-016
MW: 389.28
(4S)-4-(2 3-Dichlorophenyl)-1 4-dihydro-2 6-dimethyl-3 5-pyridinedicarboxylic Acid 3-Ethyl-d5 5-Methyl Ester; (-)-Felodipine-d5; (S)-Felodipine-d5
(S)-(-)-NICOTINE
CAS:54-11-5
Formula: C10H14N2
SA-02211-000
MW: 162.23
(-)-1-Methyl-2-[3-pyridyl]pyrrolidine; 3-[(2S)-1-Methyl-2-pyrrolidinyl]pyridine;
(S)-(-)-NICOTINE-D4
CAS:284685-07-0
Formula: C10H10D4N2
SI-02211-001
MW: 166.26
(-)-1-Methyl-2-[3-pyridyl]pyrrolidine-d4; 3-[(2S)-1-Methyl-2-pyrrolidinyl]pyridine-d4;
(S)-(-)-NOR VERAPAMIL HYDROCHLORIDE
CAS:123931-31-7
Formula: C26H37ClN2O4
SM-01187-005
MW: 477.04
(?S)-?-[3-[[2-(3 4-Dimethoxyphenyl)ethyl]amino]propyl]-3 4-dimethoxy-?-(1-methylethyl)-benzeneacetonitrile Hydrochloride; (S)-Norverapamil Hydrochloride;
(S)-(-)-O-DESMETHYL CARVEDILOL
CAS:123372-13-4
Formula: C23H24N2O4
SM-01025-009
MW: 392.45
"(S)- 2-[2-[[3-(9H-Carbazol-4-yloxy)-2-hydroxypropyl]amino]ethoxy]phenol;(S)-(-)-O-Desmethylcarvedilol;"
(S)-(-)-THALIDOMIDE
CAS:841-67-8
Formula: C13H10N2O4
SR-01301-003
MW: 258.23
(S)-(-)-2-(2 6-Dioxo-3-piperidinyl)-1H-iso-indole-1 3(2H)-dione; (S)-Thalidomide; NSC 91730;
(S)-(5S 6S 8S)-5 8-DIBENZYL-12 12-DIMETHYL-3 10-DIOXO-1-(THIAZOL-5-YL)-2 11-DIOXA-4 9-DIAZATRIDECAN-6-YL 2-(3-((2-ISOPROPYLTHIAZ
Formula: C42H56N6O7S2
SR-01490-020
MW: 821.06
(S)-1- -HYDROXY-1-(2-THIENYL)-3-DIMETHYLAMINOPROPANE
CAS:132335-44-5
Formula: C9H15NOS
SR-01312-009
MW: 185.29
(S)-N N-Dimethyl-3-(2-thienyl)-3-hydroxypropanamine; (1S)-3-(Dimethylamino)-1-(2-thienyl)-1-propanol; (S)-(-)-N N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine;
(S)-1-(2-AMINO-5-CHLOROPHENYL)-1-(TRIFLUOROMETHYL)-3-CYCLOPROPYL-2-PROPYN-1-OL
CAS:209414-27-7
Formula: C13H11ClF3NO
SR-01280-014
MW: 289.68
(S)-2-(2-Amino-5-chlorophenyl)-4-cyclopropyl-1 1 1-trifluoro-3-butyn-2-ol; (?S)-2-Amino-5-chloro-?-(2-cyclopropylethynyl)-?-(trifluoromethyl)benzenemethanol; USP Efavirenz Related Compound A
(S)-1-(4-METHOXYBENZYL)-1 2 3 4 5 6 7 8-OCTAHYDROISOQUINOLINE ACETATE SALT
CAS:103573-39-3
Formula: C19H27NO3
Sr-01201-015
MW: 317.42
(1S)-1 2 3 4 5 6 7 8-Octahydro-1-[(4-methoxyphenyl)methyl]isoquinoline Acetic Acid; (-)-1 2 3 4 5 6 7 8-octahydro-1-(p-methoxybenzyl)-Isoquinoline Acetate; (S)-1 2 3 4 5 6 7 8-Octahydro-1-[(4-methoxyphenyl)methyl]isoquinoline Acetate
(S)-1-AMINOINDANE
CAS:61341-86-4
Formula: C9H11N
SR-02157-003
MW: 133.19
(1S)-2 3-Dihydro-1H-inden-1-amine; (S)-(+)-1-Indanamine; (S)-1-Aminoindan; (S)-1-Indanylamine; (S)-2 3-Dihydro-1-Indenamine; (S)-2 3-Dihydro-1H-inden-1-amine S-(+)-1-Aminoindane; [(1S)-2 3-Dihydro-1H-inden-1-yl]amine;
(S)-1-AMINOINDANE-D3
Formula: C9H8D3N
SI-02157-004
MW: 136.21
(1S)-2 3-Dihydro-1H-inden-1-amine-d3; (S)-(+)-1-Indanamine-d3; (S)-1-Aminoindan-d3; (S)-1-Indanylamine-d3; (S)-2 3-Dihydro-1-Indenamine-d3; (S)-2 3-Dihydro-1H-inden-1-amine-d3; S-(+)-1-Aminoindane-d3; [(1S)-2 3-Dihydro-1H-inden-1-yl]amine-d3;
(S)-10-MONOHYDROXY-10 11-DIHYDRO CARBAMAZEPINE(ESLICARBAZEPINE)
CAS:104746-04-5
Formula: C15H14N2O2
SM-01130-005
MW: 254.28
(10S)-
(S)-2-(BENZYL((S)-2-((R)-CHROMAN-2-YL)-2-HYDROXYETHYL)AMINO)-1-((S)-CHROMAN-2-YL)ETHANOL OXALATE(NEBIVOLOL IMPURITY)(MIXTURE OF
Formula: C31H35NO8
SR-01260-024
MW: 549.61
(S)-2-AMINO-7-HYDROXYTETRALIN
CAS:85951-60-6
Formula: C10H13NO
SR-01325-009
MW: 163.22
(S)-7-Amino-5 6 7 8-tetrahydronaphthalen-2-ol; (S)-7-Amino-5 6 7 8-tetrahydro-2-naphthalenol; (7S)-7-Amino-5 6 7 8-tetrahydro-2-naphthalenol
(S)-2-AMINOBUTANOIC ACID HYDROCHLORIDE
CAS:5959-29-5
Formula: C4H10ClNO2
SR-01196-006
MW: 139.58
(2S)-2-Aminobutanoic Acid Hydrochloride; L-2-Aminobutyric Acid Hydrochloride; L-?-Amino-n-butyric Acid Hydrochloride
(S)-2-AMINOBUTYRAMIDE HYDROCHLORIDE
CAS:7682-20-4
Formula: C4H11ClN2O
SR-01196-005
MW: 138.6
(S)-2-Aminobutanamide Monohydrochloride; USP Levetiracetam Related Compound B;
(S)-2-CYCLOHEXYL-2-HYDROXY-PHENYLACETIC ACID
CAS:20585-34-6
Formula: C14H18O3
SR-01131-014
MW: 234.29
(?S)-?-Cyclohexyl-?-hydroxy-benzeneacetic Acid; (S)-(+)-?-Phenyl-cyclohexaneglycolic Acid;
(S)-3 -HYDROXY PRAVASTATIN LACTONE
Formula: C23H34O7
SM-01146-016
MW: 422.51
(2S 3??S)-3??-Hydroxy-2-methylbutanoic Acid (1S 3S 7S 8S 8aR)-1 2 3 7 8 8a-Hexahydro-3-hydroxy-7-methyl-8-[2-[(2R 4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester;
(S)-3 -HYDROXY PRAVASTATIN SODIUM SALT
CAS:722504-45-2
Formula: C23H35NaO8
SM-01146-011
MW: 462.51
###############################################################################################################################################################################################################################################################
(S)-3 5-DIHYDROXYLPHENYLGLYCINE
CAS:162870-29-3
Formula: C8H9NO4
SM-01532-002
MW: 183.16
?-Amino-3 5-dihydroxybenzeneacetic Acid; (S)-DHPG; L-Di-meta-hydroxyphenylglycine
(S)-3-(4-CHLOROPHENYL)-4-HYDROXYBUTYRIC ACID SODIUM SALT
Formula: C10H10ClNaO3
SM-02241-007
MW: 236.63
(S)-4-Chloro-?-(hydroxymethyl)benzenepropanoic Acid Sodium Salt; (S)-?-(p-Chlorophenyl)-?-hydroxybutyric Acid Sodium Salt;
(S)-4 5 6 7-TETRAHYDRO-N2 N6-PROPIONYL-2 6-BENZOTHIAZOLEDIAMINE
CAS:1346617-47-7
Formula: C13H19N3O2S
SR-01145-015
MW: 281.37
(S)-4-(4-AMINOBENZYL)-2-(1H)-OXAZOLIDINONE
CAS:152305-23-2
Formula: C10H12N2O2
SR-01191-006
MW: 192.21
(4S)-4-[(4-aminophenyl)methyl]-2-oxazolidinone; 4S)-4-(4-Aminobenzyl)-1 3-oxazolidin-2-one
(S)-4-(4-HYDRAZINYLBENZYL)-2-OXAZOLIDINONE
CAS:187975-62-8
Formula: C10H13N3O2
SR-01191-004
MW: 207.23
(4S)-4-[(4-hydrazinylphenyl)methyl]-2-Oxazolidinone
(S)-4-HYDROXYMETHYL AMBRISENTAN
CAS:1106685-66-8
Formula: C22H22N2O5
SM-02147-003
MW: 394.42
(?S)-?-[[4-(Hydroxymethyl)-6-methyl-2-pyrimidinyl]oxy]-?-methoxy-?-phenylbenzenepropanoic Acid
(S)-5 6 7 8-TETRAHYDRO-6-(PROPYLAMINO)-1-NAPHTHALENOL HYDROGEN SULFATE ESTER
CAS:154714-31-5
Formula: C13H19NO4S
SM-02149-003 
MW: 285.36
N-Desthienylethyl Rotigotine Sulfate;
(S)-5-HYDROXY OMEPRAZOLE
CAS:196489-27-7
Formula: C17H19N3O4S
SM-01127-013
MW: 361.42
4-methoxy-6-[[(S)-(6-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-5-methyl-3-pyridinemethanol;
(S)-5-HYDROXYMETHYL TOLTERODINE-D14 FORMATE
Formula: C23H19D14NO4
SI-01249-003 
MW: 401.6
3-[(1S)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxybenzenemethanol-d14 Formate
(S)-7-HYDROXY WARFARIN
CAS:63740-81-8
Formula: C19H16O5
SM-01188-002 
MW: 324.33
4 7-Dihydroxy-3-[(1S)-3-oxo-1-phenylbutyl]-2H-1-benzopyran-2-one; (S)-4 7-Dihydroxy-3-(3-oxo-1-phenylbutyl)2H-1-benzopyran-2-one; 7-Hydroxy-S-warfarin; S-7-Hydroxywarfarin;
(S)-9-HYDROXY RISPERIDONE
CAS:147663-01-2
Formula: C23H27FN4O3
SM-01159-006
MW: 426.48
"(9S)-3-[2-[4-(6-Fluoro-1 2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6 7 8 9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1 2-a]pyrimidin-4-one; "
(S)-ACENOCOUMAROL
CAS:66556-78-3
Formula: C19H15NO6
SR-02198-005
MW: 353.33
(S)-4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-1-benzopyran-2-one; (-)-3-(?-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin; (-)-Acenocoumarin; (S)-(-)-Acenocoumarol; (S)-(-)-Nicoumalone;
(S)-ALBUTEROL TARTRATE
Formula: C17H27NO9
SA-01002-005
MW: 389.4
###############################################################################################################################################################################################################################################################
(S)-AMLODIPINE-D4
CAS:1346616-97-4
Formula: C20H21D4ClN2O5
SI-01005-004
MW: 412.9
(4S)-2-[[2-Amino(ethoxy-d4)]methyl]-4-(2-chlorophenyl)-1 4-dihydro-6-methyl-3 5-pyridinedicarboxylic Acid 3-Ethyl 5-Methyl Ester; (-)-Amlodipine-d4; (R)-(-)-Amlodipine-d4; Levamlodipine-d4; Levoamlodipine-d4; Lodien-d4; l-Amlodipine-d4;
(S)-ATENOLOL
CAS:93379-54-5
Formula: C14H22N2O3
SR-01008-004
MW: 266.34
"4-[(2S)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide; (-)-Atenolol; "
(S)-ATENOLOL-D7
Formula: C14H15D7N2O3
SI-01008-005
MW: 273.38
4-[(2S)-2-Hydroxy-3-[(1-methylethyl-d7)amino]propoxy]benzeneacetamide; (-)-Atenolol-d7;
(S)-AZELASTINE HYDROCHLORIDE
CAS:153408-27-6
Formula: C22H25Cl2N3O
SR-01360-004
MW: 418.36
(S)-4-[(4-Chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinone Hydrochloride; (+)-Azelastine Hydrochloride;
(S)-AZELASTINE N-OXIDE (MIXTURE OF DIASTEREOMERS)
Formula: C22H24ClN3O2
SM-01360-010
MW: 397.9
(S)-4-[(4-Chlorophenyl)methyl]-2-(hexahydro-1-methyl-1-oxido-1H-azepin-4-yl)-1(2H)-phthalazinone; (+)-Azelastine N-Oxide;
(S)-BACLOFEN
CAS:66514-99-6
Formula: C10H12ClNO2
SR-02241-003
MW: 213.66
(?S)-?-(Aminomethyl)-4-chlorobenzenepropanoic Acid; (+)-Baclofen; (S)-4-Amino-3-(4-chlorophenyl)butanoic Acid; (S)-4-Amino-3-(4-chlorophenyl)butyric Acid; (S)-Baclofen; L-(+)-Baclofen; L-Baclofen; S(+)-Baclofen; d-Baclofen;
(S)-BENDROFLUMETHIAZIDE
CAS:1245935-40-3
Formula: C15H14F3N3O4S2
SR-01326-003
MW: 421.41
(3S)-3 4-Dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-2H-1 2 4-benzothiadiazine-7-sulfonamide 1 1-Dioxide;
(S)-BICALUTAMIDE
CAS:113299-38-0
Formula: C18H14F4N2O4S
SA-01014-005
MW: 430.37
(2S)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide; (S)-Casodex;
(S)-BICALUTAMIDE-D4
Formula: C18H10D4F4N2O4S
SI-01014-004
MW: 434.4
(2S)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl-d4)sulfonyl]-2-hydroxy-2-methylpropanamide; (S)-Casodex
(S)-BROMPHENIRAMINE-D6 MALEATE
Formula: C20H17D6BrN2O4
SI-01194-003
MW: 441.35
###############################################################################################################################################################################################################################################################
(S)-BUFURALOL HYDROCHLORIDE
CAS:57704-10-6
Formula: C16H24ClNO2
SR-01386-005
MW: 297.82
(?S)-?-[[(1 1-Dimethylethyl)amino]methyl]-7-ethyl-2-benzofuranmethanol; (-)-Bufuralol Hydrochloride; l-Bufuralol Hydrochloride;
(S)-BUPROPION L-TARTARIC ACID SALT
Formula: C17H24ClNO7
SR-01018-013
MW: 389.83
(2S)-
(S)-CARISBAMATE
Formula: C813CH8D2Cl15NO3
SI-02145-005
MW: 219.63
(1S)-
(S)-CARISBAMATE -D-O-GLUCURONIDE
CAS:940279-82-3
Formula: C15H18ClNO9
SM-02145-007
MW: 391.76
(1S)-2-[(Aminocarbonyl)oxy]-1-(2-chlorophenyl)ethyl ?-D-Glucopyranosiduronic Acid;
(S)-CARISBAMATE-D4
Formula: C9H6D4ClNO3
SI-02145-002
MW: 219.66
(1S)-1-(2-Chlorophenyl-d4)-1 2-ethanediol 2-Carbamate; JNJ 10234094-d4; RWJ 333369-d4; YKP 509-d4;
(S)-CETIRIZINE DIHYDROCHLORIDE
CAS:163837-48-7
Formula: C21H27Cl3N2O3
SA-01032-002
MW: 461.81
(S)-[2-[4-[(4-Chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic Acid Dihydrochloride
(S)-CITALOPRAM FLUOROPHENYLMETHANONE OXALATE IMPURITY
CAS:1217846-85-9
Formula: C28H27F2NO6
SR-01040-027
MW: 511.51
###############################################################################################################################################################################################################################################################
(S)-CITALOPRAM FREE BASE
Formula: C20H21FN2O
SA-01040-020
MW: 324.40157
(S)-CITALOPRAM N-OXIDE
CAS:917482-45-2
Formula: C20H21FN2O2
SM-01040-017 
MW: 340.39
"(S)-1-[3-(Dimethyloxidoamino)propyl]-1-(4-fluorophenyl)-1 3-dihydro-5-isobenzofurancarbonitrile; (S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1 3-dihydro-5-isobenzofurancarbonitrile N1-Oxide"
(S)-CITALOPRAM OXALATE
CAS:219861-08-2
Formula: C22H23FN2O5
SA-01040-002
MW: 414.43
(1S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1 3-dihydro-5-isobenzofurancarbonitrile Ethanedioate; Escitalopram Oxalate; (S)-(+)-Citalopram Oxalate; Cipralex;
(S)-CITALOPRAM-D4 OXALATE
Formula: C22H19D4FN2O5
SI-01040-011
MW: 418.45
(1S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1 3-dihydro-5-isobenzofurancarbonitrile-d4 Ethanedioate; Escitalopram-d4 Oxalate; (S)-(+)-Citalopram-d4 Oxalate; Cipralex;
(S)-DIDEMETHYL CITALOPRAM HYDROCHLORIDE
Formula: C18H18ClFN2O
SM-01040-016
MW: 332.8
"(1S)-1-(3-Aminopropyl)-1-(4-fluorophenyl)-1 3-dihydro-5-isobenzofurancarbonitrile Hydrochloride; (+)-(S)-1-(3-Aminopropyl)-1-(4-fluorophenyl)-1 3-dihydroisobenzofuran-5-carbonitrile Hydrochloride; (S)-Didesmethylcitalopram Hydrochloride; "
(S)-DIDEMETHYLAMINO CITALOPRAM CARBOXYLIC ACID
CAS:766508-94-5
Formula: C18H14FNO3
SM-01040-015
MW: 311.31
(1S)-
(S)-EFAVIRENZ
CAS:154598-52-4
Formula: C14H9ClF3NO2
SA-01280-004
MW: 315.67
(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1 4-dihydro-4-(trifluoromethyl)-2H-3 1-benzoxazin-2-one; DMP 266; L 743726; Stocrin; Sustiva;
(S)-EQUOL
CAS:531-95-3
Formula: C15H14O3
SR-01438-026
MW: 242.27
(S)-3-(4-Hydroxy-phenyl)-chroman-7-ol; (S)-3 4-Dihydro-3-(4-Hydroxyphenyl)-2H-1-benzopyran-7-ol; 3-(4-Hydroxy-phenyl)-chroman-7-ol; (-)-Equol; (S)-(-)-4 7-Isoflavandiol;
(S)-ESMOLOL HYDROCHLORIDE
CAS:112923-91-8
Formula: C16H26ClNO4
SR-01055-005
MW: 331.83
4-[(2S)-2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzenepropanoic Acid Methyl Ester Hydrochloride;
(S)-FESOTERODINE FUMARATE
CAS:1431511-18-0
Formula: C30H41NO7
SA-01510-002
MW: 527.65
(S)-FESOTERODINE-D7 FUMARATE
Formula: C30H34D7NO7
SI-01510-003
MW: 534.69
(S)-HYDROXY DES(BORIC ACID) BORTEZOMIB
CAS:289472-81-7
Formula: C19H24N4O3
SR-01529-009
MW: 356.42
N-[(1S)-2-[[(1S)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-Pyrazinecarboxamide; N-[(1S)-2-[[(1S)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-pyrazinecarboxamide;
(S)-HYDROXY ILOPERIDONE
CAS:501373-88-2
Formula: C24H29FN2O4
SR-02271-012
MW: 428.5
(?S)-4-[3-[4-(6-Fluoro-1 2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-?-methyl-benzenemethanol;
(S)-HYDROXY ILOPERIDONE-D3
Formula: C24H26D3FN2O4
SI-02271-013
MW: 431.51
(?S)-4-[3-[4-(6-Fluoro-1 2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-?-methyl-benzenemethanol-d3;
(S)-HYDROXY TIMOLOL
CAS:1227468-61-2
Formula: C13H24N4O4S
SM-01443-007
MW: 332.42
2-[[(2S)-2-Hydroxy-3-[[4-(4-morpholinyl)-1 2 5-thiadiazol-3-yl]oxy]propyl]amino]-2-methyl-1-propanol;
(S)-ISOTIMOLOL
CAS:158636-96-5
Formula: C13H24N4O3S
SR-01443-010
MW: 316.42
(S)-3-[(1 1-Dimethylethyl)amino]-2-[[4-(4-morpholinyl)-1 2 5-thiadiazol-3-yl]oxy]-1-propanol
(S)-KETAMINE HYDROCHLORIDE
CAS:33643-47-9
Formula: C13H17Cl2NO
SR-01392-008
MW: 274.19
(2S)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone Hydrochloride; (-)- 2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone Hydrochloride; (S)-(-)-Ketamine Hydrochloride; (+)-(S)-Ketamine Hydrochloride; (S)-(+)-Ketamine Hydrochloride; Ketanest S
(S)-KETAMINE L-TARTRATE SALT
CAS:199468-20-7
Formula: C17H22ClNO7
SR-01392-011
MW: 387.81
(S)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone [R-(R* R*)]-2 3-Dihydroxybutanedioate;
(S)-KETAMINE-D6 HYDROCHLORIDE
Formula: C13H11D6Cl2NO
SI-01392-009
MW: 280.22
###############################################################################################################################################################################################################################################################
(S)-KETOPROFEN -D-GLUCURONIDE ALLYL ESTER
Formula: C25H26O9
SR-01084-036
MW: 470.47
(S)-1-(3-Benzoly-?-methylbenzeneacetate)-?-D-glucopyranuronic Acid Allyl Ester; (S)-Ketoprofen Glucuronide Allyl Ester; (S)-Ketoprofen Allyl Glucuronate
(S)-LANSOPRAZOLE
CAS:138530-95-7
Formula: C16H14F3N3O2S
SR-01087-005
MW: 369.36
2-[(S)-[[3-Methyl-4-(2 2 2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-
(S)-LERCANIDIPINE HYDROCHLORIDE
CAS:184866-29-3
Formula: C36H42ClN3O6
SR-02267-004
MW: 648.19
(4S)-1 4-Dihydro-2 6-dimethyl-4-(3-nittrophenyl)-3 5-pyridinedicarboxylic Acid 2-[(3 3-Diphenylpropyl)methylamino]-1 1-dimethylethyl Methyl Ester Hydrochloride
(S)-LISINOPRIL
CAS:83915-83-7
Formula: C21H31N3O5?2H2O
SA-01091-002
MW: 441.52
(S)-1-[N2-(1-Carboxy-3-phenylpropyl)-L-lysyl]-L-proline Dihydrate MK-521 Acerbon Alapril Carace Coric Novatec Prinil Prinivil Tensopril Vivatec Zestril
(S)-LISINOPRIL-D5
CAS:1356905-39-9
Formula: C21H26D5N3O5
SI-01091-001
MW: 410.52
###############################################################################################################################################################################################################################################################
(S)-LOFEXIDINE
CAS:81447-79-2
Formula: C11H12Cl2N2O
SR-02084-003
MW: 259.13
2-[(1S)-1-(2 6-Dichlorophenoxy)ethyl]-4 5-dihydro-
(S)-LORAZEPAM
CAS:110032-65-0
Formula: C15H10Cl2N2O2
SR-02410-006
MW: 321.16
(S)-7-Chloro-5-(2-chlorophenyl)-1 3-dihydro-3-hydroxy-2H-1 4-benzodiazepin-2-one; (+)-Lorazepam;
(S)-METHADONE HYDROCHLORIDE
CAS:15284-15-8
Formula: C21H28CLNO
SM-01236-002
MW: 345.91
(6S)-6-(Dimethylamino)-4 4-diphenyl-3-heptanone Hydrochloride; Dextromethadone Hydrochloride; D-6-(Dimethylamino)-4 4-diphenyl-3-heptanone Hydrochloride; (+)-Methadone Hydrochloride;
(S)-METOPROLOL
CAS:81024-42-2
Formula: C15H25NO3
SA-01103-002
MW: 267.36
(2S)-
(S)-MODAFINIL-D10
Formula: C15H5D10NO2S
SI-01349-006
MW: 283.41
"2-[(S)-(Diphenylmethyl)sulfinyl]acetamide-d10; (+)-Modafinil-d10; (S)-(+)-Modafinil-d10; CRL 40983-d10;"
(S)-N-((R)-1-(NAPHTHALEN-1-YL)ETHYL)-2-(3-(TRIFLUOROMETHYL)PHENYL)PROPAN-1-AMINE
Formula: C22H22F3N
SR-01029-010
MW: 357.41
(S)-N-(1-AMINO-1-OXOBUTAN-2-YL)-4-CHLOROBUTANAMIDE
CAS:102767-31-7
Formula: C8H15ClN2O2
SR-01196-007
MW: 206.67
N-[(1S)-1-(Aminocarbonyl)propyl]-4-chlorobutanamide; (S)-N-[1-(Aminocarbonyl)propyl]-4-chlorobutanamide; USP Levetiracetam Related Compound A;
(S)-N-[4-[[((R)-2-AMINO-6 7 8 9-TETRAHYDRO-8-METHYL-4 9-DIOXO-4H-PYRAZINO[1 2-A]-1 3 5-TRIAZIN-7-YL)METHYL]AMINO]BENZOYL]-L-GLUT
Formula: C20H23N7O7
SR-02313-004
MW: 473.44
(S)-N-[4-[[((S)-2-AMINO-6 7 8 9-TETRAHYDRO-8-METHYL-4 9-DIOXO-4H-PYRAZINO[1 2-A]-1 3 5-TRIAZIN-7-YL)METHYL]AMINO]BENZOYL]-L-GLUT
Formula: C20H23N7O7
SR-02313-005
MW: 473.44
4H-Pyrazino[1 2-a]-1 3 5-triazine L-Glutamic Acid Deriv.
(S)-N-DEMETHYL DAPOXETINE
CAS:147199-39-1
Formula: C20H21NO
SM-02110-001
MW: 291.39
(?S)-N-Methyl-?-[2-(1-naphthalenyloxy)ethyl]benzenemethanamine;
(S)-N-DESETHYL OXYBUTYNIN HYDROCHLORIDE
CAS:181647-14-3
Formula: C20H28ClNO3
SM-01131-005
MW: 365.89
"(?S)-?-Cyclohexyl-?-hydroxybenzeneacetic Acid 4-(Ethylamino)-2-butyn-1-yl Ester Hydrochloride; "
(S)-N-DESPROPYL PRAMIPEXOLE
CAS:106092-09-5
Formula: C7H11N3S
SR-01145-007
MW: 169.25
"(6S)-4 5 6 7-Tetrahydro-2 6-benzothiazolediamine; (S)-2 6-Diamino-4 5 6 7-tetrahydrobenzothiazole; "
(S)-N-DIDEMETHYL DAPOXETINE
CAS:147199-40-4
Formula: C19H19NO
SM-02110-002
MW: 277.36
(S)-
(S)-N-ETHYL-N-(1-(3-(TRIFLUOROMETHYL)PHENYL)PROPAN-2-YL)BENZAMIDE
Formula: C19H20F3NO
SR-01061-009
MW: 335.36
(S)-N-METHYL PREGABALIN
CAS:1155843-61-0
Formula: C9H19NO2
SM-01397-004
MW: 173.25
(3S)-
(S)-NAPROXEN ACYL- -D-GLUCURONIDE
CAS:41945-43-1
Formula: C20H22O9
SM-01115-003
MW: 406.38
1-[(?S)-6-Methoxy-?-methyl-2-naphthaleneacetate]
(S)-NAPROXEN-D3
CAS:1094102-82-5
Formula: C14H11D3O3
SI-01115-005
MW: 233.28
###############################################################################################################################################################################################################################################################
(S)-NAPROXEN-D6 METHYL ESTER
Formula: C15H10D6O3
SI-01115-007
MW: 250.32
###############################################################################################################################################################################################################################################################
(S)-O-DESMETHYL NAPROXEN
CAS:52079-10-4
Formula: C13H12O3
SR-01115-004
MW: 216.23
(?S)-6-Hydroxy-?-methyl-2-naphthaleneacetic Acid; (S)-2-(6-Hydroxy-2-naphthyl)propionic Acid; (S)-6-O-Desmethylnaproxen; (S)-6-Demethylnaproxen;
(S)-OXYBUTYNIN CHLORIDE
CAS:230949-16-3
Formula: C22H32ClNO3
SR-01131-002
MW: 393.95
(S)-?-Phenylcyclohexaneglycolic Acid 4-(Diethylamino)-2-butynyl Ester Hydrochloride
(S)-PHENOXYBENZAMINE HYDROCHLORIDE
CAS:32378-29-3
Formula: C18H23Cl2NO
SA-01139-002
MW: 340.29
(S)-N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzenemethanamine Hydrochloride; (-)-N-Benzyl-N-(2-chloroethyl)-1-phenoxyisopropylamine Hydrochloride; (-)-Phenoxybenzamine Hydrochloride; l-Phenoxybenzamine Hydrochloride;
(S)-PHENPROCOUMON
CAS:3770-63-6
Formula: C18H16O3
SM-02192-004
MW: 280.32
4-Hydroxy-3-[(1S)-1-phenylpropyl]-2H-1-benzopyran-2-one; (S)-4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one ; S-(-)-3-(?-Ethylbenzyl)-4-hydroxy-coumarin; (-)-Phenprocoumon; S-(-)-Phenprocoumon
(S)-PRAMIPEXOLE-D5 DIHYDROCHLORIDE
CAS:1217601-58-5
Formula: C10H14D5Cl2N3S
SI-01145-001
MW: 289.28
(S)-4 5 6 7-Tetrahydro-N6-propyl-d5-2 6-benzothiazolediamine Dihydrochloride;
(S)-PREGABALIN-13C3
Formula: C513C3H17NO2
SI-01397-001
MW: 162.2
(3S)-
(S)-PROPRANOLOL -D-GLUCURONIDE SODIUM SALT
CAS:87144-73-8
Formula: C22H28NNaO8
SM-01149-010
MW: 457.45
(S)-1-[[(1-Methylethyl)amino]methyl]-2-(1-naphthalenyloxy)ethyl ?-D-Glucopyranosiduronic Acid Monosodium Salt; (-)-Propranolol Glucuronide Sodium; (S)-Propranolol Glucuronide Sodium;
(S)-RABEPRAZOLE SODIUM SALT
CAS:171440-19-0
Formula: C18H21N3NaO3S
SR-01298-019
MW: 382.43
2-[(S)-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole Sodium Salt; S-(-)-Rabeprazole Sodium Salt;
(S)-RABEPRAZOLE-D3 SODIUM SALT
CAS:1216494-11-9
Formula: C18H18D3N3NaO3S
SI-01298-020
MW: 385.45
2-[(S)-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole-d3 Sodium Salt; S-(-)-Rabeprazole-d3 Sodium Salt;
(S)-RASAGILINE MESYLATE
CAS:202464-89-9
Formula: C13H17NO3S
SR-02034-005
MW: 267.34
(1S)-2 3-Dihydro-N-2-propyn-1-yl-1H-inden-1-amine Mesylate; (S)-2 3-Dihydro-N-2-propynyl-1H-inden-1-amine Mesylate; TVP 1022 Mesylate;
(S)-RASAGILINE-13C3 MESYLATE
Formula: C1013C3H17NO3S
SI-02034-006
MW: 270.32
(1S)-2 3-Dihydro-N-2-propyn-1-yl-1H-inden-1-amine-13C3 Mesylate; (S)-2 3-Dihydro-N-2-propynyl-1H-inden-1-amine-13C3 Mesylate; TVP 1022 Mesylate-13C3;
(S)-RIVASTIGMINE
CAS:123441-03-2
Formula: C14H22N2O2
SM-01199-004
MW: 250.34
Ethylmethylcarbamic Acid 3-[(1S)-1-(Dimethylamino)ethyl]phenyl Ester; Ethylmethylcarbamic Acid 3-[1-(dimethylamino)ethyl]phenyl Ester (S)-; ENA 713 Free Base; Exelon; Rivastigmine; S-Rivastigmine; SDZ 212-713;
(S)-SERTACONAZOLE
CAS:583057-51-6
Formula: C20H15Cl3N2OS
SR-02164-006
MW: 437.77
1-[(2S)-2-[(7-Chlorobenzo[b]thien-3-yl)methoxy]-2-(2 4-dichlorophenyl)ethyl]-1H-Imidazole;
(S)-SERTACONAZOLE-D6
Formula: C20H9D6Cl3N2OS
SI-02164-007
MW: 443.81
1-[(2S)-2-[(7-Chlorobenzo[b]thien-3-yl)methoxy]-2-(2 4-dichlorophenyl)ethyl]-1H-Imidazole-d6;
(S)-SIBUTRAMINE (S)-MANDELATE
Formula: C25H34ClNO3
SR-01164-020
MW: 432
(R)-1-(1-(4-Chlorophenyl)cyclobutyl)-N N 3-trimethylbutan-1-amine (R)-2-Hydroxy-2-phenylacetate
(S)-SIBUTRAMINE HYDROCHLORIDE
Formula: C17H27Cl2N
SA-01164-009
MW: 316.31
(S)-1-?(4-?Chlorophenyl)?-?N ?N-?dimethyl-??-?(2-?methylpropyl)cyclobutanemethanami?ne Hydrochloride; (S)-BTS 54524; (S)-Reductil; (S)-Vazy
(S)-TAMSULOSIN HYDROCHLORIDE
CAS:106463-19-8
Formula: C20H29ClN2O5S
SR-01238-012
MW: 444.97
5-[(2S)-2-[[2-(-Ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride; (+)-LY 253352; (+)-YM 617; S-(+)-YM 12617; YM 12617-2
(S)-TAMSULOSIN-D3 HYDROCHLORIDE
Formula: C20H26D3ClN2O5S
SI-01238-013
MW: 447.99
5-[(2S)-2-[[2-(-Ethoxyphenoxy)ethyl]amino]propyl-d3]-2-methoxybenzenesulfonamide Hydrochloride; (+)-LY 253352-d3; (+)-YM 617-d3; S-(+)-YM 12617-d3; YM 12617-2-d3
(S)-TENOFOVIR
CAS:147127-19-3
Formula: C9H14N5O4P
SR-02018-025
MW: 287.21
P-[[(1S)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]-phosphonic Acid; (S)-9-(2-Phosphonomethoxypropyl)adenine; (S)-PMPA
(S)-TENOFOVIR DISOPROXIL FUMARATE
CAS:1432630-26-6
Formula: C23H34N5O14P
SR-02018-016
MW: 635.51
5-[[(1S)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]-
(S)-VALIOLAMINE VOGLIBOSE
CAS:1303996-66-8
Formula: C17H34N2O11
SR-01331-002
MW: 442.46
4 4 -[[(1S)-1-(Hydroxymethyl)-1 2-ethanediyl]diimino]bis[3 4-dideoxy-2-C-(hydroxymethyl)-D-epi-inositol;
(S)-VILOXAZINE HYDROCHLORIDE
CAS:56287-61-7
Formula: C13H20ClNO3
SR-02431-006
MW: 273.76
(S)-
(S)-VILOXAZINE-D5 HYDROCHLORIDE
CAS:1246816-39-6
Formula: C13H15D5ClNO3
SI-02431-007
MW: 278.79
(S)-
(S)-ZOPICLONE
CAS:138729-47-2
Formula: C17H17ClN6O3
SA-01309-006
MW: 388.81
[(9S)-8-(5-Chloropyridin-2-yl)-7-oxo-2 5 8-triazabicyclo[4.3.0]nona-1 3 5-trien-9-yl]4-methylpiperazine-1-carboxylate; Lunesta; Eszopiclone
(TETRAMETHYL-D12)-5-BROMOMETHYL-1 3-BENZENEDIACETONITRILE
CAS:1185016-59-4
Formula: C15H5D12BrN2
SI-01470-012
MW: 317.29
5-(Bromomethyl)-?1 ?1 ?3 ?3-tetra(methyl-d3)-
(Z)-4-(3 4-DICHLOROPHENYL)-3-(ETHOXYCARBONYL)-4-PHENYL-D5-BUT-3-ENOIC ACID
Formula: C19H11D5Cl2O4
SI-01163-018
MW: 384.26
2-[(3 4-Dichlorophenyl)phenyl-d5-methylene]butanedioic Acid 1-Ethyl Ester; [(3 4-Dichlorophenyl)phenyl-d5-methylene]butanedioic Acid 1-Ethyl Ester
(Z)-4-HYDROXY TAMOXIFEN
CAS:68047-06-3
Formula: C26H29NO2
SM-01172-002
MW: 387.51
4-[(1Z)-1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]phenol; (Z)-4-Hydroxytamoxifen; trans-4-Hydroxytamoxifen
(Z)-4-HYDROXY TAMOXIFEN-D5
CAS:164365-20-2
Formula: C26H24D5NO2
SI-01172-005
MW: 392.54
4-[(1Z)-1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]phenol; (Z)-4-Hydroxytamoxifen; trans-4-Hydroxytamoxifen
(Z)-AZOXYSTROBIN
CAS:143130-94-3
Formula: C22H17N3O5
SR-01010-002
MW: 403.39
(?Z)-2-[[6-(2-Cyanophenoxy)-4-pyrimidinyl]oxy]-?-(methoxymethylene)-benzeneacetic acid Methyl Ester; (Z)-2-[[6-(2-cyanophenoxy)-4-pyrimidinyl]oxy]-?-(methoxymethylene)-Benzeneacetic acid Methyl Ester;
(Z)-CINNARIZINE
CAS:750512-44-8
Formula: C26H28N2
SR-02418-005
MW: 368.51
"1-(Diphenylmethyl)-4-[(2Z)-3-phenyl-2-propen-1-yl]piperazine; (Z)-1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine; cis-Cinnarizine; "
(Z)-CINNARIZINE-D8
Formula: C26H20D8N2
SI-02418-004
MW: 376.56
1-(Diphenylmethyl)-4-[(2Z)-3-phenyl-2-propen-1-yl]piperazine-d8; (Z)-1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine-d8; cis-Cinnarizine-d8;
(Z)-DESBUTYL LUMEFANTRINE
CAS:355841-11-1
Formula: C26H24Cl3NO
SM-01313-001
MW: 472.83
(Z)-Desbutyl-benflumetol; (9Z)-?-[(Butylamino)methyl]-2 7-dichloro-9-[(4-chlorophenyl)methylene]-9H-fluorene-4-methanol
(Z)-EPROSARTAN
CAS:148674-39-9
Formula: C23H24N2O4S
SR-02282-008
MW: 424.51
"(?Z)-?-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid; (Z)-?-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid; SB 206328; "
(Z)-ETHYL 2-(2 3-DICHLOROBENZYLIDENE)-3-OXOBUTANOATE-13C4
Formula: C913C4H12Cl2O3
SI-01060-015
MW: 291.11
(2Z)-2-[(2 3-Dichlorophenyl)methylene]-3-oxobutanoic-13C4 Acid Ethyl Ester; (Z)-2-[(2 3-Dichlorophenyl)methylene]-3-oxobutanoic-13C4 Acid Ethyl Ester
(Z)-N N -(ETHENE-1 2-DIYL)BIS(2-(2 6-DIMETHYLPHENOXY)ACETAMIDE)
Formula: C22H26N2O4
SR-02403-009
MW: 382.45
(Z)-OCTA-1 5-DIEN-3-ONE
CAS:65767-22-8
Formula: C8H12O
SR-02311-001
MW: 124.18
(Z)-1 5-Octadien-3-one; cis-1 5-Octadien-3-one; (5Z)-1 5-Octadien-3-one
[(1S)-(1 2 3 )]-3-(2-AMINO-6-IODO-7H-PURIN-7-YL)-1 2-CYCLOBUTANEDIMETHANOL DIBENZOATE ESTER;
Formula: C25H24IN5O4
SR-02096-002
MW: 585.39
[(AMINOCARBONYL)THIO]-4-[2-(5-ETHYL-2-PYRIDINYL)ETHOXY]BENZENEPROPANOIC ACID ETHYL ESTER(PIOGLITAZONE IMPURITY)
CAS:868754-41-0
Formula: C21H26N2O4S
SR-01141-015
MW: 402.51
Pioglitazone Impurity E (EP)
[(R)-3-(3-FLUORO-4-MORPHOLINOPHENYL)-2-OXO-5-OXAZOLIDINYL]METHANOL
CAS:168828-82-8
Formula: C14H17FN2O4
SR-01227-010
MW: 296.3
"(R)-5-(Hydroxymethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one; (R)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-5-(hydroxymethyl)-2-oxazolidinone; (5R)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-5-(hydroxymethyl)-2-oxazolidinone; "
[[4-[2-(CYCLOPROPYLMETHOXY) ETHYL]PHENOXY]METHYL]OXIRANE
CAS:63659-17-6
Formula: C15H20O3
SR-02259-009
MW: 248.32
2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane; Betaxolol Imp. C (EP);
[[4-[2-(CYCLOPROPYLMETHOXY) ETHYL]PHENOXY]METHYL]OXIRANE-D5
Formula: C15H15D5O3
SI-02259-010
MW: 253.35
2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane; Betaxolol Imp. C (EP)-d5;
[1 1 -D2]TREHALOSE
Formula: C12D2H20O11
SI-02389-003
MW: 344.31
1-O-?-D-[1-D]Glucopyranosyl-?-D-[1-D]glucopyranoside;
[2-(DIMETHYLAMINO)-1-METHYLETHYL]- -PHENYL-BENZENEETHANOL 1-ACETATE
CAS:53990-51-5
Formula: C21H27NO2
SR-01391-008
MW: 325.44
4-Dimethylamino)-3-methyl-1 2-diphenyl- 2-Butanol Acetate; ?-[2-(Dimethylamino)-1-methylethyl]-?-phenyl-Benzeneethanol Acetate (Ester); USP Propoxyphene Related Compound B;
[3-[[[2-(DIAMINOMETHYLENEAMINO)-4-THIAZOLYL]METHYL]THIO]PROPIONYL]SULFAMIDE HYDROCHLORIDE(FAMOTIDINE IMPURITY)
CAS:76824-17-4
Formula: C8H15ClN6O3S3
SR-01059-016
MW: 374.89
3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)propanamide Hydrochloride; USP Famotidine Related Compound C;
[4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL) -1-PIPERAZINYL][(5S)-TETRAHYDRO-5-METHYL-2-FURANYL]METHANONE
CAS:1177261-85-6
Formula: C20H27N5O4
SR-02379-017
MW: 401.46
[4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL) -1-PIPERAZINYL][(5S)-TETRAHYDRO-5-METHYL-2-FURANYL]METHANONE-D8
Formula: C20H19D8N5O4
SI-02379-018
MW: 409.51
[4-(4-AMINO-6-HYDROXY-7-METHOXY-2-QUINAZOLINYL) -1-PIPERAZINYL](TETRAHYDRO-2-FURANYL)METHANONE
CAS:105356-89-6
Formula: C18H23N5O4
SR-02379-013
MW: 373.41
1-(4-Amino-6-hydroxy-7-methoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine
[4-(4-AMINO-6-HYDROXY-7-METHOXY-2-QUINAZOLINYL) -1-PIPERAZINYL](TETRAHYDRO-2-FURANYL)METHANONE-D8
Formula: C18H15D8N5O4
SI-02379-015
MW: 381.46
1-(4-Amino-6-hydroxy-7-methoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine-d8
[4-(4-AMINO-7-HYDROXY-6-METHOXY-2-QUINAZOLINYL) -1-PIPERAZINYL](TETRAHYDRO-2-FURANYL)METHANONE
CAS:105356-90-9
Formula: C18H23N5O4
SR-02379-019
MW: 373.41
1-(4-Amino-7-hydroxy-6-methoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine
[4-(4-AMINO-7-HYDROXY-6-METHOXY-2-QUINAZOLINYL) -1-PIPERAZINYL](TETRAHYDRO-2-FURANYL)METHANONE-D8
Formula: C18H15D8N5O4
SR-02379-014
MW: 381.46
1-(4-Amino-7-hydroxy-6-methoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine-d8
[4-[(2-AMINO-3-METHYL-1-OXOBUTYL) AMINO]-2-HYDROXY-5-PHENYL-1-(PHENYLMETHYL)PENTYL]-CARBAMIC ACID 5-THIAZOLYLMETHYL ESTER MONOHY
CAS:165315-97-9
Formula: C28H37ClN4O4S
SR-01490-005
MW: 561.14
[4-[4-(4-CHLOROPHENYL)-4-HYDROXY-1-PIPERIDINYL]PHENYL]CYCLOPROPYLMETHANONE
CAS:185626-66-8
Formula: C21H22ClNO2
SR-01421-048
MW: 355.86
De(1-(4-fluorophenyl)butan-1-one) N-(cyclopropyl(phenyl)methanone) Haloperidol
[4-[4-(4-CHLOROPHENYL-D4)-4-HYDROXY-1-PIPERIDINYL]PHENYL]CYCLOPROPYLMETHANONE
Formula: C21H18D4ClNO2
SI-01421-049
MW: 359.88
De(1-(4-fluorophenyl)butan-1-one) N-(cyclopropyl(phenyl)methanone) Haloperidol-d4
[4-CHLORO-2-[(1S)-3-CYCLOPROPYL-1-HYDROXY-1-(TRIFLUOROMETHYL)-2-PROPYNYL)PHENYL]CARBAMIC ACID METHYL ESTER
CAS:211563-40-5
Formula: C15H13ClF3NO3
SR-01280-009
MW: 347.05
"Methyl [4-Chloro-2-((1S)-1-trifluoromethyl-1-hydroxy-3-cyclopropyl-2-propyn-1-yl)phenyl]carbamate; SD573-Methyl Carbamate SV993;"
[S-(E)]-2-ETHYLIDENE-1 5-DIMETHYL-3 3-DIPHENYL-PYRROLIDINE (S-EDDP)
CAS:106293-57-6
Formula: C20H23N
SM-01236-016
MW: 277.4
[S-(E)]-1 5-Dimethyl-3 3-diphenyl-2-ethylidenepyrrolidine;
[UL-13C12]TREHALOSE
Formula: 13C12H22O11
SI-02389-001
MW: 354.2
1-O-?-D-[UL-13C6]Glucopyranosyl-?-D-[UL-13C6]glucopyranoside;
1 -EPI 2 2 -DIFLUORO-2 -DEOXYURIDINE
CAS:153381-14-7
Formula: C9H10F2N2O5
SR-01240-004
MW: 264.18
"1-(2-Deoxy-2 2-difluoro-?-D-erythro-pentofuranosyl)-2 4(1H 3H)-pyrimidinedione; 1 -Epi-2 -deoxy-2 2 -difluorouridine; "
1 -EPI-ENTECAVIR
CAS:1367369-78-5
Formula: C12H15N5O3
SR-01502-006
MW: 277.28
2-Amino-1 9-dihydro-9-[(1R 3R 4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; Entecavir Isomer Impurity 3; (1?R 3?R 4?S)-Entecavir Isomer;
1 -EPI-ENTECAVIR-DI-O-BENZYL ETHER
CAS:1354695-86-5
Formula: C26H27N5O3
SR-01502-021
MW: 457.52
2-Amino-1 9-dihydro-9-[(1R 3R 4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-6H-purin-6-one
1 -HYDROXY BUFURALOL(MIXTURE,OF,DIASTEREOMERS)
CAS:57704-16-2
Formula: C16H23NO3
SM-01386-002
MW: 277.36
?2-[[(1 1-Dimethylethyl)amino]methyl]-?7-methyl-
1 -HYDROXY BUFURALOL-D9(MIXTURE,OF,DIASTEREOMERS)
Formula: C16H14D9NO3
SI-01386-003
MW: 286.41
?2-[[(1 1-(Dimethylethyl-d9))amino]methyl]-?7-methyl-
1 -HYDROXY MIDAZOLAM
CAS:59468-90-5
Formula: C18H13ClFN3O
SM-01284-001
MW: 341.77
"8-Chloro-6-(2-fluorophenyl)-4H-imidazo[1 5-a][1 4]benzodiazepine-1-methanol; 1-Hydroxymidazolam; "
1 -HYDROXY MIDAZOLAM-13C3
CAS:1189677-14-2
Formula: C1513C3H13ClFN3O
SI-01284-003
MW: 344.74
"8-Chloro-6-(2-fluorophenyl)-4H-imidazo[1 5-a][1 4]benzodiazepine-1-methanol-13C3; 1-Hydroxymidazolam-13C3; "
1 -HYDROXY TRIAZOLAM
CAS:37115-45-0
Formula: C17H12Cl2N4O
SM-02191-004
MW: 359.21
1 -HYDROXY TRIAZOLAM-D4
CAS:145225-01-0
Formula: C17H8D4Cl2N4O
SI-02191-005
MW: 363.23
8-Chloro-6-(2-chlorophenyl-d4)-4H-s-triazolo[4 3-a][1 4]benzodiazepin-1-methanol; ?-Hydroxytriazolam-d4; 1-Hydroxytriazolam-d4;
1 -OXO PERAZINE
CAS:91508-47-3
Formula: C20H23N3OS
SR-02288-008
MW: 353.48
1-Methyl-4-(3-phenothiazin-10-ylpropionyl)piperazine; 1-methyl-4-[1-oxo-3-(10H-phenothiazin-10-yl)propyl]piperazine; 1-(4-Methyl-1-piperazinyl)-3-(10H-phenothiazin-10-yl)-1-propanone;
1 -OXO PERAZINE-D8
CAS:1246820-86-9
Formula: C20H15D8N3OS
SI-02288-009
MW: 361.53
1-Methyl-4-(3-phenothiazin-10-ylpropionyl)piperazine-d8; 1-methyl-4-[1-oxo-3-(10H-phenothiazin-10-yl)propyl]piperazine-d8; 1-(4-Methyl-1-piperazinyl)-3-(10H-phenothiazin-10-yl)-1-propanone-d8;
1 -OXOBUFURALOL HYDROCHLORIDE
CAS:137740-37-5
Formula: C16H22ClNO3
SM-01386-008
MW: 311.8
1-[2-[2-[(1 1-dimethylethyl)amino]-1-hydroxyethyl]-7-benzofuranyl]ethanone Hydrochloride
1 1 -[(5E)-5-METHYL-7-OXO-5-UNDECENE-1 11-DIYL] BIS
CAS:874747-30-5
Formula: "C26H34N8O5"
SR-01428-003
MW: 538.6
3 7-Dihydro-3 7-dimethyl-1-[(5E)-5-methyl-7-oxo-11-(2 3 6 7-tetrahydro-3 7-dimethyl-2 6-dioxo-1H-purin-1-yl)-5-undecen-1-yl]-1H-purine-2 6-dione; 1 1 -[(5E)-5-Methyl-7-oxo-5-undecene-1 11-diyl]bis[3 7-dihydro-3 7-dimethyl-1H-purine-2 6-dione;
1 1 -IMINOBIS[3-(3,5-XYLYLOXY) -2-PROPANOL HYDROCHLORIDE
CAS:112072-54-5
Formula: C22H32ClNO4
SR-01101-006
MW: 409.95
3 3 -Azanediylbis(1-(3 5-dimethylphenoxy)propan-2-ol) Hydrochloride; Bis[3-(3 5-dimethylphenoxy)-2-hydroxypropyl]amine Hydrochloride
1 1 -IMINOBIS[3-(3,5-XYLYLOXY-D9) -2-PROPANOL HYDROCHLORIDE
Formula: C22H14D18ClNO4
SR-01101-007
MW: 428.06
3 3 -Azanediylbis(1-(3 5-dimethylphenoxy-d9)propan-2-ol) Hydrochloride; Bis[3-(3 5-dimethylphenoxy-d9)-2-hydroxypropyl]amine Hydrochloride
1 1 -METHYLENE BIS[THEOBROMINE]
CAS:77196-87-3
Formula: C15H16N8O4
SR-01428-004
MW: 372.34
1 1 -Methylenebis[3 7-dihydro-3 7-dimethyl-1H-purine-2 6-dione;
1 2 -DEHYDRO MEPROBAMATE
CAS:25462-39-9
Formula: C9H16N2O4
SR-01382-008
MW: 216.23
2-Methyl-2-(2-propen-1-yl)-1 3-propanediol 1 3-Dicarbamate; Carbamic Acid 2-Allyl-2-methyltrimethylene Ester
1 2 3 4 6 11-HEXAHYDRO-5 12-DIHYDROXY-7-METHOXY-4 6 11-TRIOXO-2-NAPHTHACENECARBOXYLIC ACID
CAS:75694-21-2
Formula: C20H14O8
SR-02035-008
MW: 382.32
1 2 3 4-TETRAHYDRO-5-(2-OXIRANYLMETHOXY) -(2R 3S)-REL-2 3-NAPHTHALENEDIOL
CAS:627081-12-3
Formula: C13H16O4
SR-01445-004
MW: 236.26
(2R 3S)-5-(Oxiran-2-ylmethoxy)-1 2 3 4-tetrahydronaphthalene-2 3-diol
1 2 3 4-TETRAHYDRO-5-(2-OXIRANYLMETHOXY) -(2R 3S)-REL-2 3-NAPHTHALENEDIOL-D5
Formula: C13H11D5O4
SI-01445-005
MW: 241.29
(2R 3S)-5-(Oxiran-2-ylmethoxy)-1 2 3 4-tetrahydronaphthalene-2 3-diol-D5
1 2 3 4-TETRAHYDRO-6-METHYL-2 4-BIS(2-NITROPHENYL)-5-PYRIMIDINECARBOXYLIC ACID METHYL ESTER (MIXTURE OF DIASTEREOMERS)
CAS:108139-78-2
Formula: C19H18N4O6
SR-01118-013
MW: 398.37
Methyl 6-methyl-2 4-bis(2-nitrophenyl)-1 2 3 4-tetrahydropyrimidine-5-carboxylate
1 2 3 4-TETRAHYDRO-6-METHYL-2 4-BIS(2-NITROPHENYL)-5-PYRIMIDINECARBOXYLIC ACID METHYL ESTER-D3 (MIXTURE OF DIASTEREOMERS)
Formula: C19H15D3N4O6
SI-01118-014
MW: 401.39
Methyl 6-methyl-2 4-bis(2-nitrophenyl)-1 2 3 4-tetrahydropyrimidine-5-carboxylate-d3
1 2 3 9-TETRAHYDRO-4H-CARBAZOL-4-ONE
CAS:15128-52-6
Formula: C12H11NO
SR-01025-012
MW: 185.22
1 2 3 4-Tetrahydro-4-oxocarbazole; 1 2 3 4-Tetrahydrocarbazol-4-one;
1 2 3 9-TETRAHYDRO-9-METHYL-3-METHYLENE-4H-CARBAZOL-4-ONE
CAS:99614-64-9
Formula: C14H13NO
SM-01128-002
MW: 211.26
1 2 3 4-Tetrahydro-9-methyl-3-methylene-9H-carbazol-4-one;
1 2- BENZISOXAZOL- 3- YLACETIC ACID-13C2
Formula: C713C2H7NO3
SR-01192-003
MW: 179.14
(1 ?2-?Benzoxazol-?3-?yl)?acetic Acid-13C2; (Benzo[d]?isoxazol-?3-?yl)?acetic Acid-13C2; 2-(Benzisoxazol-?3-?yl)?acetic Acid-13C2; 2-?(Benzo[d]?isoxazol-?3-?yl)?acetic Acid-13C2; Benzisoxazol-?3-?ylacetic Acid-13C2; NSC 179803-13C2
1 2-CYCLOHEXYLIDENE TETRA-O-ACETYL MYO-INOSITOL
CAS:39110-61-7
Formula: C20H28O10
SR-02346-003
MW: 428.43
1 2-O-Cyclohexylidene-myo-inositol Tetraacetate; 2 3-O-cyclohexylidene-inositol Tetraacetate;
1 2-DEHYDRO-3-OXO ROCURONIUM BROMIDE
CAS:1190105-67-9
Formula: C32H49BrN2O4
SR-02388-004
MW: 605.65
1-[(5? 16? 17?)-17-(Acetyloxy)-2-(4-morpholinyl)-3-oxoandrost-1-en-16-yl]-1-(2-propen-1-yl)-pyrrolidinium Bromide
1 2-DIHYDRO BECLOMETHASONE DIPROPIONATE
CAS:114371-33-4
Formula: C28H39ClO7
SR-01520-020
MW: 523.06
(11? 16?)-9-chloro-11-hydroxy-16-methyl-17 21-bis(1-oxopropoxy)pregn-4-ene-3 20-dione; 1 2-Dihydrobeclometasone Dipropopionate;
1 2-DIHYDRO BETAMETHASONE 17-VALERATE
CAS:154713-07-2
Formula: C27H39FO6
SR-01412-029
MW: 478.59
(11?)-9-Fluoro-11 21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]-pregn-4-ene-3 20-dione
1 2-DIHYDRO BETAMETHASONE 9 11-EPOXIDE 17 21-DIPROPIONATE
Formula: C28H38O7
SR-01412-027
MW: 486.6
9? 11? 16?)-9 11-Epoxy-16-methyl-17 21-bis(1-oxopropoxy)pregna-4-ene-3 20-dione
1 2-DIHYDRO DEXAMETHASONE
CAS:426-17-5
Formula: C22H31FO5
SR-02337-013
MW: 394.48
(11? 16?)-9-Fluoro-11 17 21-trihydroxy-16-methylpregn-4-ene-3 20-dione
1 2-DIHYDRO FLUTICASONE PROPIONATE
CAS:105613-90-9
Formula: C25H33F3O5S
SR-01070-010
MW: 502.59
(6? 11? 16? 17?)-6 9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-androst-4-ene-17-carbothioic Acid S-(Fluoromethyl) Ester;
1 2-DIHYDRO FLUTICASONE PROPIONATE-D3
Formula: C25H30D3F3O5S
SI-01070-011
MW: 505.61
(6? 11? 16? 17?)-6 9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-androst-4-ene-17-carbothioic Acid S-(Fluoromethyl) Ester-d3;
1 2-DIHYDRO-BETAMETHASONE 17 21-DIPROPIONATE
CAS:80163-83-3
Formula: C28H39FO7
SR-01412-031
MW: 506.6
(11? 16?)-9-Fluoro-11-hydroxy-16-methyl-17 21-bis(1-oxopropoxy)-pregn-4-ene-3 20-dione
1 2:4 5-BISCYCLOHEXYLIDENE DL-MYO-INOSITOL
CAS:104873-71-4
Formula: C18H28O6
SR-02346-004
MW: 340.41
1 2:4 5-Di-O-cyclohexylidene-D L-myo-inositol;
1 2:4 5-DIISOPROPYLIDENE D L-MYO-INOSITOL
CAS:98974-89-1
Formula: C12H20O6
SR-02346-005
MW: 260.28
"1 2:4 5-Bis-O-(1-methylethylidene)-myo-inositol; 1 2:4 5-Bis-O-(1-methylethylidene)-DL-myo-inositol; "
1 3 4 6 7 11B-HEXAHYDRO-1-ISOBUTYL-9 10-DIMETHOXY-2H-BENZO[A]QUINOLIZIN-2-ONE
CAS:99672-64-7
Formula: C19H27NO3
SR-02204-010
MW: 317.42
"1 3 4 6 7 11b-Hexahydro-9 10-dimethoxy-1-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one"
1 3 4 6 7 11B-HEXAHYDRO-1-ISOBUTYL-9 10-DIMETHOXY-2H-BENZO[A]QUINOLIZIN-2-ONE-D7
Formula: C19H20D7NO3
SI-02204-011
MW: 324.47
"1 3 4 6 7 11b-Hexahydro-9 10-dimethoxy-1-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one-d7"
1 3 7 9-XANTHINIUM PERCHLORATE
CAS:17749-99-4
Formula: C9H13ClN4O6
SR-01189-009
MW: 308.68
3 7-Dihydro-1 3 7 9-tetramethyl-2 6-dioxo-1H-purinium Perchlorate; 1 3 7 9-Tetramethyl-2 6-dioxo-2 3 6 9-tetrahydro-1H-purin-7-ium Perchlorate; 1 2 3 6-Tetrahydro-1 3 7 9-tetramethyl-2 6-dioxopurinium Perchlorate
1 3 7-TRIMETHYLURIC ACID
CAS:5415-44-1
Formula: C8H10N4O3
SR-01021-006
MW: 210.19
Ba 2753; NSC 11259; NSC 95858; 1 3 7-Trimethyl Uric Acid; 7 9-Dihydro-1 3 7-trimethyl-1H-Purine-2 6 8(3H)-trione;
1 3 7-TRIMETHYLURIC ACID-D3
CAS:188297-95-2
Formula: C8H7D3N4O3
SI-01021-023
MW: 213.21
7 9-Dihydro-1 3-dimethyl-7-(methyl-d3)-1H-purine-2 6 8(3H)-trione;
1 3 7-TRIMETHYLURIC ACID-D9
Formula: C8HD9N4O3
SI-01021-007
MW: 219.25
Ba 2753-d9; NSC 11259-d9; NSC 95858-d9; 1 3 7-Trimethyl Uric Acid-d9; 7 9-Dihydro-1 3 7-trimethyl-1H-purine-2 6 8(3H)-trione-d9;
1 3-BIS(2-ACETYL-3-HYDROXYPHENOXY) -2-HYDROXYPROPANE
CAS:16150-44-0
Formula: C19H20O7
SR-01045-002
MW: 360.36
USP Cromolyn Sodium Related Compound A; 1 3-Bis(2-acetyl-3-hydroxyphenoxy)-2-propanol; 2 2 -[(2-Hydroxytrimethylene)dioxy]bis[6 -hydroxyacetophenone;
1 3-BIS(2-ACETYL-3-HYDROXYPHENOXY) -2-HYDROXYPROPANE-D5
Formula: C19H15D5O7
SI-01045-003
MW: 365.39
USP Cromolyn Sodium Related Compound A-D5; 1 3-Bis(2-acetyl-3-hydroxyphenoxy)-2-propanol-D5; 2 2 -[(2-Hydroxytrimethylene)dioxy]bis[6 -hydroxyacetophenone-D5
1 3-BIS-[4-(3-CHLOROPHENYL)PIPERAZIN-1-YL]PROPANE
CAS:6323-09-7
Formula: "C23H30Cl2N4"
SR-01142-016
MW: 433.42
1 1 -(1 3-Propanediyl)bis[4-(3-chlorophenyl)piperazine; 1 1 -Trimethylenebis[4-(m-chlorophenyl)piperazine; NSC 32568; Trazodone Impurity H;
1 3-BIS[4-(2-METHOXYETHYL) PHENOXY]
CAS:230975-30-1
Formula: C21H28O5
SR-01103-005
MW: 360.44
Metoprolol
1 3-DIMETHYLADAMANTANE
CAS:702-79-4
Formula: C12H20
SR-01394-017
MW: 164.29
Memantine Related Compound A
1 3-DIMETHYLURIC ACID
CAS:944-73-0
Formula: C7H8N4O3
SM-01021-008
MW: 196.16
7 9-Dihydro-1 3-dimethyl-1H-purine-2 6 8(3H)-trione; 1 3-Dimethyl Uric Acid;
1 3-DIPROPYL-7-METHYLXANTHINE
CAS:31542-63-9
Formula: C12H18N4O2
SR-01021-025
MW: 250.3
3 7-Dihydro-7-methyl-1 3-dipropyl-1H-purine-2 6-dione; 1 3-Dipropylheteroxanthine; 7-Methyl-1 3-dipropylxanthine; SC 5192
1 3-O-DIBENZYL-N-ACETYL- -D-GLUCOSAMINE
CAS:14855-31-3
Formula: C22H27NO6
SR-01516-034
MW: 401.45
Phenylmethyl 2-(Acetylamino)-2-deoxy-3-O-(phenylmethyl)-?-D-glucopyranoside
1 3-PROPANEDIOL
CAS:504-63-2
Formula: C3H8O2
SA-02252-000
MW: 76.09
1 3-Dihydroxypropan; 1 3-Propylene Glycol; 1 3-Propylenediol; 2-Deoxyglycerol; Bio-PDO; NSC 65426; PG; Susterra; Trimethylene Glycol; Zemea; Zemea Propanediol; ?-Propylene Glycol; ?-Propanediol
1 3-PROPANEDIOL-D6
Formula: C3H2D6O2
SI-02252-001
MW: 82.13
1 3-Dihydroxypropane-d6; 1 3-Propylene Glycol-d6; 1 3-Propylenediol-d6; 2-Deoxyglycerol; Bio-PDO; NSC 65426; PG; Susterra; Trimethylene glycol; Zemea; Zemea propanediol; ?-Propylene glycol; ?-Propanediol
1 3-THIAZOL-5-YLMETHYL N-[(1S 2S 4S)-4-(ACETYLAMINO)-1-BENZYL-2-HYDROXY-5-PHENYLPENTYL]CARBAMATE
CAS:1010808-43-1
Formula: C25H29N3O4S
SR-01490-023
MW: 467.58
Thiazol-5-ylmethyl N-[(2S 3S 5S)-5-Acetamido-3-hydroxy-1 6-diphenylhexan-2-yl Carbamate; Ritonavir USP Impurity A; N-[(1S 2S 4S)-4-(Acetylamino)-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamic Acid 5-Thiazolylmethyl Ester;
1 4-DIHYDRO-1-METHYL-4-OXO-3-PYRIDINECARBOXAMIDE
CAS:769-49-3
Formula: C7H8N2O2
SM-01374-001
MW: 152.15
1-Methyl-4-pyridone-3-carboxamide; 1-Methyl-4-pyridone-5-carboxamide; 3-(Aminocarbonyl)-1-methyl-4(1H)-pyridone; 5-Aminocarbonyl-1-methyl-4(1H)-pyridone; N1-Methyl-4-pyridone-5-carboxamide;
1 4-DIHYDROXY TRIAZOLAM
CAS:65686-12-6
Formula: C17H12Cl2N4O2
SM-02191-007
MW: 375.21
8-Chloro-6-(2-chlorophenyl)-4-hydroxy-4H-[1 2 4]triazolo[4 3-a][1 4]benzodiazepine-1-methanol; 1-Hydroxymethyl-4-hydroxytriazolam; ? 4-Dihydroxytriazolam;
1 7-DI(2-METHOXYPHENOXY) -2 6-DIHYDROXY-4-OXAHEPTANE
CAS:1797132-23-0
Formula: C20H26O7
SR-01008-021
MW: 378.42
1 7-DI(2-METHOXYPHENOXY) -2 6-DIHYDROXY-4-OXAHEPTANE-D6
Formula: C20H20D6O7
SI-01008-022
MW: 384.45
1 7-DIBROMO-4 5-EPOXY-14-HYDROXY-3-METHOXY-17-METHYLMORPHINAN-6-ONE
Formula: C18H19Br2NO4
SR-01294-013
MW: 473.16
1 7-DIMETHYLURIC ACID
CAS:33868-03-0
Formula: C7H8N4O3
SM-01021-018
MW: 196.16
7 9-Dihydro-1 7-dimethyl-1H-purine-2 6 8(3H)-trione;
1 7-DIMETHYLURIC ACID-D3
CAS:1189713-08-3
Formula: C7H5D3N4O3
SI-01021-019
MW: 199.18
7 9-Dihydro-1-(methyl-d3)-7-methyl-1H-purine-2 6 8(3H)-trione;
1- (2 3 5- TRI- O- ACETYL- - D- RIBOFURANOSYL) - 1 2 4- TRIAZOLE- 3- CARBOXYLIC ACID METHYL ESTER
CAS:39925-10-5
Formula: C15H19N3O9
SR-01342-003
MW: 385.33
Methyl 1-?(2 3 5-tri-?O-?acetyl-?-D-ribofuranosyl)?-1 2 4-triazole-3-carboxylate; 1-(2 3 5-Tri-O-acetyl-?-D-ribofuranosyl)-1H-1 2 4-triazole-3-carboxylic Acid Methyl Ester
1- (2 3 5- TRI- O- ACETYL- - D- RIBOFURANOSYL) - 1 2 4- TRIAZOLE- 3- CARBOXYLIC ACID METHYL ESTER-13C2
Formula: C1313C2H19N3O9
SR-01342-002
MW: 387.31
Methyl 1-?(2 3 5-tri-?O-?acetyl-?-D-ribofuranosyl)?-1 2 4-triazole-3-carboxylate-13C2; 1-(2 3 5-Tri-O-acetyl-?-D-ribofuranosyl)-1H-1 2 4-triazole-3-carboxylic Acid Methyl Ester-13C2
1- (2 3 5- TRI- O- ACETYL- - D- RIBOFURANOSYL) - 1 2 4- TRIAZOLE- 5- CARBOXYLIC ACID METHYL ESTER-13C2
Formula: C1313C2H19N3O9
SI-01342-004
MW: 387.31
1-(2 3 5-Tri-O-acetyl-?-D-ribofuranosyl)-1H-1 2 4-triazole-5-carboxylic Acid Methyl Ester
1- -HYDROXY-1-(2-THIENYL)-3-DIMETHYLAMINOPROPANE-D6
Formula: C9H9D6NOS
SR-01312-007
MW: 191.32
N N-Dimethyl-3-(2-thienyl)-3-hydroxypropanamine-d6; 3-(Dimethylamino)-1-(2-thienyl)-1-propanol-d6; N N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine-d6;
1-((2S 3S)-2-(BENZYLOXY)PENTAN-3-YL)-N-(4-(4-(4-HYDROXYPHENYL)PIPERAZIN-1-YL)PHENYL)HYDRAZINECARBOXAMIDE
CAS:345217-02-9
Formula: C29H37N5O3
SR-02060-007
MW: 503.64
1-[(1S 2S)-1-Ethyl-2-(phenylmethoxy)propyl]-N-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]hydrazinecarboxamide
1-(1,4-BENZODIOXAN-2-YLCARBONYL) PIPERAZINE
CAS:70918-00-2
Formula: C13H16N2O3
SR-01635-012
MW: 248.28
1-[(2 3-Dihydro-1 4-benzodioxin-2-yl)carbonyl]-piperazine; (2 3-Dihydrobenzo[b][1 4]dioxin-2-yl)(piperazin-1-yl)methanone; 1-(1 4-Benzodioxan-2-ylcarbonyl)piperazine; 1-[(2 3-Dihydro-1 4-benzodioxin-2-yl)carbonyl]piperazine
1-(1,4-BENZODIOXAN-2-YLCARBONYL) PIPERAZINE-D8
Formula: C13H8D8N2O3
SI-01635-013
MW: 256.33
"(2 3-Dihydro-1 4-benzodioxin-2-yl)-1-piperazinyl-d8-methanone;1-[(2 3-Dihydro-1 4-benzodioxin-2-yl)carbonyl]-piperazine-d8;"
1-(1H-BENZO[D]IMIDAZOL-2-YL)-3-METHYL-4-OXO-1 4-DIHYDROPYRIDINE-2-CARBOXYLIC ACID
CAS:1163685-30-0
Formula: C14H11N3O3
SR-01298-024
MW: 269.26
1-(1H-Benzimidazol-2-yl)-1 4-dihydro-3-methyl-4-oxo-2-pyridinecarboxylic Acid; Rabeprazole Related Compound A (USP)
1-(1H-BENZO[D]IMIDAZOL-2-YL)-3-METHYL-4-OXO-1 4-DIHYDROPYRIDINE-2-CARBOXYLIC ACID SODIUM SALT
Formula: C14H10N3NaO3
SR-01298-014
MW: 291.24
1-(1H-Benzimidazol-2-yl)-1 4-dihydro-3-methyl-4-oxo-2-pyridinecarboxylic Acid Sodium Salt; Rabeprazole Related Compound A (USP) Sodium Salt
1-(2,4,6-TRIMETHOXYBENZYL) PIPERAZINE DIHYDROCHLORIDE
CAS:113698-83-2
Formula: C14H24Cl2N2O3
SR-01304-009
MW: 339.26
1-[(2 4 6-Trimethoxyphenyl)methyl]piperazine Hydrochloride;
1-(2,6-DICHLORO-4-HYDROXPHENYL) -1 3-DIHYDROINDOL-2-ONE
CAS:73328-71-9
Formula: C14H9Cl2NO2
SR-01051-015
MW: 294.13
1-(2 6-Dichloro-4-hydroxyphenyl)-1 3-dihydro-2H-indol-2-one;
1-(2,6-DICHLORO-4-HYDROXYPHENYL) INDOLINE-2 3-DIONE-D4
Formula: C14H3D4Cl2NO3
SI-01051-016
MW: 312.14
1-(2 6-Dichloro-4-hydroxyphenyl)-1 3-dihydro-2H-indol-2-one-d4
1-(2-AMINOETHYL)-3-(5-CHLOROBENZO[C][1 2 5]THIADIAZOL-4-YL)THIOUREA
Formula: C9H10ClN5S2
SR-01175-006
MW: 287.79
1-(2-AMINOETHYL-D4)-3-(5-CHLOROBENZO[C][1 2 5]THIADIAZOL-4-YL)THIOUREA
Formula: C9H6D4ClN5S2
SI-01175-004
MW: 291.82
1-(2-CHLORO-1 2-DIPHENYLETHENYL)-4-(2-CHLOROETHOXY)BENZENE
CAS:1333466-58-2
Formula: C22H18Cl2O
SR-01264-023
MW: 369.28
Des-N N-diethylamine 4-Chloroethoxyclomiphene;
1-(2-HYDROXY-4-MERCAPTO-3-PROPYLPHENYL) ETHANONE
CAS:74891-64-8
Formula: C11H14O2S
SR-01549-004
MW: 210.29
2-?Hydroxy-?4-?mercapto-?3-?propylacetophenone
1-(2-PYRIDINYL)BENZOTRIAZOLE
CAS:13174-93-1
Formula: C11H8N4
SR-02330-006
MW: 196.21
1-(2-Pyridyl)-
1-(2-PYRIDINYL)BENZOTRIAZOLE
Formula: C11H8N15N3
SI-02330-007
MW: 199.19
1-(2-Pyridyl)-
1-(3,4,5-TRIMETHOXYBENZYL) PIPERAZINE
CAS:52146-35-7
Formula: C14H22N2O3
SR-01304-010
MW: 266.34
1-[(3 4 5-Trimethoxyphenyl)methyl]piperazine; N-(3 4 5-Trimethoxybenzyl)piperazine;
1-(3-BROMOPROPYL)-1 3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE
CAS:103784-04-9
Formula: C10H11BrN2O
SR-02150-014
MW: 255.11
1-(3-BROMOPROPYL)THEOBROMINE
CAS:6493-10-3
Formula: C10H13BrN4O2
SR-01428-002
MW: 301.14
1-(3-Bromopropyl)-3 7-dihydro-3 7-dimethyl-1H-purine-2 6-dione;
1-(3-CARBOXYPROPYL) -3 7-DIMETHYL XANTHINE-D6
Formula: C11H8D6N4O4
SI-01136-004
MW: 272.29
2 3 6 7-Tetrahydro-3 7-(dimethyl-d6)-2 6-dioxo-1H-purine-1-butanoic Acid; 3 6-Dihydro-3 7-(dimethyl-d6)-2 6-dioxopurine-1(2H)-butyric Acid
1-(3-CARBOXYPROPYL) -3 7-DIMETHYLXANTHINE
CAS:6493-07-8
Formula: C11H14N4O4
SR-01136-002
MW: 266.25
2 3 6 7-Tetrahydro-3 7-dimethyl-2 6-dioxo-1H-purine-1-butanoic Acid; 3 6-Dihydro-3 7-dimethyl-2 6-dioxopurine-1(2H)-butyric Acid
1-(3-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOLE-3-ACETIC ACID METHYL ESTER
CAS:1568-36-1
Formula: C20H18ClNO4
SR-02008-016
MW: 371.81
1-(m-Chlorobenzoyl)-5-methoxy-2-methyl-indole-3-acetic Acid Methyl Ester
1-(3-CHLOROPHENYL)-1 2-PROPANEDIONE
CAS:10557-17-2
Formula: C9H7ClO2
SR-01018-018 
MW: 182.6
1-(m-Chlorophenyl)-
1-(3-CHLOROPHENYL)PIPERAZINE HYDROCHLORIDE
CAS:13078-15-4
Formula: C10H14Cl2N2
SR-01142-017
MW: 233.14
1-(m-Chlorophenyl)piperazine Hydrochloride; 4-(3-Chlorophenyl)piperazine Hydrochloride; N-(3-Chlorophenyl)piperazine Hydrochloride; N-(m-Chlorophenyl)piperazine Hydrochloride; mCPP Hydrochloride;
1-(3-HYDROXYBUTAN-2-YL) -4-(4-(4-(4-HYDROXYPHENYL)PIPERAZIN-1-YL)PHENYL)-1H-1 2 4-TRIAZOL-5(4H)-ONE
CAS:125272-25-5
Formula: C22H27N5O3
SR-01083-021
MW: 409.48
2 4-Dihydro-2-(2-hydroxy-1-methylpropyl)-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1 2 4-triazol-3-one
1-(4-(2-CYCLOBUTOXYETHYL) PHENOXY)-3-(ISOPROPYLAMINO)PROPAN-2-OL
Formula: C18H29NO3
SR-02259-008
MW: 307.43
1-(4-(2-HYDROXY-3-(ISOPROPYLAMINO) PROPOXY)PHENYL)-2-METHOXYETHANONE
CAS:73723-85-0
Formula: C15H23NO4
SM-01103-014
MW: 281.35
1-[4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]-2-methoxyethanone; 3-[4-(Methoxyacetyl)phenoxy]-1-)isopropylamino)-2-propanol;
1-(4-(BENZYLOXY) -3-NITROPHENYL)-2-BROMOETHANONE
CAS:43229-01-2
Formula: C15H12BrNO4
SR-01073-016
MW: 350.16
"2-Bromo-1-[3-nitro-4-(phenylmethoxy)phenyl]Ethanone; 1-(Benzyloxy)-2-nitro-4-(2-bromoacetyl)benzene; 2-Bromo-1-(3-nitro-4-benzyloxyphenyl)ethanone; 2-Bromo-4 -Benzyloxy-3 -nitroacetophenone; 4 -(Benzyloxy)-2-bromo-3 -nitroacetophenone"
1-(4-AZA-8-HYDROXY-6-OXO) OCT-2-EN-1-OYLIMIDAZOLE(MIXTURE E/Z)
CAS:89186-34-5
Formula: C10H13N3O3
SR-01041-004
MW: 223.23
4-Hydroxy-1-[[3-(1H-imidazol-1-yl)-3-oxo-1-propen-1-yl]amino]-2-butanone; 1-[3-[(4-Hydroxy-2-oxobutyl)amino]-1-oxo-2-propenyl]-1H-imidazole;
1-(4-CHLOROPHENYL)CYCLOBUTANE CARBONITRILE
CAS:28049-61-8
Formula: C11H10ClN
SR-01164-022
MW: 191.66
1-(4-Chlorophenyl)cyclobutanecarbonitrile; 1-(p-Chlorophenyl)cyclobutanecarbonitrile; NSC 154613
1-(4-FLUOROPHENYL)-5-BROMOPHTHALAN
CAS:64169-66-0
Formula: C14H10BrFO
SR-01040-007
MW: 293.13
1-(4-Fluorophenyl)-5-bromo-1 3-dihydroisobenzofuran; 5-Bromo-1-(4-Fluorophenyl)-1 3-dihydroisobenzofuran; 5-Bromo-1-(4-fluorophenyl)-phthalide
1-(4-METHYLOXY-PHENYL) -4-(4-NITRO-PHENYL)-PIPERAZINE
CAS:74852-61-2
Formula: C17H19N3O3
SR-01083-023
MW: 313.35
1-(4-Methoxyphenyl)-4-(4-nitrophenyl)piperazine;
1-(5-CHLOROBENZO[C][1 2 5]THIADIAZOL-4-YL)GUANIDINE HYDROBROMIDE
Formula: C7H7BrClN5S
SM-01175-003
MW: 308.59
N-(5-Chloro-2 1 3-benzothiadiazol-4-yl)guanidine Hydrobromide; Tizanidine Metabolite M4
1-(BENZYLIDENEAMINO)PARABANIC ACID
CAS:42839-64-5
Formula: C10H7N3O3
SR-02456-008
MW: 217.18
1-Benzylideneamino-2 4 5-trioxoimidazolidine; 1-[(Phenylmethylene)amino]-2 4 5-imidazolidinetrione;
1-(BENZYLOXY) NAPHTHALENE
CAS:607-58-9
Formula: C17H14O
SM-02453-001
MW: 234.29
1-(Phenylmethoxy)naphthalene; 1-Naphthyl Benzyl Ether; Benzyl 1-Naphthyl Ether; Benzyl ?-Naphthyl Ether; NSC 4044; ?-Naphthyl Benzyl Ether;
1-(BROMOMETHYL)-7-FLUORONAPHTHALENE
CAS:70631-50-4
Formula: C11H8BrF
SR-01547-002
MW: 239.08
1-(DODECYLOXY) -N N-DIMETHYL-1-OXOPROPAN-2-AMINE OXIDE
Formula: C17H35NO3
SR-01566-001
MW: 301.46
Dodecyl-2-(N N-Dimethylamino)-propionate N-Oxide; DDAIP N-Oxide
1-(MERCAPTOMETHYL)CYCLOPROPANEACETIC ACID
CAS:162515-68-6
Formula: C6H10O2S
SR-01267-018
MW: 146.21
2-[1-(mercaptomethyl)cyclopropyl]acetic Acid
1-(NITROMETHYL)CYCLOHEXANE-D6-ACETIC ACID ETHYL ESTER
Formula: C11H13D6NO4
SI-01075-007
MW: 235.31
1-(NITROMETHYL)CYCLOHEXANEACETIC ACID ETHYL ESTER
CAS:133938-45-1
Formula: C11H19NO4
SR-01075-006
MW: 229.27
1-(RS Z)-2-(DIBUTYLAMINO)-2-[2 7-DICHLORO-9-(4-CHLOROBENXYLIDENE)]-9H-FLUOREN-4-YL]ETHANOL (LUMEFANTRINE IMPURITY)
Formula: C30H32Cl3NO
SR-01313-005
MW: 528.94
"2-(Dibutylamino)-2-[2 7-dichloro-9-(4-chlorophenyl)meth-(Z)-ylidene]-9H-fluoren-4-yl]ethanol; "
1-[(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL) CARBONYL]PIPERAZINE MONOHYDROCHLORIDE
CAS:70918-74-0
Formula: C13H17ClN2O3
SR-01635-009
MW: 284.74
USP Doxazosin Related Compound A; 1 4-Benzodioxin piperazine deriv.
1-[(4,5-DIHYDRO-3-METHYL-5-OXO-1-PHENYL-1H-PYRAZOL-4-YL) METHYLAMINO]METHANESULFONIC ACID SODIUM SALT
CAS:705941-70-4
Formula: C12H15N3NaO4S
SR-02085-006
MW: 319.31
[(4 5-Dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)methylamino]methanesulfonic Acid Sodium Salt
1-[(4-CHLOROPHENYL)PHENYLMETHYL]PIPERAZINE
CAS:303-26-4
Formula: C17H19ClN2
SR-01032-005
MW: 286.8
"1-(p-Chloro-?-phenylbenzyl)piperazine; 4-(4-Chlorobenzhydryl)piperazine; N-(4-Chlorobenzhydryl)piperazine; Norchlorcyclizine; NSC 86164; HYDROXYZINE RELATED COMPOUND A"
1-[(4-HYDRAZINYLPHENYL)METHYL]-1H-1 2 4-TRIAZOLE
CAS:144035-22-3
Formula: C9H11N5
SR-01307-007
MW: 189.22
4-(1H 1 2 4-Triazol-1-ylmethyl)phenylhydrazine;
1-[1-(4-METHOXYPHENYL) -2-(METHYLAMINO)ETHYL]CYCLOHEXANOL HYDROCHLORIDE
CAS:93413-90-2
Formula: C16H26ClNO2
SM-01186-005 
MW: 299.84
(±)-1-[1-(4-Methoxyphenyl)-2-(methylamino)ethyl]cyclohexanol Hydrochloride; Wy 45494; Venlafaxine Related Compound A;
1-[2-(2 4-DIFLUOROPHENYL)-2 3-EPOXYPROPYL]-1H-1 2 4-TRIAZOLE
CAS:86386-76-7
Formula: C11H9F2N3O
SR-01066-011
MW: 237.21
1-[[2-(2 4-Difluorophenyl)oxiranyl]methyl]-1H-1 2 4-triazole; 2-(2 4-Difluorophenyl)-2 3-epoxy-1-(1H-1 2 4-triazol-1-yl)propane; 2-(2 4-Difluorophenyl)-2-[(1H-1 2 4-triazol-1-yl)methyl]oxirane; Fluconazole Epoxy Impurity;
1-[2-(2 4-DIFLUOROPHENYL)-2 3-EPOXYPROPYL]-1H-1 2 4-TRIAZOLE-D4
Formula: C11H5D4F2N3O
SI-01066-012
MW: 241.23
1-[[2-(2 4-Difluorophenyl)oxiranyl]methyl]-1H-1 2 4-triazole-d4; 2-(2 4-Difluorophenyl)-2 3-epoxy-1-(1H-1 2 4-triazol-1-yl)propane-d4; 2-(2 4-Difluorophenyl)-2-[(1H-1 2 4-triazol-1-yl)methyl]oxirane-d4; Fluconazole Epoxy Impurity-d4;
1-[2-[(3S)-3-[3-[(1E)-2-(7-CHLORO-2-QUINOLINYL)ETHENYL]PHENYL]-3-HYDROXYPROPYL]PHENYL]ACETATE
CAS:184764-13-4
Formula: C28H24ClNO2
SR-01267-016
MW: 441.95
[S-(E)]-1-[2-[3-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]phenyl]ethanone;
1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-1 3-DIHYDRO-5-ISOBENZOFURANCARBOXAMIDE
CAS:64372-56-1
Formula: C20H23FN2O2
SR-01040-018
MW: 342.41
Citalopram Impurity A; rac-Citalopam Carboxamide; USP Citalopram Related Compound A; Escitalopram Amide Impurity
1-[3-[4-(3-CHLOROPHENYL)-1-PIPERAZINYL]PROPYL]-4-(2-PHENOXYETHYL)-1 2 4-TRIAZOLIDINE-3 5-DIONE
CAS:153707-88-1
Formula: C23H28ClN5O3
SM-01116-003
MW: 457.95
BMS 180492;
1-[4-(2-AMINOETHYLPHENYL)SULFONYL]-3-(CIS-3-HYDROXYCYCLOHEXYL)UREA TRIFLUOROACETIC ACID SALT
Formula: C17H24F3N3O6S
SR-01467-019
MW: 455.45
1-[4-(2-N-BOC-2-AMINOETHYLPHENYL)SULFONYL]-3-(CIS-3-HYDROXYCYCLOHEXYL)UREA
Formula: C20H31N3O6S
SR-01467-016
MW: 441.54
1-[4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL) -1-PIPERAZINYL]-2-HYDROXY-1-PENTANONE
CAS:152551-75-2
Formula: C19H27N5O4
SR-02379-008
MW: 389.45
1-(4-Amino-6 7-dimethoxy-2-quinazolinyl)-4-(2-hydroxy-1-oxopentyl)piperazine; A 65297; (±)-1-(4-Amino-6 7-dimethoxy-2-quinazolinyl)-4-(2-hydroxy-1-oxopentyl)piperazine
1-[4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL) -1-PIPERAZINYL]-2-HYDROXY-1-PENTANONE-D8
Formula: C19H19D8N5O4
SI-02379-009
MW: 397.5
1-(4-Amino-6 7-dimethoxy-2-quinazolinyl)-4-(2-hydroxy-1-oxopentyl)piperazine-d8; A 65297-d8; (±)-1-(4-Amino-6 7-dimethoxy-2-quinazolinyl)-4-(2-hydroxy-1-oxopentyl)piperazine-d8
1-[4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL) -1-PIPERAZINYL]-5-HYDROXY-1-PENTANONE
CAS:109678-71-9
Formula: C19H27N5O4
SR-02379-006
MW: 389.45
1-(4-Amino-6 7-dimethoxy-2-quinazolinyl)-4-(5-hydroxy-1-oxopentyl)-piperazine
1-[4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL) -1-PIPERAZINYL]-5-HYDROXY-1-PENTANONE-D8
Formula: C19H19D8N5O4
SI-02379-007
MW: 397.5
1-(4-Amino-6 7-dimethoxy-2-quinazolinyl)-4-(5-hydroxy-1-oxopentyl)-piperazine-d8
1-[4-[3-(4-ACETYL-2-METHOXYPHENOXY) PROPOXY]-3-ETHOXYPHENYL]ETHANONE
Formula: C22H26O6
SR-02271-020
MW: 386.44
1-[4-[3-(4-ACETYL-2-METHOXYPHENOXY) PROPOXY]-3-ETHOXYPHENYL]ETHANONE-D3
Formula: C22H23D3O6
SI-02271-021
MW: 389.46
1-[6-(2-PROPENYL)-ERGOLINE-8 -CARBONYL]-3-METHYL-PERHYDROPYRIMIDINE-2-ONE
Formula: C23H28N4O2
SR-01020-011
MW: 392.49
1-((6aR 9R 10aR)-7-Allyl-4 6 6a 7 8 9 10 10a-octahydroindolo[4 3-fg]quinoline-9-carbonyl)-3-methyltetrahydropyrimidin-2(1H)-one; Cabergoline Impurity A
1-[6-(2-PROPENYL)-ERGOLINE-8 -CARBONYL]-3-METHYL-PERHYDROPYRIMIDINE-2-ONE-D3
Formula: C23H25D3N4O2
SI-01020-012
MW: 395.51
1-((6aR 9R 10aR)-7-Allyl-4 6 6a 7 8 9 10 10a-octahydroindolo[4 3-fg]quinoline-9-carbonyl)-3-methyltetrahydropyrimidin-2(1H)-one-d3; Cabergoline Impurity A-d3
1-ADAMANTAN-D15-AMINE
CAS:33830-10-3
Formula: C10H2D15N
SI-02086-001 
MW: 166.34
(Adamantan-1-yl-d15)amine; 1-Adamant-d15-amine; 1-Adamantyl-d15-amine; 1-Amantadine-d15; 1-Aminoadamantane-d15; Adamantamine-d15; Adamantan-d15-amine; Adamantyl-d15amine; Amantadine-d15; NSC 341865-d15; Tricyclo[3.3.1.13 7]decane-d15-1-amine
1-AMINO-3-(3,5-DIMETHYLPHENOXY) -2-PROPANOL
CAS:66766-07-2
Formula: C11H17NO2
SR-01101-005
MW: 195.26
3-(3 5-Dimethylphenoxy)-2-hydroxypropylamine
1-AMINO-3-ADAMANTANOL
CAS:702-82-9
Formula: C10H17NO
SR-02275-005
MW: 167.25
3-Amino-1-adamantanol; 3-Amino-tricyclo[3.3.1.13 7]decan-1-ol; 1-Amino-3-hydroxyadamantane; (3-Hydroxyadamantan-1-yl)amine;
1-BENZYL-3-HYDROXY-1H-INDAZOLE SODIUM SALT
CAS:13185-09-6
Formula: C14H11N2NaO
SR-01013-002
MW: 246.24
1 2-Dihydro-1-(phenylmethyl)-3H-indazol-3-one Sodium Salt; 1-Benzyl-1H-indazol-3-ol Sodium Salt; 1-Benzyl-3-indazolone Sodium Salt;
1-BENZYL-3-HYDROXYINDAZOLE
CAS:2215-63-6
Formula: C14H12N2O
SR-01013-001
MW: 224.26
1 2-Dihydro-1-(phenylmethyl)-3H-indazol-3-one; 1-Benzyl-1 2-dihydro-3H-indazol-3-one; 1-Benzyl-1H-indazol-3-ol; 3-Hydroxy-1-benzyl-1H-indazole; 1-Benzyl-3-indazolone; NSC 247064
1-BENZYL-3-METHOXY-1H-INDAZOLE
CAS:4454-33-5
Formula: C15H14N2O
SR-01013-003
MW: 238.28
3-Methoxy-1-(phenylmethyl)-1H-indazole
1-BENZYL-4-[(5,6-DIMETHOXY-1-OXOINDAN-2-YLIDENE) METHYL]PIPERIDINE(DONEPEZIL IMPURITY)
CAS:120014-07-5
Formula: C24H27NO3
SR-01229-007
MW: 377.48
2 3-Dihydro-5 6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methylene]-1H-inden-1-one; 2-(1-Benzylpiperidin-4-ylmethylidene)-5 6-dimethoxyindan-1-one; Dehydro Donepezil;
1-BROMO-2 5 8 11 14 17-ICOSAHEXAYNE
Formula: C20H17Br
SR-02016-015
MW: 337.25
1-BROMO-6-(TRIMETHYLAMMONIUM)HEXYL BROMIDE
CAS:32765-81-4
Formula: C9H21Br2N
SR-01577-001
MW: 303.08
6-Bromo-N N N-trimethyl-1-hexanaminium Bromide; (6-Bromohexyl)trimethylammonium Bromide;
1-CHLORO DIHYDRO DUTASTERIDE
CAS:1365545-42-1
Formula: C27H31ClF6N2O2
SR-02021-004
MW: 564.99
(4aR 4bS 6aS 7S 9aS 9bS 11aR)-N-[2 5-Bis(trifluoromethyl)phenyl]-4-chlorohexadecahydro-4a 6a-dimethyl-2-oxo-1H-indeno[5 4-f]quinoline-7-carboxamide; Dutasteride Chloro Impurity;
1-CYANO-3-ISOPROPYLGUANIDINE
CAS:44830-55-9
Formula: C5H10N4
SR-01432-005
MW: 126.16
"N-Cyano-N -(1-methylethyl)guanidine; Isopropyldicyandiamide; 3-Cyano-1-isopropylguanidine; NSC 643485"
1-CYCLOPROPANE MYCOPHENOLIC ACID
CAS:125198-40-5
Formula: C18H22O6
SR-01287-007
MW: 334.36
3-(2-((4-Hydroxy-6-methoxy-7-methyl-3-oxo-1 3-dihydroisobenzofuran-5-yl)methyl)-1-methylcyclopropyl)propanoic Acid; 2-[(1 3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)methyl]-1-methyl-cyclopropanepropanoic Acid
1-CYCLOPROPYL-3-(((DIFLUOROBORYL)OXY)CARBONYL)-6-FLUORO-8-METHOXY-7-((4-METHOXYBENZYL)AMINO)QUINOLIN-4(1H)-ONE
Formula: C22H20BF3N2O5
SR-02124-022
MW: 460.21
1-CYCLOPROPYL-6 7 8-TRIFLUORO-1 4-DIHYDRO-4-OXO-3-QUINOLINECARBOXYLIC ACID ETHYL ESTER
CAS:94242-51-0
Formula: C15H12F3NO3
SR-02124-031
MW: 311.26
1-Cyclopropyl-1 4-dihydro-6 7 8-trifluoro-4-oxoquinoline-3-carboxylic Acid Ethyl Ester; 1-Cyclopropyl-6 7 8-trifluoro-1 4-dihydro-4-oxoquinoline-3-carboxylic Acid Ethyl Ester;
1-CYCLOPROPYL-6 7-DIFLUORO-1 4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID
CAS:93107-30-3
Formula: C13H9F2NO3
SM-02124-020
MW: 265.21
###############################################################################################################################################################################################################################################################
1-CYCLOPROPYL-6 7-DIFLUORO-1 4-DIHYDRO-8-HYDROXY-4-OXO-3-QUINOLINECARBOXYLIC ACID
CAS:154093-72-8
Formula: C13H9F2NO4
SR-02438-003
MW: 281.21
Moxifloxacin
1-CYCLOPROPYL-6-FLUORO-1 4-DIHYDRO-4-OXO-1 8-NAPHTHYRIDINE-3-CARBOXYLIC ACID
CAS:137118-01-5
Formula: C12H9FN2O3
SM-01215-004
MW: 248.21
1-CYCLOPROPYL-6-FLUORO-8-METHOXY-7-((4-METHOXYBENZYL) AMINO)-4-OXO-1 4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
Formula: C22H21FN2O5
SR-02124-023
MW: 412.41
1-CYCLOPROPYL-7-FLUORO-6 8-DIMETHOXY-4-QUINOLONE-3-CARBOXYLIC ACID
Formula: C15H14FNO5
SR-02124-024
MW: 307.27
1-CYCLOPROPYL-7-FLUORO-6 8-DIMETHOXY-4-QUINOLONE-3-CARBOXYLIC ACID ETHYL ESTER
Formula: C17H18FNO5
SR-02124-025
MW: 335.33
1-CYCLOPROPYL-8-ETHOXY-6 7-DIFLUORO-1 4-DIHYDRO-4-OXO-3-QUINOLINECARBOXYLIC ACID
CAS:143158-55-8
Formula: C15H13F2NO4
SR-02124-028
MW: 309.26
1-CYCLOPROPYL-8-ETHOXY-6 7-DIFLUORO-1 4-DIHYDRO-4-OXO-3-QUINOLINECARBOXYLIC ACID ETHYL ESTER
CAS:172602-83-4
Formula: C17H17F2NO4
SR-02124-026
MW: 337.32
1-CYCLOPROPYL-8-ETHOXY-6 7-DIFLUORO-1 4-DIHYDRO-4-OXO-3-QUINOLINECARBOXYLIC ACID ETHYL ESTER-D5
Formula: C17H12D5F2NO4
SI-02124-027
MW: 342.35
1-CYCLOPROPYL-8-ETHOXY-6 7-DIFLUORO-1 4-DIHYDRO-4-OXO-3-QUINOLINECARBOXYLIC ACID-D5
Formula: C15H8D5F2NO4
SI-02124-029
MW: 314.3
1-DECANOYL-RAC-GLYCEROL
CAS:2277-23-8
Formula: C13H26O4
SR-01396-006
MW: 246.34
###############################################################################################################################################################################################################################################################
1-DECANOYL-RAC-GLYCEROL-D5
Formula: C13H21D5O4
SI-01396-007
MW: 251.37
###############################################################################################################################################################################################################################################################
1-DEHYDRO ALDOSTERONE
CAS:76959-24-5
Formula: C21H26O5
SR-01494-005
MW: 358.43
(11?)-11 21-Dihydroxy-3 20-dioxopregna-1 4-dien-18-al; ?1-Aldosterone; 11? 21-Dihydroxy-3 20-dioxopregna-1 4-dien-18-al; 1-Dehydroaldosterone;
1-DESHYDROXY 1-OXO TERBUTALINE SULFATE
Formula: C24H34N2O6?H2SO4
SR-01213-004
MW: 544.62
2-(tert-Butylamino)-1-(3 5-dihydroxyphenyl)ethanone Sulfate (1:2); USP Terbutaline Related Compound A;
1-DESHYDROXY MITOXANTRONE
Formula: C22H28N4O5
SR-02381-007
MW: 428.48
###############################################################################################################################################################################################################################################################
1-DESMETHYL 2-METHYL GRANISETRON (GRANISETRON IMPURITY A)
CAS:127472-42-8
Formula: C18H24N4O
SR-02288-018
MW: 312.41
"endo-N-(9-Methyl-9-Azabicyclo[3.3.1]non-3-yl)-2-methyl-2H-indazole-3-carboxamide; Granisetron Impurity A; USP Granisetron Related Compound A; "
1-EPI-DARUNAVIR
Formula: C27H37N3O7S
SR-02209-002
MW: 547.66
[(1R 2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenyl-methyl)propyl]carabamic Acid (3R 3aS 6aR)-Hexahydrofuro[2 3-b]-furan-3-yl Ester
1-ETHYL 3-METHYL 2-ACETAMIDO-2-(4-OCTYLPHENETHYL)MALONATE
Formula: C24H37NO5
SR-02265-014
MW: 419.55
Propanedioic Acid 2-(Acetylamino)-2-[2-(4-octylphenyl)ethyl]-1-ethyl 3-methyl Diester;
1-ETHYL 3-METHYL 2-ACETAMIDO-2-(4-OCTYLPHENETHYL)MALONATE-D3
Formula: C24H34D3NO5
SR-02265-015
MW: 422.57
Propanedioic Acid 2-(Acetylamino)-2-[2-(4-octylphenyl)ethyl]-1-ethyl 3-methyl Diester-d3;
1-FLUORO-1-DES[2-[(2-HYDROXYETHYL) AMINO]ETHYLAMINO] MITOXANTRONE
CAS:1195810-93-5
Formula: C18H17FN2O5
SR-02381-005
MW: 360.34
1-Fluoro-5 8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9 10-anthracenedione
1-HYDROXY CARVEDILOL
CAS:146574-41-6
Formula: C24H26N2O5
SM-01025-033
MW: 422.47
4-[2-Hydroxy-3-[[2-(2-methoxyphenoxy)ethyl]amino]propoxy]-9H-carbazol-1-ol; BM 910183; SB 209995
1-HYDROXY CARVEDILOL 1-O- -D-GLUCURONIDE
CAS:131087-98-4
Formula: C30H34N2O11
SM-01025-034
MW: 598.6
4-[2-Hydroxy-3-[[2-(2-methoxyphenoxy)ethyl]amino]propoxy]-9H-carbazol-1-yl ?-D-Glucopyranosiduronic Acid
1-HYDROXY FENTANYL
CAS:99624-68-7
Formula: C22H28N2O2
SM-01487-007
MW: 352.47
2-Hydroxy-N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide; ?-1-Hydroxyfentanyl
1-HYDROXY IBUPROFEN (IBUPROFEN IMPURITY L)(MIXTURE OF DIASTEREOMERS)
CAS:53949-53-4
Formula: C13H18O3
SM-01282-012
MW: 222.28
"4-(1-Hydroxy-2-methylpropyl)-?-methylbenzeneacetic Acid;2-[4 -(1-Hydroxy-2-methylpropyl)phenyl]propionic Acid; Ibuprofen Impurity L;"
1-HYDROXY PIOGLITAZONE HYDROCHLORIDE
CAS:146062-46-6
Formula: C19H21ClN2O4S
SM-01141-030
MW: 408.9
5-[[4-[2-[5-(1-Hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2 4-thiazolidinedione Monohydrochloride; 5-[[4-[2-[5-(1-Hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2 4-thiazolidinedione Hydrochloride (1:1)
1-HYDROXY VALDECOXIB
CAS:181695-81-8
Formula: C16H14N2O4S
SM-01243-005
MW: 330.36
4-[5-(Hydroxymethyl)-3-phenyl-4-isoxazolyl]-benzenesulfonamide;
1-HYDROXY VALDECOXIB-13C2 15N
CAS:1346601-29-3
Formula: C1415C2H14N15NO4S
SI-01243-006
MW: 333.34
4-[5-(Hydroxymethyl)-3-phenyl-4-isoxazolyl]-benzenesulfonamide-13C2 15N;
1-HYDROXY-2 7-DIAMINO MITOSENE(MIXTURE,CIS/TRANS)
CAS:1192552-64-9
Formula: C14H16N4O5
SR-02159-007
MW: 320.3
(2S)-
1-HYDROXY-3-NITRODEAMINO FINGOLIMOD
CAS:899822-99-2
Formula: C19H31NO5
SR-02265-006
MW: 353.45
3-(Hydroxymethyl)-3-nitro-1-(4-octylphenyl)-1 4-butanediol
1-HYDROXY-4-METHYLESTRA-1 3 5(10)-TRIEN-17-ONE
CAS:4954-08-9
Formula: C19H24O2
SR-01414-016
MW: 284.39
1-Hydroxy-4-methyl-estra-1 3 5(10)-trien-17-one
1-HYDROXYBENZOTRIAZOLE HYDRATE
CAS:123333-53-9
Formula: C6H7N3O2
SR-02330-001
MW: 153.14
HOBt Hydrate; Benzotriazol-1-ol Hydrate; 1-Hydroxy-1H-benzotriazole Hydrate; 1-Oxy-benztriazol Hydrate;
1-ISOPROPYL ETODOLAC
CAS:849630-65-5
Formula: C18H23NO3
SR-01058-002
MW: 301.38
8-Ethyl-1 3 4 9-tetrahydro-1-(1-methylethyl)-Pyrano[3 4-b]indole-1-acetic Acid
1-KETO KETOROLAC
CAS:113502-52-6
Formula: C14H11NO2
SR-01203-006
MW: 225.24
5-Benzoyl-2 3-dihydro-1H-pyrrolizin-1-one; USP Ketorolac Related Compound C;
1-METHOXY AMIODARONE
CAS:1087223-70-8
Formula: C26H31I2NO4
SR-01004-005
MW: 675.34
"[4-[2-(Diethylamino)ethoxy]-3 5-diiodophenyl][2-(1-methoxybutyl)-3-benzofuranyl]methanone; [2-[(1RS)-1-Methoxybutyl]benzofuran-3-yl][4-[2-(diethylamino)ethoxy]-3 5-diiodophenyl]methanone; Amiodarone Impurity G; "
1-METHYL ADENOSINE
CAS:15763-06-1
Formula: C11H15N5O4
SR-01082-025
MW: 281.27
(2R 3S 4R 5R)-2-(Hydroxymethyl)-5-(6-imino-1-methyl-1H-purin-9(6H)-yl)tetrahydrofuran-3 4-diol;
1-METHYL BIGUANIDE HEMISULFATE MONOHYDRATE
Formula: C3H11N5O?1/2H2SO4
SR-01102-002
MW: 182.19
N-Methylimidodicarbonimidic Diamide Hemisulfate Monohydrate; N-Methyl-N -guanylguanidine Hemisulfate Monohydrate;
1-METHYL ETHYNYL ESTRADIOL
CAS:15071-66-6
Formula: C21H26O2
SR-01414-002
MW: 310.43
"1-Methyl-19-nor-17?-pregna-1 3 5(10)-trien-20-yne-3 17-diol; 17-Ethynyl-1-methylestradiol; NSC 29746; Impurity J"
1-METHYL MEBENDAZOLE
CAS:132119-11-0
Formula: C17H15N3O3
SR-02136-004
MW: 309.32
(5-Benzoyl-1-methyl-1H-benzimidazol-2-yl)carbamic Acid Methyl Ester;
1-METHYL XANTHINE
CAS:6136-37-4
Formula: C6H6N4O2
SM-01389-013
MW: 166.14
3 9-Dihydro-1-methyl-
1-METHYL XANTHINE-D3
CAS:1216430-61-3
Formula: C6H3D3N4O2
SI-01389-014
MW: 169.16
3 9-Dihydro-1-(methyl-d3)-
1-METHYL-1H-BENZOTRIAZOLE-5-METHANAMINE
CAS:499770-77-3
Formula: C8H10N4
SR-02330-004
MW: 162.19
1-(1-Methyl-1H-benzotriazol-5-yl)methanamine;
1-METHYL-1H-INDOLE-3-CARBONYL CHLORIDE
CAS:126921-19-5
Formula: C10H8ClNO
SR-02449-001
MW: 193.63
1-METHYL-2-(METHYLTHIO)IMIDAZOLE
CAS:14486-52-3
Formula: C5H8N2S
SR-02200-007
MW: 128.2
1-Methyl-2-(methylthio)imidazole; 2-Methylthio-3-methylimidazole
1-METHYL-4-[5-(2-METHYLSULFAMOYLETHYL)-1H-INDOL-3-YL]PYRIDINIUM CHLORIDE(NARATRIPTAN IMPURITY)
Formula: C17H20ClN3O2S
SR-01449-006
MW: 365.88
1-METHYL-D3-INDAZOLE-3-CARBOXYLIC ACID (GRANISETRON IMPURITY D)
Formula: C9H5D3N2O2
SI-01080-006
MW: 179.19
1-Methyl-d3-1H-indazole-3-carboxylic Acid;
1-METHYLIMIDAZOLE
CAS:616-47-7
Formula: C4H6N2
SM-02200-003
MW: 82.1
1-Methyl-1H-imidazole
1-METHYLIMIDAZOLE-D3
CAS:16650-76-3
Formula: C4H3D3N2
SI-02200-004
MW: 85.12
1-(Methyl-d3)-1H-imidazole;
1-METHYLURIC ACID
CAS:708-79-2
Formula: C6H6N4O3
SM-01389-011
MW: 182.14
7 9-Dihydro-1-methyl-1H-purine-2 6 8(3H)-trione; 1-Methyl-uric Acid;
1-METHYLURIC ACID-D3
CAS:1189480-64-5
Formula: C6H3D3N4O3
SI-01389-012
MW: 185.16
7 9-Dihydro-1-(methyl-d3)-1H-purine-2 6 8(3H)-trione; 1-(Methyl-d3)uric Acid;
1-N-ETHYLGARAMINE SULFATE
CAS:864371-49-3
Formula: C15H31N3O6 ?xH2SO4
SR-02038-009
MW: 349.42
2-Deoxy-6-O-[3-deoxy-4-C-methyl-3-(methylamino)-?-L-arabinopyranosyl]-N1-ethyl-D-streptamine Sulfate Salt
1-N-UREIDO TOBRAMYCIN
Formula: C19H38N6O10
SR-02140-009
MW: 510.54
1-NITRO FEBANTEL
CAS:63470-85-9
Formula: C15H14N2O4S
SR-02280-003
MW: 318.35
2-Methoxy-N-[2-nitro-5-(phenylthio)phenyl]-acetamide
1-O-[(TERT-BUTYL)DIMETHYLSILYLOXY]-9-CARBOXYLATE- 9-TETRAHYDRO CANNABINOL
CAS:138285-38-8
Formula: C27H42O4Si
SM-01324-022
MW: 458.71
###############################################################################################################################################################################################################################################################
1-O-[(TERT-BUTYL)DIMETHYLSILYLOXY]-9-FORMYL- 9-TETRAHYDRO CANNABINOL
CAS:138285-36-6
Formula: C27H42O3Si
SM-01324-023
MW: 442.71
###############################################################################################################################################################################################################################################################
1-O-ACETYL-3 5-BIS(4-CHLOROBENZOYL)-2-DEOXY-D-RIBOSE
CAS:1207459-15-1
Formula: C21H18Cl2O7
SR-02207-009
MW: 453.27
1-Acetate 3 5-Bis(4-chlorobenzoate)-2-deoxy-D-erythro-pentofuranose;
1-O-LEVULINOYL RESVERATROL DIACETATE
CAS:861446-23-3
Formula: C23H22O7
SR-01262-022
MW: 410.42
4-Oxo-pentanoic acid 3-(Acetyloxy)-5-[(1E)-2-[4-(acetyloxy)phenyl]ethenyl]phenyl Ester
1-OXO FEXOFENADINE METHYL ESTER
CAS:154477-55-1
Formula: C33H39NO4
SR-01063-005
MW: 513.67
###############################################################################################################################################################################################################################################################
1-OXO FEXOFENADINE-D10 METHYL ESTER
Formula: C33H29D10NO4
SI-01063-006
MW: 523.73
###############################################################################################################################################################################################################################################################
1-PHENYL-1-(2-PYRIDYL)ETHANOL
CAS:19490-92-7
Formula: C13H13NO
SR-02032-003
MW: 199.25
?-Methyl-?-phenyl-2-pyridinemethanol; ?-Methyl-?-pyridylbenzyl Alcohol; NSC 28862;
1-PHENYL-1-(2-PYRIDYL)ETHANOL-D5
CAS:99430-79-2
Formula: C13H8D5NO
SR-02032-002
MW: 204.28
?-Methyl-?-phenyl-2-pyridinemethanol-d5; ?-Methyl-?-pyridylbenzyl Alcohol-d5; NSC 28862-d5;
1-PIPERIDINEETHANOL-D4
CAS:1189705-44-9
Formula: C7H11D4NO
SI-01152-019
MW: 133.22
?-Piperidinoethanol-d4; 1-(2-Hydroxyethyl)piperidine-d4; 2-(1-Piperidino)ethanol-d4; 2-(1-Piperidinyl)ethanol-d4; 2-(N-Piperidino)ethanol-d4; 2-(Piperid-1-yl)ethanol-d4;
1-PROPYL ETODOLAC
CAS:57816-83-8
Formula: C18H23NO3
SR-01058-001
MW: 301.38
1-Ethyl-1 3 4 9-tetrahydro-8-(1-methylethyl)-Pyrano[3 4-b]indole-1-acetic Acid;
1-TESTOSTERONE
CAS:65-06-5
Formula: C19H28O2
SR-01321-017
MW: 288.42
(5? 17?)-
10 -HYDROXY 4-TIBOLONE
CAS:105186-35-4
Formula: C21H28O3
SM-01383-012
MW: 328.45
(7? 17?)-
10 -HYDROXY D-(-)-NORGESTREL
CAS:21508-50-9
Formula: C21H28O3
SR-01539-016
MW: 328.45
10?-Hydroxy Levonorgestrel; (17?)-13-Ethyl-10 17-dihydroxy-18 19-dinorpregn-4-en-20-yn-3-one; 13-Ethyl-10 17-dihydroxy-18 19-dinor-17?-pregn-4-en-20-yn-3-one; Levonorgestrel Impurity I (EP)
10 -HYDROXY DEXTROMETHORPHAN HYDROCHLORIDE
CAS:1330164-12-9
Formula: C18H26ClNO2
SR-01201-012
MW: 323.86
(9S 13S 14S)
10 -HYDROXY NORETHINDRONE
CAS:1236-00-6
Formula: C20H26O3
SR-01410-003
MW: 314.42
###############################################################################################################################################################################################################################################################
10 -HYDROXYL DEXTRORPHAN 3-O- -D-GLUCURONIDE
Formula: C23H31NO8
SM-01049-012
MW: 449.49
(9? 13? 14?)-10?-Hydroxy-17-methylmorphinan-3-yl ?-D-Glucopyranosiduronic Acid
10 -HYDROXYL N-DEMETHYL DEXTRORPHAN 3-O- -D-GLUCURONIDE SODIUM SALT (>85%)
Formula: C22H28NNaO8
SM-01049-010
MW: 457.45
(9? 13? 14?)-10?-Hydroxy-morphinan-3-yl ?-D-Glucopyranosiduronic Acid Sodium Salt
10 -METHOXY-1-METHYL-9 10-DIHYDROLYSERGOL
CAS:35155-28-3
Formula: C18H24N2O2
SM-01117-001
MW: 300.4
###############################################################################################################################################################################################################################################################
10 -METHOXY-9 10-DIHYDROLYSERGOL
CAS:35121-60-9
Formula: C17H22N2O2
SM-01117-002
MW: 286.37
10-O-Methyllumilysergol; 10-Methoxydihydrolysergol; 10-O-Methyllumilysergol; 10?-Methoxy-9 10-dihydrolysergol; 10?-Methoxydihydrolysergol; 10?-Methoxylumilysergol; 8?-(Hydroxymethyl)-10?-methoxy-6-methylergoline; Luol; O10-Methyllumilysergol;
10 -PEROXY 4-TIBOLONE
CAS:105186-34-3
Formula: C21H28O4
SR-01383-009
MW: 344.44
(7? 17?)-
10 11-DEHYDRO MISOPROSTOL(MIXTURE,OF,DIASTEREOMERS)
CAS:58682-86-3
Formula: C22H36O4
SR-01110-006
MW: 364.52
(13E)-(+/-)-16-Hydroxy-16-methyl-9-oxoprosta-10 13-dien-1-oic Acid Methyl Ester;
10 11-DIHYDRO-10-HYDROXY CARBAMAZEPINE
CAS:29331-92-8
Formula: C15H14N2O2
SM-01130-001
MW: 254.28
10 11-Dihydro-10-hydroxy-5H-dibenz[b f]azepine-5-carboxamide; 10-Hydroxy-10 11-dihydrocarbamezepine; BIA 2-005; GP 47779; Licarbazepine;
10 11-DIHYDRO-10-HYDROXY CARBAMAZEPINE-D3
CAS:1189917-36-9
Formula: C15H11D3N2O2
SI-01130-003
MW: 257.3
10 11-Dihydro-10-hydroxy-5H-dibenz[b f]azepine-5-carboxamide-d3; 10-Hydroxy-10 11-dihydrocarbamezepine-d3; BIA 2-005-d3; GP 47779-d3; Licarbazepine-d3;
10 20-DI-O-METHOXYMETHYL SN-38
CAS:1246820-40-5
Formula: C26H28N2O7
SM-02130-008
MW: 480.51
10 20-Di-O-methoxymethyl-7-ethyl-10-hydroxycamptothecin; Di-MOM SN-38; (4S)-4 11-Diethyl-4 9-bis(methoxymethoxy)-1H-pyrano[3 4 :6 7]indolizino[1 2-b]quinoline-3 14(4H 12H)-dione;
10-(N-BOC-AMINO)DECANOIC ACID
CAS:173606-50-3
Formula: C15H29NO4
SR-01396-003
MW: 287.4
10-[[(1 1-Dimethylethoxy)carbonyl]amino]decanoic Acid;
10-[3-(DIMETHYLAMINO)PROPYL]- -ETHYL-10H-PHENOTHIAZINE-2-METHANOL 5-OXIDE
CAS:89453-67-8
Formula: C20H26N2O2S
SR-02127-015
MW: 358.5
2-(1-Hydroxypropyl) Promazine Sulfoxide
10-HYDROXY AMITRIPTYLINE OXALATE
Formula: C22H25NO
SM-02181-003
MW: 383.44
5-[3-(Dimethylamino)propylidene]-10 11-dihydro-
10-HYDROXY CAMPTOTHECIN
CAS:19685-09-7
Formula: C20H16N2O5
SM-02130-003
MW: 364.35
(4S)-4-Ethyl-4 9-dihydroxy-1H-pyrano[3 4 :6 7]indolizino[1 2-b]quinoline-3 14(4H 12H)-dione; (S)-10-Hydroxycamptothecin; Hydroxycamptothecin; NSC 107124; USP Irinotecan Related Compound A:
10-HYDROXY CAMPTOTHECIN-D5
Formula: C20H11D5N2O5
SI-02130-004
MW: 369.38
(4S)-4-(Ethyl-d5)-4 9-dihydroxy-1H-pyrano[3 4 :6 7]indolizino[1 2-b]quinoline-3 14(4H 12H)-dione; (S)-10-Hydroxycamptothecin-d5; Hydroxycamptothecin-d5; NSC 107124-d5;
10-HYDROXY CODEINE
CAS:1777-89-5
Formula: C18H21NO4
SR-01297-018
MW: 315.36
"(5? 6?)-7 8-Didehydro-4 5-epoxy-3-methoxy-17-methyl-morphinan-6 10-diol; 10-Hydroxy-codeine; 7 8-Didehydro-4 5?-epoxy-3-methoxy-17-methyl-morphinan-6? 10-diol; NSC 63826"
10-HYDROXY CODEINE-D3
Formula: C18H18D3NO4
SI-01297-019
MW: 318.38
"(5? 6?)-7 8-Didehydro-4 5-epoxy-3-methoxy-17-methyl-morphinan-6 10-diol-d3; 10-Hydroxy-codeine-d3; 7 8-Didehydro-4 5?-epoxy-3-methoxy-17-methyl-morphinan-6? 10-diol-d3; NSC 63826-d3"
10-HYDROXY NALTREXONE
CAS:604767-82-0
Formula: C20H23NO5
SR-01114-029
MW: 357.4
(5?)-17-(Cyclopropylmethyl)-4 5-epoxy-3 10 14-trihydroxymorphinan-6-one;
10-HYDROXY NALTREXONE METHYL ETHER
Formula: C21H25NO5
SR-01114-015
MW: 371.43
10-Hydroxynaltrexone-3-methyl Ether; (5?)-17-(Cyclopropylmethyl)-4 5-epoxy-10 14-dihydroxy-3-methoxy-morphinan-6-one;
10-HYDROXY OXYCODONE
Formula: C18H21NO5
SR-01294-009
MW: 331.36
(5?)-4 5-Epoxy-10 14-dihydroxy-3-methoxy-17-methylmorphinan-6-one; 10-Hydroxyoxycodone;
10-HYDROXY OXYCODONE-D3
Formula: C18H18D3NO5
SI-01294-010
MW: 334.38
(5?)-4 5-Epoxy-10 14-dihydroxy-3-methoxy-17-methylmorphinan-6-one-d3; 10-Hydroxyoxycodone-d3;
10-HYDROXY-9-[(DIMETHYLAMINO)METHYL]-5-ETHOXY-(20S 5RS)-CAMPTOTHECIN
CAS:504413-76-7
Formula: C25H27N3O6
SI-01247-010
MW: 465.5
(4S)-10-[(Dimethylamino)methyl]-12-ethoxy-4-ethyl-4 9-dihydroxy-1H-pyrano[3 4 :6 7]indolizino[1 2-b]quinoline-3 14(4H 12H)-dione
10-KETO DEXTROMETHORPHAN
CAS:57969-05-8
Formula: C18H23NO2
SR-01201-007
MW: 285.38
(9R 13S 14S)
10-METHOXY VINPOCETINE-D5
Formula: C23H23D5N2O3
SI-02231-006
MW: 385.51
###############################################################################################################################################################################################################################################################
10-METHYLENE N-NORDEXTROMETHORPHAN
CAS:1346599-91-4
Formula: C18H23O
SR-01201-016
MW: 269.38
10-O-ACETYL SN-38
CAS:946821-59-6
Formula: C24H22N2O6
SM-02130-009
MW: 434.44
10-Acetyloxy-7-ethylcamptothecin; 10-Hydroxy-7-ethylcamptothecin 10-Acetate; (4S)-9-(Acetyloxy)-4 11-diethyl-4-hydroxy-1H-pyrano[3 4 :6 7]indolizino[1 2-b]quinoline-3 14(4H 12H)-dione;
10-O-ACETYL SN-38-D3
Formula: C24H19D3N2O6
SI-02130-010
MW: 437.46
10-Acetyloxy-7-ethylcamptothecin-d3; (4S)-9-(Acetyloxy)-4 11-diethyl-4-hydroxy-1H-pyrano[3 4 :6 7]indolizino[1 2-b]quinoline-3 14(4H 12H)-dione-d3; 10-Hydroxy-7-ethylcamptothecin 10-Acetate-d3
10-O-METHOXYMETHYL SN-38
CAS:1246815-54-2
Formula: C24H24N2O6
SM-02130-007
MW: 436.46
7-Ethyl-10-O-methoxymethyl-10-hydroxycamptothecin; 10-Hydroxy-10-O-methoxymethyl-7-ethylcamptothecin; 10-MOM SN-38; (4S)-4 11-Diethyl-4-hydroxy-9-(methoxymethoxy)-1H-pyrano[3 4 :6 7]indolizino[1 2-b]quinoline-3 14(4H 12H)-dione;
10-OXO DOCETAXEL
CAS:167074-97-7
Formula: C43H51NO14
SR-02042-002
MW: 805.86
(?R ?S)-
10-OXO NALTREXONE
CAS:96445-13-5
Formula: C21H23NO5
SR-01114-014
MW: 369.41
10-Oxo-3-O-methylnaltrexone; 10-Ketonaltrexone-3-methyl Ether; (5?)-17-(Cyclopropylmethyl)-4 5-epoxy-14-hydroxy-3-methoxy-morphinan-6 10-dione;
10-OXODEXTRORPHAN O- -D-GLUCURONIDE
CAS:1399983-88-0
Formula: C23H29NO8
SM-01049-020
MW: 447.48
(9? 13? 14?)-17-Methyl-10-oxomorphinan-3-yl ?-D-Glucopyranosiduronic Acid
11 -HYDROXY CANRENONE
CAS:192569-17-8
Formula: C22H28O4
SM-01023-004
MW: 356.46
(11? 17?)-11 17-Dihydroxy-3-oxopregna-4 6-diene-21-carboxylic Acid
11 -HYDROXY MEXRENONE
CAS:192704-56-6
Formula: C24H32O6
SR-01323-007
MW: 416.51
"(7? 11? 17?)-11 17-Dihydroxy-3-oxopregn-4-ene-7 21-dicarboxylic Acid ?-Lactone Methyl Ester; 11? 17?-Dihydroxypregn-4-en-3-one 7? 21-dicarboxylic Acid ?-Lactone Methyl Ester; 11?-Hydroxymexrenone; "
11 -HYDROXY PROGESTERONE
CAS:80-75-1
Formula: C21H30O3
SM-02161-008
MW: 330.46
(11?)-11-Hydroxypregn-4-ene-3 20-dione; 11-Hydroxyprogesterone; 4-Pregnene-11?-ol-3 20-dione; DG 322B; NSC 3350; Pregn-4-en-11?-ol-3 20-dione; U 0384;
11 16 17 21-TETRAHYDROXYPREGNA-1 4-DIENE-3 20-DIONE
CAS:13951-70-7
Formula: C21H28O6
SM-01461-010
MW: 376.44
(11? 16?)-11 16 17 21-Tetrahydroxypregna-1 4-diene-3 20-dione; 16?-Hydroxyprednisolone;
11 16 17 21-TETRAHYDROXYPREGNA-1 4-DIENE-3 20-DIONE-D3
Formula: C21H25D3O6
SI-01461-009
MW: 379.46
(11? 16?)-11 16 17 21-Tetrahydroxypregna-1 4-diene-3 20-dione-d3; 16?-Hydroxyprednisolone-d3;
11 17-DIFUROATE MOMETASONE FUROATE
CAS:1370190-33-2
Formula: C32H32Cl2O8
SR-01498-008
MW: 615.5
(11? 16?)-9 21-Dichloro-11 17-bis[(2-furanylcarbonyl)oxy]-16-methyl-pregna-1 4-diene-3 20-dione
11-ACETOXY- 9-TETRAHYDRO CANNABINOL
CAS:26108-47-4
Formula: C23H32O4
SM-01324-015
MW: 372.5
(6aR-trans)-6a 7 10 10a-Tetrahydro-1-hydroxy-6 6-dimethyl-3-pentyl-6H-dibenzo[b d]pyran-9-methanol ?-Acetate;
11-CIS 13-CIS
CAS:3555-80-4
Formula: C20H28O2
SR-01156-006
MW: 300.44
(11-cis 13-cis)-
11-CIS-ACITRETIN
CAS:1067630-53-8
Formula: C21H26O3
SR-01508-009
MW: 326.43
(2E 4Z 6E 8E)-9-(4-methoxy-2 3 6-trimethylphenyl)-3 7-dimethyl-2 4 6 8-nonatetraenoic Acid;
11-CIS-ACITRETIN-D3
Formula: C21H23D3O3
SI-01508-010
MW: 329.45
(2E 4Z 6E 8E)-9-(4-methoxy-2 3 6-trimethylphenyl)-3 7-dimethyl-2 4 6 8-nonatetraenoic Acid-d3;
11-DEOXY CORTISOL-D7 (MAJOR)
Formula: C21H23D7O4
SI-01419-008
MW: 353.5
11-Deoxy-17-hydroxycorticosterone-d7; 17 21-Dihydroxypregn-4-en-3 20-dione-d7; 4-Pregnene-17? 21-diol-3 20-dione-d7;
11-DEOXY FUSIDIC ACID
CAS:1013937-16-0
Formula: C31H48O5
SR-02401-006
MW: 500.71
(3? 4? 8? 9? 13? 14? 16? 17Z)-16-(Acetyloxy)-3-hydroxy-29-nordammara-17(20) 24-dien-21-oic Acid;
11-DESETHYL IRINOTECAN
CAS:103816-16-6
Formula: C31H34N4O6
SR-01248-009
MW: 558.62
###############################################################################################################################################################################################################################################################
11-DESETHYL IRINOTECAN-D10
Formula: C31H24D10N4O6
SI-01248-010
MW: 568.69
###############################################################################################################################################################################################################################################################
11-DESMETHYL RIFAXIMIN
Formula: C42H49N3O11
SR-02304-003
MW: 771.85
4-Deoxy-pyridol[1? 2?-1 2]imidazo[5 4-c]rifamycin SV; 11-Desmethyl Rifamycin L 105; 11-Desmethyl Rifaxidin; 11-Desmethyl Fatroximin; 11-Desmethyl Normix; 11-Desmethyl Rifacol; 11-Desmethyl Xifaxan;
11-DESMETHYL RIFAXIMIN-D4
CAS:1316302-12-1
Formula: C42H45D4N3O11
SR-02304-004
MW: 775.88
4-Deoxy-pyridol[1? 2?-1 2]imidazo[5 4-c]rifamycin SV-d4; 11-Desmethyl Rifamycin L 105-d4; 11-Desmethyl Rifaxidin-d4; 11-Desmethyl Fatroximin-d4; 11-Desmethyl Normix-d4; 11-Desmethyl Rifacol-d4; 11-Desmethyl Xifaxan-d4;
11-ENT-MIFEPRISTONE
Formula: C29H35NO2
SR-01285-007
MW: 429.59
(11? 17?)--
11-HYDROXY DIHYDRO LORATADINE
CAS:133284-74-9
Formula: C22H25ClN2O3
SR-01093-019
MW: 400.9
4-(8-Chloro-6 11-dihydro-11-hydroxy-5H-benzo[5 6]cyclohepta[1 2-b]pyridin-11-yl)-1-piperidinecarboxylic Acid Ethyl Ester;
11-HYDROXY- 9-TETRAHYDROCANNABINOL 1-O- -GLUCURONIDE
CAS:68497-85-8
Formula: C27H38O9
SR-01324-007
MW: 506.59
###############################################################################################################################################################################################################################################################
11-HYDROXY- 9-TETRAHYDROCANNABINOL 1-O- -GLUCURONIDE-D9
Formula: C27H29D9O9
SI-01324-006
MW: 515.64
###############################################################################################################################################################################################################################################################
11-HYDROXY- 9-TETRAHYDROCANNABINOL 11-O- -GLUCURONIDE
CAS:68497-84-7
Formula: C27H38O9
SR-01324-008
MW: 506.59
###############################################################################################################################################################################################################################################################
11-HYDROXY-N-METHYL DIHYDRO LORATADINE
CAS:38089-93-9
Formula: C20H23ClN2O
SR-01093-018
MW: 342.86
8-Chloro-6 11-dihydro-11-(1-methyl-4-piperidinyl)-5H-benzo[5 6]cyclohepta[1 2-b]pyridin-11-ol;
11-HYDROXYLAURIC ACID
CAS:32459-66-8
Formula: C12H24O3
SM-01088-001
MW: 216.32
11-Hydroxydodecanoic Acid
11-KETO FUSIDIC ACID
CAS:16711-91-4
Formula: C31H46O6
SM-02401-003
MW: 514.69
(3? 4? 8? 9? 13? 14? 16? 17Z)-16-(Acetyloxy)-3-hydroxy-11-oxo-
11-KETO FUSIDIC ACID CYCLIC 3-(ETHYLENE ACETAL)
Formula: C33H48O7
SM-02401-011
MW: 556.73
11-MERCAPTOUNDECANOIC ACID-D20
CAS:170942-42-4
Formula: C11H2D20O2S
SI-01396-002
MW: 238.48
"11-Mercaptoundecanoic-2 2 3 3 4 4 5 5 6 6 7 7 8 8 9 9 10 10 11 11-d20 Acid; 11-Thioundecanoic Acid-d20; ?-Mercaptoundecanoic Acid-d20;"
11-NOR- 9-TETRAHYDRO CANNABINOL-9-CARBOXYLATE ACYL- -D-GLUCURONIDE
CAS:76448-35-6
Formula: C27H36O10
SM-01324-011
MW: 520.57
1-O-[[(6aR 10aR-6a 7 8 10a-Tetrahydro-1-hydroxy-6 6-dimethyl-3-pentyl-6H-dibenzo[b d]pyran-9-yl]carbonyl]-
11-NOR- 9-TETRAHYDRO CANNABINOL-9-CARBOXYLATE ACYL- -D-GLUCURONIDE-D9
Formula: C27H27D9O10
SI-01324-012
MW: 529.62
1-O-[[(6aR 10aR-6a 7 8 10a-Tetrahydro-1-hydroxy-6 6-dimethyl-3-pentyl-6H-dibenzo[b d]pyran-9-yl]carbonyl]-
11-NOR- 9-TETRAHYDRO CANNABINOL-9-CARBOXYLIC ACID
CAS:96912-65-1
Formula: C19H24O4
SR-01324-026
MW: 316.39
"(6aR 10aR)-6a 7 8 10a-Tetrahydro-1-hydroxy-6 6-dimethyl-3-propyl-6H-Dibenzo[b d]pyran-9-carboxylic Acid; (6aR-trans)-6a 7 8 10a-Tetrahydro-1-hydroxy-6 6-dimethyl-3-propyl-6H-Dibenzo[b d]pyran-9-carboxylic Acid "
11-NOR- 9-TETRAHYDRO CANNABINOL-9-CARBOXYLIC-D5 ACID
CAS:949596-03-6
Formula: C19H19D5O4
SI-01324-027
MW: 321.42
"(6aR 10aR)-6a 7 8 10a-Tetrahydro-1-hydroxy-6 6-dimethyl-3-propyl-6H-Dibenzo[b d]pyran-9-carboxylic-d5 Acid; (6aR-trans)-6a 7 8 10a-Tetrahydro-1-hydroxy-6 6-dimethyl-3-propyl-6H-Dibenzo[b d]pyran-9-carboxylic-d5 Acid "
11-O-TRIETHYLSILYL-16-O-TRIMETHYLSILYL (8R 11R 12R 16RS)-MISOPROSTOL-D5
Formula: C31H55D5O5Si2
SI-01110-008
MW: 574.01
(8R 11R 12R 16RS)-16-Methyl-9-oxo-11-[(triethylsilyl)oxy]-16-[(trimethylsilyl)oxy]-
11-OXO ANDROSTERONE
CAS:1231-82-9
Formula: C19H28O3
SM-02372-005
MW: 304.42
(3? 5?)-3-Hydroxyandrostane-11 17-dione; 11-Oxoandrosterone;
11-OXO FLUTICASONE PROPIONATE
CAS:1219174-94-3
Formula: C25H29F3O5S
SR-01070-012
MW: 498.55
(6? 16? 17?)-6 9-Difluoro-16-methyl-3 11-dioxo-17-(1-oxopropoxy)androsta-1 4-diene-17-carbothioic Acid S-(Fluoromethyl) Ester;
11-OXO FLUTICASONE PROPIONATE-D3
Formula: C25H26D3F3O5S
SI-01070-013
MW: 501.57
(6? 16? 17?)-6 9-Difluoro-16-methyl-3 11-dioxo-17-(1-oxopropoxy)androsta-1 4-diene-17-carbothioic Acid S-(Fluoromethyl) Ester-d3;
11-OXO-BETAMETHASONE DIPROPIONATE
CAS:64967-90-4
Formula: C28H35FO7
SR-01412-033
MW: 502.57
(16?)-9-Fluoro-16-methyl-17 21-bis(1-oxopropoxy)-pregna-1 4-diene-3 11 20-trione
12(S)-HYDROXY (5Z 8Z 10E 14Z)-EICOSATETRAENOIC ACID
CAS:54397-83-0
Formula: C20H32O3
SM-02016-012
MW: 320.47
[S-(E Z Z Z)]-12-Hydroxy-5 8 10 14-eicosatetraenoic Acid; 12-HETE; 12-Hydroxy-5 8 10 14-eicosatetraenoic Acid; 12-Hydroxyeicosatetraenoic Acid; 12-L-Hydroxy-5 8 10 14-eicosatetraenoic Acid;
12(S)-HYDROXY (5Z 8Z 10E 14Z)-EICOSATETRAENOIC ACID-D4
Formula: C20H28D4O3
SI-02016-013
MW: 324.49
[S-(E Z Z Z)]-12-Hydroxy-5 8 10 14-eicosatetraenoic Acid-d4; 12-HETE-d4; 12-Hydroxy-5 8 10 14-eicosatetraenoic Acid-d4; 12-Hydroxyeicosatetraenoic Acid-d4; 12-L-Hydroxy-5 8 10 14-eicosatetraenoic Acid-d4;
12-AMINO MINOCYCLINE
CAS:864073-42-7
Formula: C23H28N4O6
SR-01504-005
MW: 456.49
(4S 4aS 5aR 12aS)-12-Amino-4 7-bis(dimethylamino)-1 4 4a 5 5a 6 11 12a-octahydro-3 10 12a-trihydroxy-1 11-dioxo-2-naphthacenecarboxamide;
12-HYDROXY IRINOTECAN
CAS:185336-12-3
Formula: C33H38N4O7
SM-01248-005
MW: 602.68
###############################################################################################################################################################################################################################################################
12-HYDROXYLAURIC ACID
CAS:505-95-3
Formula: C12H24O3
SM-01088-005
MW: 216.32
12-Hydroxydodecanoic Acid; NSC 159293; NSC 664211; ?-Hydroxydodecanoic Acid; ?-Hydroxylauric Acid
12-HYDROXYLAURIC-D20 ACID
Formula: C12H4D20O3
SI-01088-002
MW: 236.44
12-Hydroxydodecanoic-d20 Acid; NSC 159293-d20; NSC 664211-d20; ?-Hydroxydodecanoic-d20 Acid; ?-Hydroxylauric-d20 Acid
12-O-METHYL CLARITHROMYCIN
CAS:128940-83-0
Formula: C39H71NO13
SR-01275-004
MW: 761.98
6 12-Di-O-methylerythromycin; 6 12-Di-O-methylerythromycin A; Clarithromycin EP Impurity F;
12-O-METHYL CLARITHROMYCIN-D3
Formula: C39H68D3NO13
SI-01275-005
MW: 765
6 12-Di-O-methylerythromycin-d3; 6 12-Di-O-methylerythromycin A-d3; Clarithromycin EP Impurity F-d3;
13-CIS ACITRETIN
CAS:69427-46-9
Formula: C21H26O3
SM-01508-002
MW: 326.43
9-(4-Methoxy-2 3 6-trimethylphenyl)-3 7-dimethyl-2 4 USP Acitretin Related Compound A 6 8-nonatetraenoic Acid 13-cis-Etretin Isoacitretin Isoetretin Ro 13-7652
13-CIS ACITRETIN O- -D-GLUCURONIDE
CAS:146090-81-5
Formula: C27H34O9
SR-01508-007
MW: 502.55
(Z E E E)-1-[9-(4-Methoxy-2 3 6-trimethylphenyl)-3 7-dimethyl-2 4 6 8-nonatetraenoate] ?-D-Glucopyranuronic Acid; Isoacitretin Glucuronide;
13-CIS ACITRETIN-D3
Formula: C21H23D3O3
SI-01508-001
MW: 329.45
9-(4-Methoxy-d3-2 3 6-trimethylphenyl)-3 7-dimethyl-2 4 6 8-nonatetraenoic Acid 13-cis-Etretin-d3 Isoacitretin-d3 Isoetretin-d3 Ro 13-7652-d3
13-CIS ACITRETIN-D3 O- -D-GLUCURONIDE
Formula: C27H31D3O9
SI-01508-008
MW: 505.57
(Z E E E)-1-[9-[4-(Methoxy-d3)-2 3 6-trimethylphenyl]-3 7-dimethyl-2 4 6 8-nonatetraenoate] ?-D-Glucopyranuronic Acid; Isoacitretin-d3 Glucuronide;
13-CIS-FENRETINIDE
CAS:75686-07-6
Formula: C26H33NO2
SR-02019-005
MW: 391.55
13-cis-N-(4-Hydroxyphenyl)retinamide; WH 13